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ABSTRACT 
Variability in peripheral Quantitative Computed Tomography (pQCT) 
measurement sites limits direct comparisons of results between studies. Further, it is 
unclear what estimates or surrogates of bone strength are most indicative of changes in 
fracture resistance due to aging, disease, or interventions. The purpose of this study was 
to examine the effects of age and gender on tibia morphology, and to relate indicators of 
tibia mass and shape to hip and spine areal bone mineral densities (aBMD) and bone 
mineral content (BMC) as assessed by Dual Energy X-ray Absorptiometry (DXA). 
Additional purposes of this study were to determine which tibia site or sites are most 
sensitive for detecting age, gender, or menopause-related morphology changes.  
Methods: Self-identifying Caucasian men (n=55) and women (n=59) ages 20-59 years 
had their total body, lumbar spine, and dual proximal femur aBMD and BMC measured 
with DXA (GE Lunar Prodigy).  Body composition (total and leg bone free lean body 
mass (BFLBM) and fat mass (FM)) were assessed from the total body scan. Their non-
dominant tibias were measured with pQCT (Stratec XCT 3000) at every 10% of the 
limb length from 5%-95% from distal to proximal.  Volumetric BMD, BMC, and area 
of the total, cortical and trabecular bone were determined. Also, periosteal (PeriC) and 
endosteal (EndoC) circumferences, cortical thickness (CTh), bone strength index (BSI), 
strength strain index (SSI), moments of inertia (Imax, Imin) mass ratios, and strength to 
mass ratios were quantified. General health information, menstrual history, dietary 
intake averaged over the previous year, and lifetime bone specific physical activity 
(BPAQ) were assessed by questionnaires for regression analysis.  Participants were 
grouped by decade and by gender. Results: Bone morphology and strength 
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characteristics varied along the tibia in a nonlinear fashion. There were significant 
(p<0.01) site effects for all BMC, vBMD, area, strength (SSI, Imin, Imax, SSI:Tot.BMC 
ratio), PeriC and EndoC. Total vBMD peaked at the 35%, while cortical BMC peaked 
at 55% with minimums at 5% and 85%. Total BMC, SSI, SSI:Tot.BMC ratio, and Imax 
all peaked at the 85% site. Large gender differences (21-28%) in Tot.BMC were 
paralleled by differences in Tot.Area (14-25%), due to differences in Cort.BMC and 
area (21-25%) (p<0.01). Gender differences (p<0.01) in Imax, SSI, and SSI:Tot.BMC 
ratio were smallest at the 15% sites and increased through the diaphysis. Women had 
significantly (p<0.05) greater Cort.vBMD than men. Men had significantly (p<0.01) 
greater Tot.BMC ratios at 5%:35% 5%:65%, and 5%:85%.  Site*gender interaction 
effects were significant (p<0.05) for area, BMC, circumference, and strength variables. 
CTh and total vBMD were lowest (p<0.05) in 50-59 yr group, and several trends 
(p<0.10) existed for BMC variables. EndoC was highest in the 50-59 yr group, and 
Imax was highest in the 40-49 yr group. Site*age interactions existed for Cort.vBMD, 
Tot.BMC, SSI, Imax, EndoC, and SSI:Tot.BMC. There were significant age effects for 
total vBMD and area, trabecular area, cortical area, SSI, Imax, and SSI:Tot.BMC. BMC 
ratios for 5:35% and 5:65% were highest (p<0.05) the in 20-29 yr group. Tibia total 
BMC and vBMD were moderately-to-strongly correlated with hip BMC and aBMD 
values (r = 0.31-0.76). Conclusion: Gender differences were mostly found in bone size 
variables, whereas age differences were mostly found in density and cortical thickness 
values. The magnitude of age and gender differences also varied by measurement site. 
Standardization of measurement sites is recommended for future reference database 
development and comparison.  
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CHAPTER I 
INTRODUCTION 
 Material and structural properties of bone tissue adapt in response to imposed 
strain from mechanical loading (27).  Most mechanical loading on bone comes from 
muscular contractions, and is important for the development and maintenance of bone 
strength. In addition to bone loss that occurs with aging and after menopause (67), 
research has shown that prolonged unloading of a bone results in bone content loss that 
may not completely recover once an individual has already reached their peak bone 
mass (70).  Excessive bone loss due to prolonged unloading places one at greater risk 
for osteoporosis, which is characterized by decreased bone mineral density (BMD) and 
a deterioration of microarchitecture, making bone more fragile and susceptible to 
fracture (49). 
 Osteoporosis and low bone mass is known to affect over 44 million Americans, 
and is a causal risk factor for hip and vertebral fractures (54). The incidence of fractures 
increases with age in both men and women, and the lifetime risk for osteoporotic 
fractures has reported to be comparable to or greater than getting heart disease or certain 
cancers (54). Prevention of osteoporosis to prevent fragility fractures is of interest, as 
hip fractures increase mortality risk (15). Treating osteoporotic fractures has been 
reported to cost from nearly $17 billion to over $36 billion (90). The primary measure 
for the diagnosis of osteoporosis is BMD, a surrogate of bone strength, as fracture risk 
increases up to a factor of 3 for each standard deviation decrease in BMD (39). 
However, fracture risk also increases with suboptimal bone geometry, changing 
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material properties of bone, and higher rates of bone loss that cannot be measured by a 
single BMD test (12). 
 Many aspects of bone quality and fracture risk in humans can be assessed 
noninvasively, including the mass, size, and shape of bones. Dual-Energy X-ray 
Absorptiometry (DXA) measures areal BMD (aBMD) and bone mineral content (BMC) 
in a 2-dimensional plane and is used to diagnose osteoporosis, as normative values for 
aBMD have been developed for postmenopausal women (24). Areal BMD is not a true 
bone density, as it is calculated by dividing the BMC by the bone area in the frontal 
view. The utility of DXA is limited since normative values are based primarily on 
Caucasian populations (49), many fragility fractures occur before an individual meets 
the DXA-based criteria for osteoporosis (90), and DXA is unable to measure cross-
sectional bone geometry or separate cortical and trabecular bone data to aid in the 
prediction of bone strength.  
Peripheral Quantitative Computed Tomography (pQCT) complements DXA 
because it can assess total, cortical and trabecular volumetric BMD (vBMD), mass, 
area, and tissue distribution in cross-sectional slices of long bones. This can provide 
information about resistance to fracture from bending, torsional, and compressive loads, 
and pQCT-assessed bone variables have been shown to strongly predict breaking 
strength (86).  Men typically have larger bone cross-sectional areas than women, 
providing greater resistance to fracture (59).  Gender comparisons of bone loss patterns 
appear to be age and menopausal status dependent.  Evidence suggests that men and 
premenopausal women lose trabecular bone in a similar fashion before midlife (68), but 
that at menopause, trabecular and cortical bone loss is accelerated in women. Trabecular 
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bone loss still predominates during this time, but in late menopause, total bone loss 
slows and further losses come predominantly from cortical bone. In later life in men, 
bone loss accelerates, primarily from cortical bone (67, 69).  In both men and women, 
cortical and trabecular bone losses markedly affect the structural integrity of the bone, 
and these losses can individually be detected with pQCT (22, 67). However, pQCT 
cannot be used to diagnose osteoporosis (5), since adult normative data have not been 
developed for pQCT measures, and pQCT is unable to measure the most clinically 
relevant sites (proximal femur and lumbar spine). Currently, the International Society 
for Clinical Densitometry (ISCD) Position Stand (5) reports that the distal radius can be 
used to predict hip fracture risk for postmenopausal women. However, obtaining a 
forearm scan without movement artifact can present a challenge, often requiring repeat 
scans.  
To date, there are no recommendations for using the tibia for bone health 
assessment or hip fracture risk prediction.  Given that the tibia is exposed to multiple 
modes, frequencies, durations, amplitudes and rates of mechanical loading from 
physical activities, its characteristics may be more closely related to the hip than the 
forearm.  Since it is relatively easy to obtain a tibia pQCT scan without movement 
artifact, exploring the relationships between tibia bone characteristics and hip and spine 
characteristics deserves consideration. Detecting bone loss from pathologies, aging, or 
disuse, or predicting fracture risk with the tibia will be more valuable if it is known at 
which tibia site(s) bone loss can be detected most readily, and under what bone loss 
conditions. Variability in selected tibia sites between studies can make comparison of 
results or development of screening recommendations more difficult.  Studies that 
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include more representative sites of the tibia can better define the clinical scope of the 
pQCT. Also, as the cross-sectional cortical and trabecular morphology is not 
homogeneous throughout the tibia, it is possible that a ratio or combination of tibia sites 
may be a valuable indicator of trabecular- or cortical-specific bone changes to better 
predict fracture risk, or to improve treatment strategies (14).  The purpose of this study 
was to examine the relationship of age and gender with tibia morphology, and to relate 
indicators of tibia mass and shape on hip and spine aBMD and BMC as assessed by 
DXA. Additional purposes of this study were to determine which tibia site or sites are 
most sensitive for detecting age-, gender-, or menopause-related morphology changes. 
Research Questions 
The specific research questions of this study were as follows. 
1. What relationships do age and gender have with bone mass, bone shape, and 
bone strength indicators throughout the adult tibia? 
2. What tibia site(s) and characteristics are most sensitive for detecting age-related 
differences? 
3. What tibia site(s) and characteristics are most sensitive for detecting menopause-
related differences? 
4. What are the relationships between pQCT-assessed bone mass, bone shape, and 
bone strength indicators at individual tibia sites or as ratios between multiple 
tibia sites and DXA-assessed bone mass and aBMD? 
Hypotheses 
1. I hypothesized that men would have greater periosteal circumference, cortical 
thickness, total and cortical area, total vBMD and SSI than women at any tibia 
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site and any age. With age, women would develop a greater endosteal 
circumference than men. Men and premenopausal women would have similar 
cortical vBMD, trabecular content and vBMD. Trends for increases in bone size 
would begin at age 40 for both genders, but rates of change would be more rapid 
for women.  
2. I hypothesized that sites closest to the bone ends would be most sensitive to age 
related changes. There would be decreases in cortical area and thickness, and 
decreases in trabecular content. There would be increases in total and trabecular 
bone area. SSI (measure of torsional strength at diaphyseal sites) would not 
significantly change with decreased cortical content when total bone area 
increases. The ratio of total bone mass between the 5% site and more proximal 
sites until 75% would decrease. 
3. I hypothesized that menopause-related changes would be most evident with 
trabecular content and vBMD loss in the distal and proximal tibia sites (5%, 
15%, and 95%), and cortical area and thickness loss in the diaphyseal sites. 
Also, there would be a change in the ratio of cortical content in diaphyseal sites 
to trabecular content in epiphyseal sites.  
4. I hypothesized that total BMC of a tibia slice would be the strongest predictor of 
hip aBMD and BMC variables at any given pQCT site, but correlations would 
be strongest at non-diaphyseal sites. Total area, cortical BMC and area would be 
strongly related to hip aBMD and BMC. Volumetric BMD would only be 
correlated to hip aBMD and BMC variables at the tibia 5%, 15%, 85%, and 95% 
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sites, and would not be related at sites 25-75%. Trabecular bone variables would 
not be related to hip aBMD or BMC variables at sites 35-75% 
Significance of the Study 
 The measurement of areal BMD by Dual-Energy X-Ray Absorptiometry (DXA) 
is the gold standard for the diagnosis of osteoporosis in Caucasian postmenopausal 
women (102).  However, BMD is now recognized as only one of several aspects of 
whole bone strength, including the amount, shape and architecture of the bone, and 
bone material properties (11).   Peripheral QCT is a relatively new technique which 
measures bone geometry and volumetric BMD for the total bone as well as the 
trabecular and cortical compartments of the bone, thus providing additional information 
about bone strength characteristics compared to DXA.  The significance of this study is 
helping determine age- and gender-related changes to tibia morphology that affects 
resistance to fracture, and relating these findings to DXA-measured hip and spine 
aBMD to help develop clinical utility for pQCT. 
Assumptions 
1. Subjects accurately and honestly completed all questionnaires. 
2. Questionnaires used in this study were valid and appropriate for use in this study 
population. 
3. Women accurately knew their menopausal status. 
Delimitations 
1. Bone quality findings can only be applied to healthy Caucasian men and women 
ages 20-59 years. 
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2. Findings from this study can only be applied to men and women who are not 
completely sedentary, and men and women who do not engage in more than 15 
hours of moderate to vigorous exercise per week. 
3. Subjects with amputations, cerebral vascular accidents, or knee or hip 
replacements were excluded from the study. 
4. Pregnant women were excluded from the study. 
5. Individuals taking oral contraceptives, hormone replacement therapy (androgens 
or estrogens), or medications for bone health were excluded from the study. 
Limitations 
1. Participants were healthy volunteers and thus may not be truly representative of 
the larger population.  
2. The DXA has a 300 pound weight limit, therefore participants were required to 
weigh less than 300 lbs. 
3. Since this was a cross-sectional study, previous bone health or rates of bone 
remodeling cannot be known. 
Operational Definitions 
Areal Bone Mineral Density (aBMD) - the amount of bone mineral per unit of a 2-
dimensional geometric area as measured by BMC/area (24). 
Bone Mineral Content (BMC) - the amount of mineral mass measured in a bone, bony 
area, or the body. 
Bone Remodeling Sequence - the sequence of bone renewal that consists of the 
resorption of old or damaged bone and the deposition of new bone in place where old 
bone was removed (52).  
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Bone Strength Index (BSI) - a product of squared total vBMD and area. It gives a 
measure of compressive bone strength at the metaphysis. 
Cortical Bone - compact, highly calcified (~90%) bone, predominately found on the 
diaphysis of long bones. 
Dual-Energy X-Ray Absorptiometry (DXA) - a low-voltage x-ray procedure that 
quantifies fat and bone free lean body mass, and the areal bone mineral content (g) and 
density (g/cm
2
) of the total body, lumbar spine, forearm, and proximal femur (24). 
Endosteal Circumference- internal perimeter of the cortical bone (14). 
Imax - Termed as the larger of Ix and Iy. (See Moment of Inertia of an Area) 
Imin - Termed as the smaller of Ix and Iy. (See Moment of Inertia of an Area) 
Moment of Inertia of an Area (AKA: Second Moment of an Area, Cross-Sectional 
Moment of Inertia)- With respect to an axis in the plane of the area: Ix = ʃ y
2
 dA, Iy = ʃ 
x
2
 dA, where x is the perpendicular distance from dA, an element of the area, to the y-
axis, and y is the perpendicular distance from dA to the x-axis. In this document, the 
central axes are assumed (the axes intersect at the center of mass of the object) (103). 
Osteoblast - a mononucleated cell arising from the mesenchymal stem cell lineage. Its 
function is to promote bone formation by producing type I collagen and other 
noncollagenous proteins, and assisting with the initiation of bone resorption (51). 
Osteoclast - a large, multinucleated cell arising from the hematopoietic cell lineage. Its 
function is to the resorption of bone for the purposes of bone remodeling and calcium 
homeostasis (51). 
Osteocyte - a mature bone cell that is thought to be the mechanostat, or strain sensor, of 
the bone tissue (9). 
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Osteoporosis - characterized by low bone mass and a deterioration of microarchitecture 
of bone tissue, leading to increased fragility and increased risk of fracture (51).  
Periosteal Circumference- external perimeter of the tibia cross-section (14). 
Peripheral Quantitative Computed Tomography (pQCT)- a low-voltage x-ray procedure 
that quantifies total, trabecular, and cortical volumetric bone mineral density (mg/cm
3
) 
(ToD, TrD and CoD, respectively), bone mineral content (mg/mm) (ToC, TrC, and 
CoC, respectively), bone area (mm
2
) (ToA, TrA, and CoA, respectively), moments of 
inertia (mm
3
) and resistance, and strength-strain indices (85). 
Section Modulus - Moment of Inertia of an Area divided by the maximum radius. It is a 
measure of rigidity (103). 
Strength Strain Index (SSI) - a cortical density weighted section modulus of the bone. It 
gives a measure of bending and torsional strength of diaphyseal sites.  
Trabecular Bone - also called cancellous bone; spongy bone enclosing spaces filled with 
bone marrow, blood vessels and connective tissue, and is only 15-25% calcified.  It 
fulfills primarily metabolic functions for the body (51). 
Volumetric Bone Mineral Density - the amount of bone mineral content in a 3 
dimensional volume. 
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CHAPTER II 
REVIEW OF LITERATURE 
Introduction 
The ability of bone to resist fracture is related to the geometry and structure of 
the bone, as well as the amount of bone (11, 12). Bone is an anisotropic composite 
material, organized to withstand loads that are customarily placed upon it (47). The load 
that causes bone to fracture is dependent on the bone site being tested, the magnitude of 
the load, the duration of the load, and the direction that the load is applied in reference 
to the bone site being tested (11, 51).  When the bone receives excessive loading in a 
manner that is not customary, a fracture is more likely to occur.   
Assessment of bone strength is important for identifying persons at greater risk 
of fracture and for monitoring bone health interventions and treatments.  Many 
characteristics related to bone strength can be measured by noninvasive imaging 
techniques, including with Dual Energy X-ray Absorptiometry (DXA) and peripheral 
Quantitative Computed Tomography (pQCT).  pQCT has now been used in research for 
several years to describe the effects of aging, gender, menopause, mechanical loading 
and unloading, pharmaceutical treatments, and pathologies on cortical and trabecular 
bone health.  However, pQCT still has very limited clinical utility due to the 
heterogeneity of scanning locations and analysis techniques in research, and the 
resulting lack of a reference database with which to evaluate patient results. The 
purpose of this review is to examine current findings on how pQCT-assessed bone 
characteristics, with a primary focus on the tibia, have been shown to predict failure 
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loads, and how pQCT-assessed tibia morphology is affected by aging, gender, 
menopause, and mechanical loading and unloading. The literature is presented in the 
following sections: 1. Bone Characteristics and Fracture Risk, 2. Age- and Gender-
Related Effects on Bone Characteristics, 3. Effects of Menopause on Bone Health, 4. 
Effects of Physical Activity on Bone Characteristics, and 5. Effects of Unloading on 
Bone Health. 
Bone Characteristics and Fracture Risk 
DXA has been used for many years for diagnosing osteoporosis, since areal 
bone mineral density (aBMD) is predictive of fracture risk and is used as a surrogate of 
bone strength. Areal BMD and BMC values from DXA are based on two dimensional 
imaging in the sagital or frontal planes, and can only give total aBMD and BMC values. 
DXA is unable to separate cortical and trabecular bone characteristics, limiting the 
clinician‟s ability to detect the pattern of bone loss. Bone geometry data is limited to the 
area, and DXA cannot give any indication about cross-sectional shape. Also, the weight 
limit of DXA tables limits the access to spine and hip scans for larger people.   
Separate analyses of total, cortical, and trabecular bone and information about 
bone geometry is accomplished with pQCT by imaging transverse slices of known 
thickness in the appendicular skeleton. Tibias can enter the gantry from two directions, 
allowing for heavier subjects to be scanned, requiring only a sufficiently strong chair. 
Further, pQCT scans also have a lower effective radiation dose than DXA, lowering the 
risk for children that require screening.  
The precision and accuracy of pQCT has been demonstrated in multiple studies. 
Sievanen et al. (85) reported coefficients of variation ranging from 0.5% to 7.7%, 
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depending on the variable being measured. Typically, area and strength index (which 
incorporates area) measures had greater variability than density values.  Wachter et al. 
(88, 89) showed that cancellous BMD measurement of resected femoral neck specimens 
by pQCT was more closely related (r = 0.73 - 0.82) to Young‟s modulus and strength 
determined by uniaxial compression testing than apparent trabecular thickness, 
separation or number determined by CT scans and subsequent image analysis. Cortical 
BMD measurement of resected femoral diaphysis specimens also was strongly 
correlated with yield stress (r = 0.77 for polynomial regression). Total area and 
trabecular and total bone density of the radius measured by pQCT have been reported to 
show strong agreement with CT scans (4). Ashe et al. utilized radial specimens from 
female cadavers to perform pQCT scans at the 4% and 30% sites and a DXA forearm 
scan (2). Ashe et al. then performed ashing, histomorphometry, and biomechanical 
testing of the 30% site. Total BMC of the 4% and 30% sites; cortical BMC, thickness, 
and area at the 30% sites; and 33% aBMD (DXA) all similarly predicted forearm failure 
load (r
2
 = 0.75 – 0.81). Polar strength-strain index (SSI), total and cortical vBMD were 
moderate predictors (r
2
 = 0.47-0.61) of failure load, however, total area of the 30% site 
and 4% aBMD were not effective predictors. Wilhelm et al. validated the measurement 
of SSI, a function of cortical density and bone geometry in cadaver radii, showing that 
SSI was very strongly related to failure loading in 3 and 4 point bending tests (100). 
These findings were in agreement with those of Siu et al., showing that aBMD and 
strength indices incorporating both cortical BMD and area with pQCT predicted long 
bone strength similarly, and that the strength index predicted failure better than cortical 
vBMD or area alone (86). 
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Assessment of cortical bone depends on the relationship between cortical 
thickness and scan resolution. Essentially, the cortical thickness must be consistently 
thicker than the resolution of the scan, or invalid results will be generated because of 
partial volume effects.  Each voxel (a 3-D pixel) is assigned a density value that is the 
average density within that voxel. A voxel at the border between bone and soft tissue, 
for example, may include both bone and soft tissue, but the average density will dictate 
whether that voxel will be considered bone or soft tissue during analysis.  There are 
differing amounts of cortical and trabecular bone at different sites of a long bone, 
therefore multiple sites may be needed if investigators wish to gain information about 
cortical and trabecular bone quality. Recently, Capozza et al. proposed the use of bone 
mass ratios of multiple tibia sites and “distribution/mass” curves as new indicators of 
bone health or potential diagnostic tools (14). Their study utilized a small sample in a 
narrow age range, and did not compare the measured ratios to any diagnostic criteria. 
Therefore, while their ideas have merit, more studies are needed to determine what 
normal ratios are versus what ratios could be considered pathological. 
Age- and Gender-Related Effects on Bone Characteristics 
Incidences of fragility fractures are higher in women than men, and increase 
with age for both genders (54).  Gender and age differences in fracture risk are related 
to cross-sectional bone geometry, which cannot be measured with DXA.  Center et al. 
estimated femoral neck vBMD from DXA scans by taking the measured diameter of a 
section of the femoral neck, and then assumed the femoral neck to be a cylinder to 
obtain a volume (15). This was performed to account for bone size differences between 
genders, but is limited by the assumption that bone content is uniform throughout the 
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cross-sectional slice.  In this cross-sectional study of older men and women with and 
without hip fracture (15), men in the nonfracture group had approximately 14% greater 
aBMD and almost 33% greater BMC and CSA at the femoral neck than did women. 
Gender differences in aBMD (21%), BMC (39%) and CSA (38%) were more evident in 
the hip fracture group. Women without hip fractures had greater aBMD, vBMD, BMC 
(24-29%) and CSA (6%) than women with hip fractures, and men without hip fractures 
had higher BMD and BMC (19-23%) amounts, but CSA was similar. In men, vBMD 
was more sensitive for predicting hip fracture than aBMD, but aBMD and vBMD 
sensitivity was similar in women. However, the specificity for predicting hip fracture 
was better for aBMD for both men and women.  
Studies using pQCT tibia scans have demonstrated BMC, vBMD, and area 
differences between genders and between age groups within gender. Wilks et al. found 
that at the 4% tibia site, gender differences were highest for trabecular BMC (35-41%) 
and smallest for trabecular vBMD (9-19%) (101). At the 38% tibia site, gender 
differences in cortical BMC corresponded to differences in cortical area, and there were 
no significant differences in cortical vBMD or circularity. There were, however, gender 
differences of 38-53% in torsion strength, and relative strength differences were greater 
than content and area differences. Gender differences were larger between controls than 
they were between athletic groups. 
In a study by Nieves et al. examining gender-related differences in bone 
characteristics in adolescent elite military cadets, proximal femur BMC and aBMD 
values were significantly greater in males than height- and weight-matched females, but 
lumbar spine values were not significantly different (55). Further, all total and cortical 
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bone variables of the tibia diaphysis, including vBMD, area, content, and thickness 
were 5%-14% lower in females. Endosteal circumference was the only bone quality 
variable that did not reach statistical significance. The authors did note significant 
differences in lean mass, and these differences explained part of the gender differences 
in bone parameters. 
Evans et al. (23) examined tibia 4%, 38%, and 66% characteristics in male and 
female military recruits. Area values were 21.7-25.6% smaller in women, but when 
adjusting for height and weight, area differences were reduced to 9.4-15.8%. Moments 
of inertia values were 41.5-44.6% lower in women, and were 27.4-31.2% lower after 
adjusting for height and weight. Interestingly, cortical vBMD was 2-3% higher in 
women, both before and after adjusting for body size. These results suggest that the 
distribution of the bone mass was more important for gender differences in bone 
strength than was bone mass or bone density.   
Age-related differences in tibia bone quality have been reported in young adult 
and middle-aged adults.  Sherk et al. reported that men ages 50-64 years had lower 
trabecular vBMD and tended to have lower total vBMD at the 4% tibia site than men 
ages 18-30 years (82). Total vBMD was also lower at the tibia 66% site in middle-aged 
men. Although the tibia 4% site is common for examining the epiphysis, there is 
variability in scan locations for the diaphysis, as 38%, 50%, and 66% have all be used 
by researchers. Since studies have not compared the ability to detect small bone changes 
between the diaphyseal sites, direct comparison between studies should be done with 
caution. 
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Effects of Menopause on Bone Health 
Few studies investigating the effects of menopause in the absence of co-
morbidities on tibia bone strength and morphology have been conducted using the non-
high resolution pQCT.  Some pQCT studies exclusively scanned the radius, which is 
difficult to scan without having movement artifact. The International Society for 
Clinical Densitometry Position Stand states that the radius can be used to predict hip 
fracture in postmenopausal women, but not in other populations (5). The radius is 
relatively non-weight bearing, thus it may be a poorer indicator of the ability of the 
skeleton to adapt to mechanical loading than the weight-bearing tibia.   
Peripheral QCT scanning has shown sensitivity in detecting vBMD, BMC, and 
area changes and rates of bone loss in pre, peri, and postmenopausal women, but the 
magnitude of differences can depend on scan analysis methods.  Whether a voxel is 
considered cortical bone or trabecular bone depends on the setting of density threshold.  
A higher density threshold will reduce the number of voxels that are considered cortical 
bone, but vBMD will increase simply because of the changed exclusivity of analysis. 
Hasagawa et al. reported that distal forearm vBMD (30-35%), cortical area, cortical 
thickness and moments of interia values were markedly lower in postmenopausal 
women than premenopausal women, and differences in cortical bone variables were 
much larger (58-64% lower in postmenopausal) when a higher threshold was used for 
analysis (18-37% lower in postmenopausal women for lower threshold) (30). Further, 
age-matched postmenopausal women with vertebral fracture had lower vBMD, cortical 
area, cortical thickness and moments of inertia values than postmenopausal women 
without fracture. Again, these differences were magnified when higher thresholds were 
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used. Roldan et al. found that late postmenopausal women had increased cortical 
porosity than premenopausal women by determining the proportions of the tibia slice 
within low, medium, and high vBMD thresholds (74).   
Rates of trabecular bone loss in the distal radius were similar for naturally and 
ovariectomized postmenopausal women in a study by Hernandez et al., but rates of 
cortical and total bone loss were greater in naturally postmenopausal women (33). The 
researchers did note a large heterogeneity of bone loss in both groups. Since the distal 
radius is typically used for total and trabecular bone analysis, it is unclear if rates of 
bone loss would have differed between groups at a diaphyseal site. Since neither 
Hasegawa et al. nor Hernandez et al. measured the tibia, it is not known if sites exposed 
to higher amounts of mechanical loading would have resulted in smaller group 
differences (31, 33). 
In a longitudinal study measuring spine aBMD with DXA and vBMD with QCT 
for 5 years and radius and tibia vBMD with pQCT for 4 years, perimenopausal women 
were shown to experience the most rapid losses in BMD at the spine as measured by 
QCT and DXA and linear regression analysis compared to premenopausal and late 
postmenopausal women (5.47%/yr and 2.59%/yr, respectively, vs. 2.35%/yr and 
1.51%/yr for premenopausal, and 2.24%/yr and 1.39%/yr for late postmenopausal), 
trabecular vBMD at the distal radius (4.92%/yr, vs. 1.22%/yr and 2.45%/yr) and tibia 
(6.45%/yr vs. 1.58%/yr and 1.98%/yr), and total vBMD of the tibia (5.07%/yr vs. 
2.05%/yr and 2.34%/yr at metaphysis; 3.84%/yr vs. 1.33%/yr (premenopausal) at 
diaphysis), compared to premenopausal and late postmenopausal women, based on 
linear regression analysis (36).  Measured spine BMD losses were up to 2 times greater 
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with QCT than DXA. Measured rates of trabecular bone loss were greater than rates of 
total bone loss.  Mean rates of vBMD losses in the tibia were larger than vBMD losses 
in the radius.  Bone density losses appeared higher in perimenopausal women than early 
postmenopausal women, but variability was also greater, so differences were not 
significant. Rates of BMD loss in the spine and distal radius and tibia sites were higher 
in women within the first 5 years of menopause than women more than 5 years after 
menopause (spine: 4.76%/yr (QCT) and 2.29%/yr (DXA) vs. 2.28%/yr (QCT) and 
1.37%/yr (DXA); radius and tibia: 2.74%/yr – 5.27%/yr vs. 1.58%/yr – 2.28%/yr). 
Similar findings were reported by Tsurusaki et al. (91). Similar rates of bone 
loss occurred in the tibia between premenopausal and late postmenopausal women, 
which ranged between less than ¼ to ½ the rate of bone loss in perimenopausal women. 
Strangely, although correlations between tibia pQCT variables and spinal QCT were 
stronger than correlations between radius pQCT variables and spinal QCT, odds ratios 
of radius variables for fracture risk were reported, but odds ratios for tibia variables 
were not.  It is apparent that more research is needed to determine the sensitivity of the 
pQCT for detecting rapid bone changes in the tibia specific to menopause, and relating 
the findings to predicting fracture risk.  
Effects of Physical Activity on Bone Characteristics 
Frost greatly contributed to the development of the Utah paradigm of skeletal 
physiology (27).  This paradigm can largely be considered a physiological explanation 
of Wolff‟s Law, which states that bone architecture is designed to meet the functional 
demands of the bone.  The general mechanism that allows the skeleton to detect where 
and when a bone needs more strength or has too much, based on modeling and 
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remodeling thresholds, is referred to as the mechanostat (27). Most mechanical loading 
on bone comes from muscular contractions (27), and loading varies by magnitude, rate, 
duration, and the frequency of loading. Bone adapts to a combination of these variables 
by arranging tissue in a manner that is least likely to fracture from previously 
experienced loads (24, 27, 51).  Turner proposed that to stimulate the bone modeling 
process, loads must be dynamic, be non-routine, and can be of short duration (92).  
Since the bone remodeling cycle typically takes 3-6 months to complete (52), long-term 
(12-24 months) training studies are required to detect meaningful bone changes by 
noninvasive imaging. As a result, many studies have quantified the effects of physical 
activity on bone health via regression analyses or by cross-sectional studies of athletic 
and nonathletic groups.  
Relationships between physical activity levels and aBMD and BMC may be age 
and gender-specific, as Hogstrom et al. found that total and high impact physical 
activity predicted femoral neck BMC and aBMD in men (r
2
 = 0.41-0.61), but not in 
women (35). Uusi-Rasi et al. found that physically active premenopausal women had 
6.9% higher distal tibia trabecular vBMD than postmenopausal women, and tibial shaft 
BMC, cortical area, and BSI were 5-8.6% higher in postmenopausal women (94). 
Several studies have utilized an osteogenic index (OI) of activities, which uses 
ground reaction forces, time durations, and frequency of participating in the activity, as 
a predictor of bone health (19, 57).  It has been reported that the OI of activities 
decreases with age in men. Lifetime and mid adulthood (ages 19-50 yrs) OI was 
positively associated with velocity of sound (VOS) of the heel using ultrasound, total 
and cortical area, cortical content, and polar moment of inertia using QCT with 
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differences ranging from 7-14% between the lifetime high-impact and lifetime low-
impact groups (19). There was little evidence in this study to suggest that high impact 
activities in youth was protective of bone health if later life physical activities were low-
impact, as bone characteristics in this group were not significantly different than those 
of the lifetime low-impact group. Activity levels did not predict DXA-based bone 
variables, but hip aBMD variables were highest in the lifetime high-impact group.  
The effects of physical activity on bone health can also depend on the age of 
high-impact activity participation, and whether activity levels are maintained 
throughout the lifespan or are interrupted.  In a cross-sectional study by Nilsson et al., 
young men ages 18-20 yrs who were continuously active from childhood through early 
adulthood had greater cortical area, thickness, and vBMD; trabecular vBMD; and 
periosteal circumference of the 25% tibia site compared to men who ceased to be active 
during late childhood (mean ± SD duration of inactivity: 3.4 ± 2.5 yrs) and men who 
had always inactive (57). Tibia values were significantly higher in men that ceased to be 
active compared to men that were always inactive, demonstrating lasting positive 
effects of interrupted previous physical activity during adolescence. Quantifying the 
osteogenic index of previous activities did not improve the relationship between tibia 
bone quality and previous physical activity, as they each predicted between 1.3-7.9% of 
the variability in cortical bone quality. The duration of inactivity was significantly 
negatively correlated with cortical bone variables, but was not a significant predictor of 
cortical bone variables. 
Just as high-impact activities are associated with greater BMD and BMC values, 
several studies have found that muscular power is predictive of bone strength. Ashe et 
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al. reported that muscle power predicted up to 9% of variance in bone strength indices 
at midtibia in older women (3).  Recently, Cousins et al. found that older men in the 
highest quartile of leg power had significantly (2.7-4.8%) greater total area at the distal 
tibia than all lower quartile groups (18). Further, SSI, section modulus, and cortical area 
at the 66% tibia site were 4-6% higher in men in the highest quartile of leg power than 
those in the lowest quartile. Distal tibia total area and 66% tibia cortical area and vBMD 
were also highest in men in the highest physical activity quartile. 
Direct comparisons of athletic and untrained populations have illustrated the 
effects of physical activity on bone mass, area or distribution. Higher impact activities 
and activities that resist gravity are most beneficial. Colletti et al. examined spine and 
hip aBMD in resistance-trained young adult men, and found that they had greater 
lumbar spine, femoral neck, and trochanter aBMD than controls, but radius aBMD was 
not significantly different between these two groups (17).  
Premenopausal women athletes competing in high-impact, odd-impact, and 
repetitive low-impact sports had greater SSI values at mid-tibia than controls (63). 
Cortical BMC values were 12-43% higher in athletes than controls, depending on 
athletic group or tibia section (anterior, posterior, lateral, medial). However, there were 
no significant differences in bone strength between athletic groups. As a model of high-
impact and high-magnitude loading, Heinonen et al. tested elite triple jumpers and 
compared femur and tibia bone characteristics to gender-, age-, height-, and weight-
matched controls (32). They found that cortical thickness and area percent differences 
ranged from 19-24% in the tibial diaphysis and 52-56% at the distal tibia, and total and 
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trabecular vBMD percent differences ranged from 18-41% at the tibia and femur 
epiphyseal sites.  Total area differences were usually not significant.   
Liu et al. had complementary results, as young male jumpers had significantly 
greater polar moments of intertia, and greater cortical content, area, and thickness in the 
tibia than swimmers and untrained controls (47).  Further, total area was greater in 
jumpers than controls. Bone characteristics of male swimmers were not significantly 
different from controls. Activity-based differences in bone characteristics were far more 
evident in women, as group differences in men were typically 8-10%, whereas 
differences in women ranged from 4-82%. Female jumpers had significantly lower 
cortical vBMD, but greater cortical BMC, thickness and area, total area, polar moments 
of inertia, and SSI than controls.  Further, jumpers had greater total vBMD, cortical 
BMC, thickness, and area, and polar moments of inertia than swimmers. Interestingly, 
swimmers had lower total and cortical vBMD than controls, but had greater total and 
trabecular area, polar moments of inertia, and SSI. Area was negatively correlated with 
cortical vBMD in this study. 
Wilks et al. found that race walkers, long and middle distance runners, and 
sprinters all had more favorable bone characteristics in the tibia than controls, and there 
were no significant differences between running and walking groups in bone 
characteristics (100).  Male sprinters had 6-8% greater total area and trabecular BMC, 
and 15% greater trabecular vBMD than controls at the tibia 4% site. Male long distance 
runners also had greater total area than controls. Female sprinters had 18% greater 
trabecular BMC and 13% greater trabecular vBMD than controls, and middle distance 
runners had 8% greater trabecular vBMD than controls. Activity group differences in 
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cortical BMC corresponded with group differences in area and bone strength at the 38% 
site, and differences were more evident in women than in men (4-17% greater than 
controls in men, 8-26% greater than controls in women). Interestingly, while cortical 
BMC, cortical area and bone strength increased as rates of loading increased (race 
walking to sprinting), cortical vBMD was highest in controls. Within gender, activity-
group differences in forearm bone characteristics were largely nonexistent.  
While muscular contractions may be necessary for maintenance of bone quality, 
they may not always be sufficient.  Smathers et al. showed that competitive cyclists had 
7.1% lower AP spine aBMD than age- and weight-matched untrained controls (87). 
Total hip, trochanter, and femoral neck aBMD was 1.7-4.8% lower in cyclists, and 
aBMD differences existed regardless of resistance training status. However, there was 
no significant difference in the prevalence of osteopenia or osteoporosis between 
cyclists and controls.  In a recent study by Sherk et al., resistance-trained young men 
had significantly greater lumbar spine and femoral neck aBMD than rock climbers and 
untrained controls, but there were no significant differences in any pQCT-measured 
bone characteristics in the tibia or forearm (81). This may have been a result of sample 
size, or lifetime bone loading history, as subjects were only required to be engaged in 
their activities for 1 year. 
Effects of Unloading on Bone Health 
As tibia scanning with pQCT is able to detect bone differences in activity or 
athletic groups, pQCT is also used to detect rapid bone losses from skeletal unloading. 
Modes of prolonged skeletal unloading used in research included bed rest, stroke, spinal 
cord injuries, space flight, and amputation. Bed rest studies have used varied durations 
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of unloading, but all have shown large losses in bone content. Thirty-five days of bed 
rest resulted in bone content losses of up to 3%, depending on the tibial or femur site 
examined in a study by Rittweger et al. (73). Cortical bone content losses were greater 
than trabecular bone losses, and cortical losses at the proximal tibia exceeded 15%. 
Bone cross-sectional area, endosteal circumference, and periosteal circumference did 
not greatly change during the 5 weeks of bed rest. In 2005, Rittweger et al. reported 
smaller losses in a protocol using 90 days of bed rest plus 14 days of recovery (71). 
Mean tibia BMC losses of up to 2% occurred, with the largest changes occurring at the 
epiphysis. This small mean change, however, was likely due to large intersubject 
variability. A protocol of 60 days of bed rest caused approximately 3.5-4% decreases in 
trochanter and hip aBMD in healthy women (88). Finally, simply not using a limb while 
a fracture is healing is likely to cause decreases in bone density. Veitch et al. reported 
total and trabecular vBMD losses of 18%-30% in tibiae 24 weeks post-fracture (96). 
Large decrements in tibia and femur bone mass (25-58%), total and trabecular 
vBMD (45-73%), and cortical area (28-43%) in men and women with spinal cord 
injuries have been reported (22, 72). Eser et al. have suggested that after spinal cord 
injury, bone may take up to 7 years to reach a steady state, based on exponential decay 
curves (22). Even with unilateral paralysis, bone losses are not limited to the paretic 
side. Lazoura et al. found that between 3 and 12 months post-stroke, men showed 
decreases in femoral neck and trochanter BMD of 8.3% each in the unaffected side and 
11.8% and 10.4%, respectively, for the paretic side (43).  Female stroke patients lost 
nearly 11% of BMD from the nonparetic femoral neck and trochanter and lost 
approximately 13% on the paretic side. Jorgensen et al. followed patients for one year 
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post-stroke, and found that BMC of the paretic leg decreased 7%, whereas the 
nonparetic leg decreased by 2% (38). BMC losses in the paretic leg became significant 
at 7 months post-stroke, and losses were slightly more severe in patients who did not 
learn to walk 2 months after stroke. These results are comparable to a study by Pang et 
al., where patients who were more than one year post-stroke had 3.7-4.8% difference 
between hip aBMD values (61).  
Both complete and incomplete recoveries of bone characteristics after unloading 
have been reported in literature. Spaceflight for 4-6 months resulted in femoral neck 
total, trabecular and cortical vBMD losses of 4-16.5%, cortical and total mass losses of 
11-12%, and cortical volume losses of 8%.  Total and cortical volume showed the most 
complete recovery in 12 months post-flight, with preflight to 12-month recovery ratio 
values of 0.99 and 1.05, respectively. Total and trabecular vBMD values exhibited the 
weakest recovery, with preflight to 12-month recovery ratio values of 0.91 and 0.89. 
After 12 months of recovery from spaceflight, femoral neck bending and compression 
strength estimations were 10% and 14% lower than preflight values (41). Rittweger et 
al. conducted a 1-year follow-up of their 90-day bed rest study and found that bone 
losses of the tibial diaphysis was insignificant by 6 months post bed rest, and at 1 year 
there was a significant increase in BMC (70). Losses were still statistically significant 
for the tibial epiphysis after 1 year. 
Lower limb amputations are a special case of skeletal unloading in nature, and 
the degree of bone quality losses partly depends on whether the amputation occurs 
above or below the knee. Transfemoral amputees have exhibited the largest relative 
differences between limbs, ranging from 16% to 58% differences in hip aBMD (45, 77, 
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80). When testing WWII amputee veterans with an average time since amputation of 26 
years, the affected hip had 18-25% lower aBMD than the unaffected hip (40). 
Transtibial and transfemoral results were not reported separately in that study. 
Differences in hip aBMD in transtibial amputees have been reported to be between 8-
17% (45, 76, 80). One human study in transtibial and transfemoral amputees tested 
volumetric bone characteristics of the end of the residual limb using pQCT, and found 
lower total and cortical vBMD and residual limb area, compared to a comparable slice 
on the intact limb (80). 
Summary 
 Research has shown that tibia scans with pQCT can predict failure loads, and 
has illustrated some effects of age, gender, menopause, and mechanical loading on 
bone. However, optimal pQCT scanning locations, analysis algorithms, and results 
interpretation have not been clearly established, and the clinical scope has not been 
defined.  Also, the cost of a pQCT is much greater than DXA, and current acquisition 
and analysis software for pQCT is not as user friendly as the software for DXA.  It is 
possible, however, that with continued research, pQCT tibia scanning can be optimized, 
and software can become more user-friendly as clinical use guidelines become more 
established. These advances may make assessment of bone health with pQCT a 
sufficiently highly effective technique for bone health screening for at-risk populations 
so as to rationalize its cost.   
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CHAPTER III 
METHODS 
This cross-sectional study assessed age and gender differences in bone mass, 
bone shape, and bone strength indicators throughout the adult tibia. In addition, this 
study helped to determine what tibia site(s) are most sensitive to age-related or 
menopause-related changes.  Finally, this study assessed relationships between pQCT-
assessed bone mass, bone shape, and bone strength indicators at individual tibia sites or 
as ratios between multiple tibia sites and DXA-assessed bone mineral content (BMC) 
and areal bone mineral density (aBMD). 
Participants 
 Participants for this study were Caucasian men and women ages 20-59 years 
(n=114). Fifteen subjects per gender, per decade were tested for the 20-29 year olds and 
50-59 year olds.  Also, 15 men ages 30-39, 10 men ages 40-49, 14 women ages 30-39, 
and 15 women ages 40-49 were tested.  Volunteers were recruited from the Norman and 
Oklahoma City areas. Participants read and signed a written consent form and an 
Authorization to Use or Disclose Protected Health Information form. All methods were 
approved by the University of Oklahoma Institutional Review Board. 
Inclusion Factors 
1. Participants were healthy and free of any disease or disorder known to cause 
changes in bone health. 
2. Men and women were between 20-59 years of age. 
3. Premenopausal women subjects were with regular menstrual cycles (eumenorrheic). 
4. Men and women self-identified as being Caucasian. 
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Exclusion Factors 
1. Individuals with amputations or who had had a cerebral vascular accident were not 
allowed to participate. 
2. Women who were pregnant or thought they might be pregnant were not allowed to 
participate. 
3. Women who were taking oral contraceptives, DepoProvera, or hormone replacement 
therapy were not allowed to participate. Women were also not taking any other form of 
birth control containing hormones. 
4. Men who were taking androgen replacement therapy or anabolic steroids were not 
allowed to participate. 
5. Individuals who participated in more than 15 hours of moderate to vigorous exercise 
per week were not allowed to participate. 
6. Individuals who participated in fewer than 75 minutes of moderate to vigorous 
physical activity per week were not allowed to participate. 
7. Individuals who exceeded the 300-pound weight limit were not allowed to 
participate. 
8. Individuals with any metabolic diseases known to cause significant losses of BMD 
were not allowed to participate. 
9. Individuals with a hip replacement and/or a metal device implanted in the hips were 
not allowed to participate. 
10. Individuals who were not Caucasian were not allowed to participate. 
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Research Design 
This cross-sectional study employed a mixed factorial research design with two 
group variables (gender and age decade) and one repeated measures variable (limb site). 
This study tested healthy men and women who were grouped by decade. Participants 
had their non-dominant leg scanned with pQCT at 10 cross-sectional sites, ranging from 
5% to 95% of the limb length. Also, participants had their total body, lumbar spine, and 
dual proximal femur scanned with DXA. Characteristics of the tibia were compared 
between genders, age group, and tibia site. These variables were also used to predict 
DXA-assessed aBMD and BMC values. 
Timeline of Subject Recruitment and Testing 
Subjects were recruited by flyers, mass email, and by word of mouth. They were 
screened for inclusion/exclusion criteria before making an appointment for testing.  All 
testing occurred during a single visit to the University of Oklahoma Bone Density 
Research Laboratory. 
Questionnaires 
Several questionnaires were administered to gather information regarding 
important potential confounding variables that affect bone health such as medications, 
menstrual history, and physical activity levels.  Dietary analyses were conducted to 
assess energy, calcium and vitamin D intakes.  Energy availability (difference between 
energy intake and energy expenditure) is important to consider since energy deficits 
have been shown to affect bone metabolism (96). 
The following questionnaires were used in this study.  
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1. Medical History Screening – This form was used to identify whether 
subjects met the inclusion/exclusion criteria for the study and to document 
medications taken by subjects. 
2. Bone-Specific Physical Activity Questionnaire (BPAQ) – This validated 
questionnaire was used to quantify exposure to bone-loading physical 
activities throughout the lifespan (99). 
3. Block 2005 Food Frequency Questionnaire – The 110-item questionnaire 
was analyzed for nutrient intake (calcium, phosphorous, Vitamin D) and for 
energy intake (total kcal, protein grams, % intake as protein).  This 
instrument is an updated version of the original 100-item Block Food 
Frequency Questionnaire used by the National Cancer Institute. 
4. Menstrual History (women only) – This questionnaire provided information 
about menstrual cycle characteristics, menopausal status, and previously-
used oral contraceptive or hormone replacement therapy. 
Body Weight and Height 
Body weight and height were measured during each visit to the Bone Density 
Laboratory using a wall stadiometer and a Tanita BWB-800 digital scale (Tanita 
Corporation of America, Inc., Arlington Heights, IL).   
Bone Scans 
1.  Dual-Energy X-Ray Absorptiometry (DXA) 
DXA (GE Lunar Prodigy, Prodigy enCORE software version 13.31.016, 
Madison, WI) was used to measure areal BMD (g/cm
2
) and BMC (g) of the total body, 
anterioposterior (AP) lumbar spine (L1-L4), and the dual proximal femur (femoral 
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neck, trochanter, and total hip).  Quality assurance testing (QA) was performed each 
day that scans were performed to ensure that the DXA was operating properly.  The first 
step of QA for the DXA was a scanning calibration block of known density, and a series 
of mechanical functioning tests, which the software ran automatically.  All individual 
tests must pass for the overall QA to pass.  The second step of the QA testing was 
scanning a phantom spine block of known density.  The L2-L4 density must fall within 
the predetermined range to pass.  
  For the total body scan, the participants laid supine on the DXA table with arms 
close to the sides.  Velcro straps were placed around their legs to ensure that the legs 
remained still and relaxed.  For the AP lumbar spine scan, the legs were lifted and 
supported by a foam block, such that the there was a bend in the knee, and the angle 
created by the thighs and the scanning bed was between 45-90 degrees.  The technician 
ensured that the iliac crests were even, and the lumbar spine was resting flat on the 
scanner bed.  The scanner arm was centered with the torso as marked by the 
participant‟s navel, and placed approximately 5 cm below the navel to ensure that the 
iliac crests as well as the T12 vertebra were visible on the scan.  Arms were crossed 
over the chest such that the upper arms were perpendicular to the scanner bed.  The scan 
progressed from L5 to T12 vertebrae.  Scan speeds for the total body and lumbar spine 
were determined by the measured thickness of the subject at the naval (Thick = >25 cm; 
Standard = 13 – 25 cm; and Thin  = < 13 cm). The dual femur scans were performed 
using the detail setting. Participants‟ legs were internally rotated and secured in place to 
ensure proper exposure of the femoral neck and the femur was positioned parallel to the 
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scanning boundary.  The scan began just below the pubic symphysis, centered on the 
thigh being scanned, and finished 3 to 4 sweeps above the head of the femur. 
  The in vitro precision and accuracy of the DXA GE Lunar Prodigy in the Bone 
Density Research Laboratory was 0.6% and 0.8%, respectively.  The in vivo precision 
(%CV) was less than 1% for all of the BMD sites (total body – 0.6%, AP spine – 0.9%, 
dual proximal femur – 0.4 to 0.8%).  All DXA scans were performed by the same 
qualified technician. 
2.  Peripheral Quantitative Computed Tomography (pQCT) 
A pQCT scanner XCT 3000 with software version 6.00 (Stratec Medizintechnik 
GmbH, Pforzheim, Germany) was used to measure cortical vBMD (mg/cm
3
), BMC 
(mg/mm), and area (mm
2
); trabecular vBMD (mg/cm
3
), BMC (mg/mm), and area 
(mm
2
); and total bone vBMD (mg/cm
3
), BMC (mg/mm) and area (mm
2
) at 10 sites of 
the non dominant tibia from 5-95% (distal to proximal) of the tibia length in 10% 
increments.  Compressive, bending and torsional strength was estimated from these 
scans and were represented as bone strength (BSI), strength-strain indices (SSI) (mm
3
), 
moments of inertia (Imax, Imin), and SSI:Total BMC ratios. Other variables that are 
indicative of bone size and shape that were recorded were periosteal (PeriC) (mm) and 
endosteal circumferences (EndoC) (mm), the ratio of Imax/Imin, and cortical thickness 
(CTh). Also, Total BMC ratios between 5% and 15%, 5% and 35%, 5% and 65%, and 
5% and 85% were determined, based on ratios at or near sites suggested by Capozza et 
al. (14) (5%:15%, 5%:35%), commonly used sites (5%:15%, 5%:35%, 5%:65%), or at a 
potentially new useful site (5%:85%). Total cross-sectional area (TCSA) (mm
2
), fat 
cross-sectional area (FCSA) (mm
2
), and muscle cross-sectional area (MCSA) (mm
2
) 
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were determined at the tibia 65% site. This series of scans provided representative 
sampling for the entire tibia, and took 30-45 minutes to complete. Quality assurance test 
scans were completed each testing day, where a phantom cone of known densities 
underwent a scout view scan, and a series of 4 scans that the software ran automatically.  
The densities must be within 99% accuracy in order for the quality assurance test to 
pass.  
Scan sites were determined by measuring the length of the tibia from the medial 
tibial plateau to the apex of the medial malleolus, and directing the software to measure 
at percentages of the limb length proximal to a distal reference point. To perform the 
scans, each participant was seated in the scanning chair with the limb in the support 
holders and positioned in the center of the scanning area. The participant was asked to 
remain very still.  Scans were performed as 2 sets of 5 in order to reduce the duration of 
continued stillness for the subject.  In the Bone Density Research Laboratory, the in 
vivo (%CV) precision for measuring total bone vBMD, BMC and area at the tibia 4%, 
38%, and 66% sites ranged from 0.3-1.9%.   Precision ranges for measuring vBMD, 
BMC and area variables for the trabecular and cortical compartments were 1.1-5% and 
0.5-1.7%, respectively.  All pQCT scans were performed by the same qualified 
technician.  Figure 1 shows a sample scan for all 10 sites.  
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Figure 1. Representative examples of all 10 tibia sites from 5% to 95% of the tibia 
length from distal to proximal. 
 
The Stratec software uses contour and peeling methods (modes) based on 
threshold ranges that differentiate bone from soft tissue, and then differentiates cortical 
from trabecular bone. All scans were analyzed by the same technician. Sites 15%-75% 
were analyzed using the same modes to obtain total and cortical bone characteristics.  
Since trabecular bone was visible in many participants at the 15% site, this information 
was also used at this site.  Total and trabecular bone characteristics were determined at 
the 5% and 85% sites.  Since the 85% site typically had a viable cortical shell to negate 
partial volume effects cortical characteristics were used at this site. Partial volume 
effects occur at the border between soft tissue and the cortical shell, and between 
cortical bone and trabecular bone, when a voxel contains both bone and soft tissue or 
both cortical and trabecular bone.  A voxel is given a value that is the average of all 
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density values within the voxel.  Cortical shells that are thin relative to the scan 
resolution are more prone to under or over estimations in cortical values.  The 95% 
proved to be a very unique site for assessing bone quality, as there was no cortical shell, 
and required a special set of analysis techniques.  Only trabecular vBMD was used from 
this site due to the large intersubject variability in characteristics. 
The outer threshold used for determining total bone characteristics of the 
diaphyseal sites was 710 mg/cm
3
, and the inner threshold was 480 mg/cm
3
. The 
threshold used for defining cortical bone was 710 mg/cm
3
. Contour mode 1, Peel mode 
2 and Cort Mode 2, which are all driven by user-defined thresholds, were used for these 
sites. When evaluating SSI, a cortical threshold of 480 mg/cm
3
 was used to allow 
subcortical bone to be included in the strength determination. To prevent streaking 
effects caused by analyzing bone cross-sections with a discontinuous cortical shell, the 
outer threshold used for determining total bone characteristics of the 5% and 85% sites 
was 650 mg/cm
3
, and an inner threshold of 169 mg/cm
3
. Contour mode 3 and Peel 
mode 4 were used.  The cortical threshold remained at 710 mg/cm
3
.  The thresholds 
used for the 95% site were 40 and 480 mg/cm
3
.  Contour mode 3 and peel mode 4 were 
used at this site. 
The Stratec software gave information about mass moments of inertia (I) in the 
x-y plane; however, the axes of the image were rotated with respect to the principal axes 
of the tibia slice.  To obtain the rotated Ix and Iy, the following translation was used: 
α = (tan-1 (2Ixy/(Ix-Iy)))/2 
Irotatedx = (Ix + Iy)/2 + ((Ix - Iy)/2)cos2α – Ixysin2α 
Irotatedy = (Ix + Iy)/2 - ((Ix - Iy)/2)cos2α + Ixysin2α 
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The larger value was denoted as Imax, and the smaller value was denoted as Imin.  Bone 
strength index is a compressive strength index that was calculated by two equations 
because they have been reported differently in manuals and literature: 
BSI1 = Total vBMD * Total Area
2
  
BSI2 = (Total Area * Total vBMD)
2
 
In order to segment the images into fat, muscle and bone so that the cross-
sectional areas of each can be determined, pQCT images were analyzed with the 
integrated software using median filter modes for noise suppression. The „F03F05‟ filter 
combined a 3x3 median filter with a threshold range of -500 to 500 mg/ccm with a 5x5 
median filter with a threshold range of -500 to 300 mg/ccm. Since pQCT analysis 
outputs were designed primarily for cancellous (Calcbd) and cortical (Cortbd) bone 
characterization, acquiring muscle CSA and fat CSA data from pQCT images was a 
function of two Calcbd analyses of an image using separate thresholds ranges to peel 
away fat, muscle, and bone (and marrow). Both analyses used a threshold-driven 
contour detection and peel. The segmentation threshold value range used in analysis 1 
to separate fat + marrow from muscle + bone was -100 to 40 mg/ccm, and the threshold 
value range used in analysis 2 to separate bone from muscle and marrow from fat was 
710 and 40 mg/ccm. Total area of analysis 1 represented total CSA. Muscle CSA is 
derived by subtracting the bone area of analysis 2 from muscle + bone area of analysis 
1. Fat CSA was derived by subtracting the marrow area of analysis 2 from the fat + 
marrow area of analysis 1.  
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Statistical Analyses 
Data are reported as mean ± SE for all dependent variables.  Statistical analyses 
were performed using SPSS for Windows version 18.0 (SPSS, Inc., Chicago, IL).  Four 
(decade) by two (gender) by n (site) repeated measures ANOVAs were used to detect 
significant site, age, gender, site*age, site*gender, age*gender, and site*age*gender 
effects on all tibia variables at each site.  Bonferroni post hoc tests were used for 
pairwise age-group and site comparisons when testing for main effects.  When a 
site*gender interaction was significant, independent t-tests were performed to determine 
gender differences at each site.  When a significant site*age interaction occurred, one-
way ANOVAs were used to determine age group differences at each site.  When a 
significant age*gender interaction occurred, gender differences were determined for 
each age group, and age group differences were determined within each gender.  
Specifically, total BMC, vBMD, area, and periosteal circumference were compared at 
sites 5%-85%. Trabecular BMC, vBMD and area were compared between the 5%, 15%, 
and 85% sites. Cortical BMC, vBMD, area, endosteal circumference, SSI, Imax, Imin, 
SSI:Total BMC, and cortical thickness were compared between sites 15%-85%.  The 
bone mass ratios were also compared between genders and age groups.  Four (decade) 
by two (gender) ANOVAs were used to detect significant age, gender, and age*gender 
interaction effects for the DXA aBMD and BMC variables. 
The prevalence of osteopenia and osteoporosis was determined using T-scores 
according to the World Health Organization criteria (normal, T-score ≥ –1.0; 
osteopenia, T-score –1.1 to –2.4; and osteoporosis, T-score  –2.5) using the young 
adult reference database (5, 85).  The association between age or gender group with the 
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prevalence of osteopenia or osteoporosis was determined using Chi-Square analyses. 
Gender-specific T-scores were generated for the tibia total BMC ratios based on the 20-
29 year age group.  Zero Order Pearson Product Moment Correlation Coefficients were 
used to determine relationships between dietary variables (energy intake, 
calcium/vitamin D intake), body composition, age, bone-loading physical activity 
scores from BPAQ, and the bone variables.  Significant correlates were then used as 
covariates in the previously described analyses. Also, significant correlates were used in 
stepwise linear regression with pQCT bone variables to predict DXA-derived bone 
variables. The level of significance was set at p ≤ 0.05. The assumption of sphericity 
was violated in every pQCT-related repeated measures ANOVA, so the Greenhouse-
Geisser adjustment was used to determine significance. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
The purpose of this study was to examine the effects of age and gender on tibia 
morphology, and to relate indicators of tibia mass and shape on hip and spine aBMD 
and BMC as assessed by DXA. Additional purposes of this study were to determine 
which tibia site or sites are most sensitive for detecting age, gender, or menopause-
related morphology changes.   
General Subject Characteristics 
Participants were grouped by gender and decade from 20-59 years.  There were 
15 participants each in the 20-29 (20s) men and women, 30-39 (30s) men, 40-49 (40s) 
women, and 50-59 (50s) men and women groups.  There were 14 women in the 30-39 
group, and 10 men in the 40-49 group. There were a total of 114 participants. Of the 
women participants, 32.2% (n = 19) were postmenopausal. None of the women, 
regardless of menopausal status, had taken any form of estrogen or progesterone in the 
past year, including oral contraceptives, NuvaRing, DepoProvera, Mirena IUD, 
Premarin, or other estrogen/progesterone patches or vaginal creams. Of the 
premenopausal women (n = 38), 71% (n = 27) were previous oral contraceptive users, 
and the time since last usage ranged from 1 year to 31 years.  Two women were 
perimenopausal according to self-report.  The time since menopause ranged from 1 to 
20 years, and 6 of the 19 postmenopausal women had had a hysterectomy.  Of the 
postmenopausal women, 4 were previous hormone replacement therapy (HRT) users, 
and the time since HRT use ranged from 1 year to 8 years.   
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Body Composition by DXA 
Table 1 shows the age, height, weight and body composition variables (bone-
free lean body mass (BFLBM), fat mass (FM), body fat %) of each group.  Two-way 
ANOVAs were used for age and gender with body composition variables.  As expected, 
there was a significant (p < 0.01) difference between age groups. There was not a 
significant age difference within gender groups. Men were significantly (p < 0.01) taller 
and heavier than women, and they had significantly (p < 0.01) greater total and leg 
BFLBM. There were no significant age effects for height or BFLBM, but there was a 
trend for an age effect for weight (p = 0.060).  There was a significant (p < 0.01) age 
effect for total body FM and significant age (p < 0.05) and gender (p < 0.01) effects for 
leg FM, where the 40s age group had higher fat mass values than the 20s age group, and 
women had greater leg fat mass values than men. The overall weight range for this 
study was 46.8 kg (women) -131.8 kg (men), and body fat percentage ranged from 15.3-
51.5% in women and 6.2-44.6% in men.   
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Table 1. Age and Body Composition Variables for Each Group. (Mean ± SE) 
Variable Age & 
Gender 
Group 
20-29 
M = 15 
W = 15 
30-39 
M = 15 
W = 14 
40-49 
M = 10 
W = 15 
50-59 
M = 15  
W = 15 
Age 
c 
 Men     24.3 ± 0.8     34.6 ± 0.8     46.1 ± 0.9     54.8 ± 0.8 
(yrs) Women     21.2 ± 0.3     35.3 ± 0.9    47.0 ± 0.5     55.2 ± 0.7  
Ht
a
 Men   176.9 ± 1.6   180.4 ± 1.3   177.3 ± 1.9  178.9 ± 2.2 
(cm) Women   165.2 ± 1.3   163.6 ± 2.4  164.4 ± 1.4   165.3 ± 1.6  
Wt
a
 Men     82.9 ± 4.1     91.7 ± 3.5     90.0 ± 5.9    88.1 ± 4.6 
(kg) Women     65.0 ± 3.1     69.2 ± 3.7    78.7 ± 5.7     73.1 ± 4.2  
BFLBM
a
 Men     63.5 ± 2.4     61.0 ± 1.2     60.2 ± 2.6     59.9 ± 2.1 
(kg) Women     39.8 ± 1.1     40.9 ± 1.9    44.7 ± 2.0     37.5 ± 2.9  
FM
c
 Men     16.2 ± 2.1     27.1 ± 3.0     26.3 ± 3.9    24.8 ± 2.9 
(kg) Women     21.9 ± 2.3     24.8 ± 2.5     31.7 ± 4.0     37.5 ± 2.9  
Leg Men     21.8 ± 0.9    21.2 ± 0.6    20.6 ± 1.1    20.4 ± 0.8 
BFLBM
a 
(kg) Women     13.7 ± 0.5    14.0 ± 0.7    15.3 ± 0.7    13.6 ± 0.7 
Leg Men       5.2 ± 0.7      8.8 ± 1.0      7.2 ± 1.2      6.7 ± 0.8 
FM (kg)
ad
 Women       8.6 ± 0.9    10.1 ± 1.1    12.3 ± 1.6    11.2 ± 1.3 
Total body 
fat %
ac
 
Men    19.0 ± 2.2    28.5 ± 2.4    28.1 ± 2.6    27.3 ± 1.7 
Women    33.1 ± 1.8    35.4 ± 2.3    38.1 ± 2.9    39.7 ± 2.2 
Significant gender difference 
a
 p < 0.01, 
b
 p < 0.05. Significant age effect 
c
 p<0.01 
d
 p<0.05. Ht: 
Height; Wt: Weight; BFLBM: Bone-Free Lean Body Mass; FM: Fat Mass. 
 
Physical Activity and Diet 
 Bone-specific physical activity levels throughout the lifespan were assessed by 
questionnaire and are reported in Table 2.  There were significant (p < 0.05) age and 
gender effects for past and total physical activity, where 20s were more active than 50s, 
and women were more active than men.  Age*gender interaction effects were 
significant for total physical activity (p < 0.05), but this was only a trend for past 
physical activity (p = 0.07). There were no significant group differences in current bone 
loading physical activity.  Dietary intake averaged over the previous year was assessed 
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with a food frequency questionnaire, and average daily caloric intake, absolute and 
relative protein intake, and calcium, phosphorous, and vitamin D intakes are also 
reported in Table 2.  There were significant (p < 0.01) gender differences in total intake 
and protein intake, percentage of total intake as protein, and phosphorous intake, where 
men consumed more than women.  Significant age group differences were found for 
protein (p < 0.05) and phosphorous intake (p < 0.01); both declined with age.  
Age*gender interactions (p < 0.05) were found for % of intake as protein, calcium 
intake and phosphorous intake. Calcium intake declined with age in men, and increased 
with age in women.  Almost 1/3 (37/114) of this sample had an average daily calcium 
intake below the estimated average daily requirement of 800 mg/day, and 55/114 (48%) 
had an average daily intake below the recommended dietary allowance of 1000 mg/day 
(75). Over half of the participants (64/114) had an average daily vitamin D intake below 
the estimated average requirement of 400 IU/day, and 95/114 participants were below 
the recommended dietary allowance of 600 IU/day (75). 
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Table 2. Physical Activity (PA) and Selected Dietary Intake Variables for Each 
Group. (Mean ± SE) 
Variable Age & 
Gender 
Group 
20-29 
M = 15 
W = 15 
30-39 
M = 15 
W = 14 
40-49 
M = 10 
W = 15 
50-59 
M = 15  
W = 15 
Current PA Men  4.0 ± 0.8 4.5 ± 1.6 4.3 ± 1.4 3.1 ± 1.1 
Women     11.6 ± 6.2 5.2 ± 1.1 3.8 ± 1.8 2.0 ± 0.7 
Past PA
bd
 Men   64.9 ± 10.3 69.1 ± 16.6 75.8 ± 19.8 57.5 ± 11.4 
Women   179.8 ± 33.7 125.1 ± 48.2 112.3 ± 33.9 36.0 ± 7.0 
Total PA
bdf
 Men     34.4 ± 5.2 36.8 ± 8.2 40.0 ± 10.1 30.3 ± 5.6 
Women  95.7 ± 15.7   65.2 ± 24.1 58.1 ± 17.5 19.0 ± 3.5 
Total Intake
a
 
(kcal) 
Men    2426 ± 302 1984 ± 158  1869 ± 191 1582 ± 127 
Women    1680 ± 193 1433 ± 127  1699 ± 142 1579 ± 192 
Protein
ad
 (g) Men      112 ± 16 80 ± 7 74 ± 9 64 ± 5 
Women        65 ± 8 55 ± 5 68 ± 6 59 ± 7 
% Protein
af
 Men        19 ± 1 16 ± 1 16 ± 0 16 ± 1 
Women        16 ± 0 15 ± 1 16 ± 1 15 ± 1 
Calcium
f
 (mg) Men    1432 ± 196  1021 ± 104   1137 ± 159   976 ± 122 
Women  870 ± 122  919 ± 103 1265 ± 150 1265 ± 150 
Phosphorous
acf
 
(mg) 
Men    1960 ± 272  1333 ± 117 1309 ± 149   1058 ± 84 
Women    1154 ± 137    968 ± 90   1237 ± 96 1137 ± 139 
Vitamin D 
(IU) 
Men  649 ± 267    338 ± 63 306 ± 87 413 ± 66 
Women      236 ± 51    336 ± 64 377 ± 76 387 ± 65 
Significant gender difference 
a
 p < 0.01, 
b
 p < 0.05. Significant age effect 
c
 p<0.01 
d
 p<0.05. 
Significant age*gender interaction 
e
 p < 0.01, 
f
 p < 0.01. 
 
Areal Bone Mineral Density, Bone Mineral Content, and Osteoporosis 
Classifications 
Table 3 shows the total body, lumbar spine (L1-L4) and proximal femur (total 
hip, femoral neck, trochanter) aBMD values of each group. Figure 2 shows the lumbar 
spine and proximal femur aBMD values by age group. Total body aBMD was 
significantly (p < 0.01) greater in men than women. There was also a significant          
(p < 0.05) age effect, however, there were no significant pairwise differences between 
age groups.  When correcting for BFLBM, age and gender effects for total aBMD were 
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no longer significant, but a trend (p = 0.08) appeared for age*gender interaction effects.  
Lumbar spine aBMD was not significantly different between groups.  Correcting for 
total BFLBM made the gender differences significant (Estimated means ± SE: Men: 
1.201 ± 0.024; Women: 1.289 ± 0.023, p < 0.05) and caused a trend (p = 0.096) for an 
age*gender interaction. Correcting lumbar spine aBMD for total FM caused an age 
trend to appear (p = 0.07). There were significant (p < 0.01) age and gender effects for 
all hip aBMD variables. Total hip, femoral neck, and trochanter aBMD was 7.6%, 
6.3%, and 11.5% lower, respectively, in women compared to men. Trochanter aBMD 
was only 0.4% lower in women after correcting for total BFLBM, making the gender 
difference nonsignificant. The 20s group had 10.3% and 15.2% greater trochanter 
aBMD than the 30s and 50s group, respectively, and correcting for total BFLBM 
reduced age differences to only 0.3-2.2%.  Correcting for total FM did not affect hip 
aBMD results.   
Gender differences in BMC were more pronounced, as shown in Figure 3. The 
gender effect was significant (p < 0.01) for L1-L4 lumbar spine, as values were 16% 
lower in women.  Gender effects were no longer significant when correcting for 
BFLBM, but remained significant when correcting for FM. Age and gender effects on 
total hip and femoral neck BMC were each significant (p < 0.01). In pairwise 
comparisons, the 20s group had significantly (p < 0.01) greater total hip (13.4%) and 
femoral neck (20%) BMC than the 50s group.  There was a trend (p = 0.083) for 40s to 
have greater total hip BMC than 50s.  Age differences in total hip BMC were less 
pronounced, but still significant (p < 0.05) when correcting for BFLBM, and 20s still 
had greater BMC than the 50s group.  Age differences in femoral neck BMC become 
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more pronounced after correcting for BFLBM, as there was a trend for the 20s group to 
have greater femoral neck BMC than the 30s group (p = 0.056), and the 20s group had 
significantly (p ≤ 0.05) greater BMC values than the 40s (9.4%) and 50s (16.5%) group. 
Men had 29% and 23% greater total hip and femoral neck BMC, respectively, than 
women. Correcting for BFLBM in the total hip BMC comparison resulted in the gender 
effect becoming a trend (p = 0.075), and the gender difference was reduced to 7.4%.  
When correcting for BFLBM, the gender effect on femoral neck BMC was no longer 
significant (1.5% difference), however, the age*gender interaction became a trend       
(p = 0.085). In the 30s and 50s groups, women had greater BMC values than men.  The 
total hip BMC differences between 20s and 50s were reduced to 4.8% when correcting 
for FM, but this difference was still significant (p < 0.05).  Also, the gender difference 
in total hip BMC was slightly increased to 30.4%. Correcting for FM very slightly 
increased the gender effect on femoral neck BMC, and resulted in the 20s group having 
significantly (p < 0.05) greater femoral neck BMC (11-12% greater) than all other age 
groups. Men had 48% greater trochanter BMC than women (p < 0.01), and when 
correcting for BFLBM or for FM, the gender difference remained significant (p < 0.05, 
14% and 49% greater in men, respectively). Age group effects were not significant for 
trochanter BMC, but when correcting for FM, the age effect became a trend (p = 0.088).  
Gender differences were also significant (p < 0.01) for total body BMC, and remained 
significant (p < 0.05) after correcting for BFLBM. 
Table 4 shows the prevalence of osteopenia and osteoporosis in this sample.  No 
women and only one man met the criterion for osteoporosis at any site.  At the lumbar 
spine, 23.6% of men and 5.0% of women had a T-score between -1.0 and -2.4. For the 
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hip sites, 14.5%, 25.5%, and 32.7% of men and 16.9%, 20.3%, and 23.7% met the 
criterion for osteopenia at the total hip, femoral neck, and greater trochanter, 
respectively.  Both gender and age were significantly associated with lumbar spine 
osteoporosis classification, but surprisingly, men had the higher prevalence.  There were 
no significant associations between gender and osteoporosis classification at any hip 
site.  There was a trend for significant associations with age and total hip (p = 0.088) 
and trochanter (p = 0.086) osteoporosis classification. Age was significantly (p < 0.05) 
associated with femoral neck osteoporosis classification. 
Table 3. Areal Bone Mineral Density (aBMD) of the Total Body, AP Lumbar 
Spine, and Proximal Femur (Total Hip, Femoral Neck, Trochanter). (Mean ± SE) 
aBMD 
(g/cm
2
) 
Age & 
Gender 
Group 
20-29 
M = 15 
W = 15 
30-39 
M = 15 
W = 14 
40-49 
M = 10 
W = 15 
50-59 
M = 15  
W = 15 
Total Body Men  1.319 ± 0.017 1.271 ± 0.028 1.322 ± 0.036 1.232 ± 0.022 
Women  1.187 ± 0.019 1.203 ± 0.020 1.194 ± 0.016 1.164 ± 0.022 
L1-L4  
Lumbar Spine 
Men  1.293 ± 0.024 1.206 ± 0.043 1.285 ± 0.063 1.215 ± 0.038 
Women  1.245 ± 0.025 1.305 ± 0.032 1.238 ± 0.026 1.184 ± 0.035 
Total Hip
ac
 Men  1.244 ± 0.038 1.076 ± 0.044 1.143 ± 0.045 1.029 ± 0.028 
Women  1.086 ± 0.038 1.057 ± 0.030 1.036 ± 0.025 0.968 ± 0.028 
Femoral 
Neck
ac 
 
Men  1.240 ± 0.044 1.065 ± 0.043 1.081 ± 0.043 0.969 ± 0.024 
Women  1.103 ± 0.038 1.047 ± 0.036 0.989 ± 0.023 0.945 ± 0.026 
Trochanter
ac 
(20s>30s, 50s) 
Men  1.027 ± 0.034 0.877 ± 0.040 0.963 ± 0.047 0.857 ± 0.762 
Women  0.856 ± 0.034 0.830 ± 0.028 0.821 ± 0.026 0.779 ± 0.024 
Significant gender difference 
a
 p < 0.01, 
b
 p < 0.05. Significant age effect 
c
 p<0.01 
d
 p<0.05. 20s: 
20-29 age group; 30s: 30-39 age group; 40s: 40-49 age group; 50s: 50-59 age group. 
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Figure 2. Lumbar Spine and Proximal Femur Areal Bone Mineral Density (aBMD) by Age 
Group. (Mean ± SE). *p < 0.01, *p < 0.05: Significantly different from 20-29 group. 
#
p < 0.05: 
Significantly different from 30-39 group. 
 
Figure 3. Bone Mineral Content of the Lumbar Spine (L1-L4) and Proximal Femur for Each 
Group. Mean ± SE. *p < 0.01: Gender effect significant at all sites.  †p < 0.05: 20s > 50s at 
Femoral Neck. 
 
* 
* 
* 
*† 
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Table 4. Prevalence of Normal/Osteopenia/Osteoporosis at the Lumbar Spine and 
Proximal Femur. (Mean ± SE) 
Age 
Group 
Gender Group L1-L4
ab
 Total Hip Femoral 
Neck
a
 
Trochanter 
20-29 Men (n = 15) 15/0/0 15/0/0 14/1/0 14/1/0 
 Women (n = 15) 15/0/0 12/3/0 13/2/0 11/4/0 
30-39 Men (n = 15) 9/6/0 13/2/0 11/4/0 6/9/0 
 Women (n = 14) 14/0/0 12/2/0 13/1/0 13/1/0 
40-49 Men (n = 10) 7/3/0 9/1/0 7/3/0 8/2/0 
 Women (n = 15) 15/0/0 14/1/0 13/2/0 13/2/0 
50-59 Men (n = 15) 11/4/0 10/5/0 9/6/0 8/6/1 
 Women (n = 15) 12/3/0 11/4/0 8/7/0 8/7/0 
a
p < 0.05 Significant association for age group and bone health status 
b
p < 0.01 Significant 
association for gender and bone health status. 
 
Soft Tissue Measurements by pQCT 
 Soft tissue comparisons were also made using pQCT. Total (TCSA), fat 
(FCSA), and muscle (MCSA) cross-sectional areas were determined at the 65% tibia 
site, and group values are reported in Table 5. There was no significant age or 
age*gender interaction for TCSA, and there was only a trend (p = 0.099) for a gender 
effect. There were significant (p ≤ 0.05) age and gender effects for FCSA, as women 
had greater FCSA values, and there was a trend (p = 0.057) for 20s to have lower FCSA 
than 40s. Men had significantly (p < 0.01) greater MCSA than women. 
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Table 5. Total (TCSA), Fat (FCSA) and Muscle (MCSA) of the Calf Muscles. 
(Mean ± SE) 
Age Gender TCSA (mm
2
) FCSA (mm
2
)
ab
 MCSA (mm
2
)
a
 
20-29 Men (n = 15) 11111.7 ± 360.8 1314.9 ± 163.2 9101.4 ± 360.6 
 Women (n = 15) 10302.2 ± 562.2 2788.0 ± 282.2 6988.6 ± 327.5 
30-39 Men (n = 15) 11937.0 ± 557.3 2196.1 ± 291.4 8985.2 ± 311.3 
 Women (n = 14) 10669.9 ± 562.4 3095.2 ± 344.8 6996.7 ± 282.1 
40-49 Men (n = 10) 11945.2 ± 496.3 1741.7 ± 276.0 9462.2 ± 329.4 
 Women (n = 15) 12353.8 ± 809.8 4172.6 ± 585.1 7609.7 ± 291.8 
50-59 Men (n = 15) 11441.7 ± 490.0 1534.3 ± 169.7 9154.3 ± 388.3 
 Women (n = 15) 10628.7 ± 548.9 3080.2 ± 305.7 7011.2 ± 341.4 
a
p < 0.01 Significant gender effect. 
b
p < 0.05 Significant age effect. 
Bone Characteristics by pQCT 
Figures 4 and 5 present the total BMC and area values for each age and gender 
group at each site, respectively. Total BMC values along the tibia uniquely exhibited a 
quintic form. The lowest values were at the 15% site, and the highest values were at the 
85% site. There were significant site, site*gender, site*age, and gender effects, and 
there was a trend for a significant age effect.  The 55%, 65%, and 75% sites were not 
significantly different from each other.  Total BMC was 21-27.9% lower in women than 
men, with the largest difference occurring at the 5% site and the smallest difference at 
the 75% site. All sites were significant for gender.  Age was only significant at the 85% 
site, but pairwise comparisons did not find significant differences between decades.  
Means were highest in the 20s group at the 5% and 85% sites. 30s and 40s groups were 
within 2.5% of each other at all sites (within 1% at 15-75) and were same or greater 
than 20s at 15-75. 35% was 5.4% higher in 40 yr olds and 40s were 7.5% higher than 
50s at this site.  When correcting for total BFLBM, the site*gender interaction was no 
longer significant, and the age trend was lost.  A trend (p = 0.094) for a site*age*gender 
interaction appeared, in that gender differences appeared to be greatest in 40s, which 
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varied by site.  This is potentially because women appeared to be similar between 20s 
and 30s, then lower in 40s, and then 40s were similar to 50s. In men, there were 
increases until 40s, then values were lower in 50s. However, these findings were not 
significant. When correcting for total FM, age became significant (p < 0.05), with 20s 
having higher values than 50s, and again the 5% and 85% sites had the most marked 
declines. 
For total area, there were significant (p < 0.05) site, site*gender, gender, and age 
effects.  Total area was not significantly different between the 15% and 45% sites, but 
all other sites were different.  Gender differences were significant at every site, and 
ranged from 14.4% (at 5%) to 24.6% (at 35%) lower in women.  Total area was 3.3% 
(at 55%)-23.4% (at 15%) lower in 20s than 30s, and this difference was significant (p < 
0.05). When correcting for BFLBM, the gender*site interaction was lost. The 
significant age effect was lost when correcting for FM. 
 
Figure 4. Total BMC at Each Tibia Site from 5% to 85% of the Limb Length. Mean ± SE. *p < 
0.01; Gender effect significant at all sites. †p < 0.05 Significant age effect. Sites 55%-75% were 
similar (p > 0.05) to each other. 
* 
† 
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Figure 5. Total Bone Area at Each Tibia Site from 5% to 85% of the Limb Length. Mean ± SE. 
*p < 0.01 (0.05 at 5% site); Gender significant at all sites.  Trend for age effect at sites 5% (p = 
0.075) and 15% (p = 0.064). 15% site similar to 45% site. 
 
Figures 6 and 7 present the cortical BMC and area values for each age and 
gender group at each site, respectively. Unlike the relationship between the total BMC 
and area curves, the shape of the cortical area curve along the tibia strongly resembled 
the cortical BMC curve.  There were significant (p < 0.01) site, site*gender interaction, 
and gender effects, and there was a trend for the age effect. Cortical BMC peaked at the 
55% site, was lowest at the 15% site, and the shape of the curve appeared to take on a 
quadratic form. The only sites that were not significantly different from each other were 
35% versus 75% and 45% versus 65%.  Gender differences were significant at all sites, 
and cortical BMC was 21.3-24.6% lower in women. Gender differences were larger at 
the tibia ends (15%, 85%).  The site*gender interaction was no longer significant when 
BFLBM was used as a covariate, and the age trend was lost. Interestingly, the age effect 
* 
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became significant when FM was used as a covariate, but pairwise comparisons were 
not significant. 
For cortical area, there were significant (p < 0.01) site, site*gender interaction, 
and gender effects, and there was a trend (p = 0.097) for an age effect. The 25% site 
was not significantly different from the 85% site, and the 55% site was not significantly 
different from the 65% site. All other sites were significantly different.  Cortical area 
peaked at the 55% and 65% sites. Cortical area was 23-25.6% lower in women, and this 
range was consistent throughout the tibia.  When correcting for BFLBM, the 
site*gender interaction and age trend were lost. When correcting for FM, age became 
significant (p < 0.05), but pairwise comparisons were not significant. 
 
Figure 6. Cortical BMC at Each Tibia Site from 5% to 85% of the Limb Length. Mean ± SE. * 
p < 0.01; Gender effect significant at all sites. Similar sites were 35% and 75%, and 45% and 
65%. 
* 
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Figure 7. Cortical Bone Area at Each Tibia Site from 15% to 85% of the Limb Length. Mean ± 
SE. *p < 0.01; Gender effect significant at all sites. 25% site was similar to the 85% site, and 
55% site was similar to 65% site. 
 
Figures 8 and 9 show the total and cortical volumetric BMD (vBMD) at each 
site.  There were significant (p < 0.05) site, gender*site, age*site, and age effects for 
Total vBMD.  Total vBMD values along the tibia also appeared to take on somewhat of 
a quadratic pattern, and values peaked at the 35% site. The 25% and 55% sites were the 
only sites that were not significant from each other.  Gender differences in total vBMD 
ranged from being 9.9% lower in women at the 5% site to 1.2% higher in women at the 
45% site.  Women had greater vBMD than men from the 35%-65% sites, but these 
differences were not significant. Gender differences were significant at the 5%, 15%, 
and 85% sites, and there was a trend at the 25% site.  Subjects in the 20s group had 
significantly greater total vBMD than 50s, and there was a trend for 40s to have greater 
total vBMD than 50s (3.3-7.2% lower).  Total vBMD values were 5.4-17.2% lower in 
* 
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50-somethings than 20-somethings, and differences were highest at the 5%, 15%, 75%, 
and 85% sites.  
Significant (p < 0.01) site, site*age, and gender effects, and a trend (p = 0.083) 
for site*gender existed for cortical vBMD.  Cortical vBMD very gradually increased as 
the site became more distal, peaking at the 25% site.  The 15% site was not significantly 
different from the 65% site, and the 25% was not significantly different from the 35% 
site.  There was a trend for age at the 25% site, and age groups were within 2% of each 
other at all sites. Cortical vBMD values were 0.9-2.0% higher in women, and this was 
significant at sites 25%-75%. There was a trend (p = 0.052) for a gender difference at 
the 85% site. When correcting for BFLBM, the site*gender interaction trend 
disappeared, but when correcting for FM, site*gender became significant, as gender 
effects were significant (p < 0.05) at all sites except for the 15% site. 
 
Figure 8. Total Volumetric Bone Mineral Density (vBMD) at Each Tibia Site from 5% to 85% 
of the Limb Length. Mean ± SE. †p < 0.01 (p < 0.05 at 25%); Age effect significant at all sites. 
*p < 0.01; **p < 0.05; Significant gender effect. 25% site similar (p > 0.05) to 55% site. 
* 
* 
** 
† 
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Figure 9. Cortical Volumetric Bone Mineral Density (vBMD) at Each Tibia Site from 15% to 
85% of the Limb Length. Mean ± SE. *p < 0.01; Gender effects were significant at sites 25%-
75%. Trend for gender at 85% (p = 0.052). Similar sites were 15% to 65%, and 25% to 35%. 
 
Figures 10, 11, and 12 show trabecular BMC, area, and vBMD values for each 
group at the 5%, 15%, and 85% sites.  There were significant (p < 0.01) site and gender 
effects, site*gender*age interaction and a trend for an age effect (p = 0.08) and a 
site*gender interaction (p = 0.06) effect for trabecular BMC.  Trabecular BMC values 
were highest at the 5% site and lowest at the 15% site.  Male trabecular BMC values 
were 17.7-24.7% higher than women values overall.  At the 5% site, gender differences 
were largest in the 20s (41% lower in women), and smallest in the 50s (10.8% lower in 
women.)  At the 15% site, 20s and 30s women had 117.5% and 7.9% higher trabecular 
BMC values, whereas 40s and 50s women had 52.3% and 59.7% lower trabecular BMC 
values.  Finally, at the 85% site, 20s women had 5.1% higher values than men, but 30s, 
40s, and 50s women had 11.3%, 42.5%, and 40.1% lower values than men. Correcting 
* 
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for BFLBM eliminated the site*gender interaction trend and the site effect, but made 
the age effect significant (p < 0.05), with 50s having lower values than 20s.  Correcting 
for FM made the site*gender interactions and age effect significant (p < 0.05). In this 
analysis, 50s had lower values than 20s and 30s, and gender effects were much greater 
at the 5% and 85% sites than the 15% site.   
There were significant (p < 0.05) site and age*gender interaction effects for 
trabecular vBMD.  Trabecular vBMD was 40%, 136%, and 73% higher in 20s women 
than 20s men at the 5%, 15%, and 85% sites, respectively. It was 34%, 38%, and 52% 
higher in 30s women than 30s men, but it was 26%, 42%, and 56% lower in 40s women 
than 40s men, and 32%, 58%, and 53% lower in 50s women than 50s men.  Also, while 
trabecular vBMD in women was highest in the 20s age group, it was highest in the 40s 
age group in men.  At the 5% site, 20s women had significantly (p < 0.05) greater 
trabecular vBMD values than 50s women, and at the 85% site, 20s women were 
significantly (p < 0.05) greater than 40s and 50s women. The age*gender interaction 
effect remained significant when correcting for BFLBM, but the site effect was no 
longer significant. Correcting for FM did not affect the trabecular vBMD results.   
Site, gender, age, and site*gender interaction effects were significant (p < 0.05) 
for trabecular area.  Correcting for BFLBM eliminated the site*gender interaction and 
the gender effect, but correcting for fat mass did not affect the trabecular area results. 
The 15% tibia site was significantly lower than the 5% and 85% sites, but 5% and 85% 
sites were not significantly different.  Men had 11.7-16.7% greater trabecular bone area 
than women at all 3 sites (p < 0.05), and the largest difference was at the 85% site.  The 
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30s group had significantly (12.3-27.7%) greater trabecular area than the 20s group     
(p < 0.01). 
 
Figure 10. Trabecular Bone Mineral Content (BMC) of the 5%, 15%, and 85% sites. Mean ± 
SE.  Significant site, gender, and site*gender*age effect (p < 0.01). All sites are significantly 
different. * p < 0.01 Gender effect. † p < 0.05; 20-29 group different from 50-59 group in men. 
# p < 0.05; 20-29 group different from 40-49 and 50-59 groups in women. 
 
 
†* 
#* 
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Figure 11. Trabecular Volumetric Bone Mineral Density of the 5%, 15%, and 85% Sites. Mean 
± SE. Significant site and age*gender interaction effects, p < 0.05. 5% significantly (p < 0.01) 
different than 15% and 85%. # p < 0.05 Significant difference between 20-29 group and 50-59 
group in women. ‡ p < 0.05 Significant difference between 20-29 group and 40-49 group in 
women. 
 
Figure 12. Trabecular Area of the 5%, 15% and 85% Sites. Mean ± SE. Significant site, gender, 
age, and site*gender interaction effects. 15% site is significantly different from 5% and 85% (p 
< 0.01).  * p < 0.01, ** p < 0.05 Gender significant at all sites. † p < 0.01 30s age group > 20s 
age group.  
# ‡
# 
**
† 
*
* 
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Total BMC ratios of 5%:15%, 5%:35%, 5%:65%, and 5%:85% were calculated 
to evaluate trabecular-to-cortical bone proportions within the tibia, and are displayed in 
Table 6. The total BMC 5%:15% ratio was highest, whereas the 5%:85% ratio was 
lowest. The 5%:15% ratio only showed a trend (p = 0.071) for a gender effect.  For the 
5%:35% ratio, there was a significant (p < 0.05) age and gender effect, and a trend (p = 
0.078) for an age*gender interaction effect.  Men had 5.4% higher values than women. 
Significant age group differences for the 5:35% ratio were between 20s and 30s (11.1% 
lower in 30s), 20s and 40s (8.1% lower in 40s), and a trend (p = 0.051) for 20s and 50s 
(8% lower in 50s). The 5%:65% ratio had a significant (p < 0.01) age and gender effect. 
For this ratio, 20s were significantly greater than 30s (7.9%, p < 0.05) and 50s (8.7%, p 
< 0.01). Men had 8% higher values than women. Finally, the 5%:85% ratio had a 
significant (p < 0.01) gender effect, where men had 5% greater values.  T-scores for the 
5%:35% and 5%:65% total BMC ratios were generated for each gender, based on the 
20s age group.  They were significantly correlated (r = 0.24-0.27, p<0.05) with hip T-
scores. Means, SD, and SE for the pQCT results are shown in tabular form in 
APPENDIX D. 
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Table 6. Total BMC Ratios between Tibia Sites. (Mean ± SE) 
  Total BMC Ratio 
Age Gender 5%:15% 5%:35%
b
 5%:65%
a
 5%:85%
a
 
20-29 Men (n = 15) 1.34 ± 0.04 1.02 ± 0.03 0.87 ± 0.02 0.75 ± 0.02 
 Women (n = 15) 1.20 ± 0.02 0.91 ± 0.03 0.79 ± 0.02 0.70 ± 0.02 
30-39
de
 Men (n = 15) 1.24 ± 0.02 0.90 ± 0.02 0.80 ± 0.01 0.76 ± 0.02 
 Women (n = 14) 1.16 ± 0.02 0.84 ± 0.02 0.73 ± 0.02 0.69 ± 0.01 
40-49
c
 Men (n = 10) 1.23 ± 0.03 0.92 ± 0.02 0.83 ± 0.02 0.86 ± 0.05 
 Women (n = 15) 1.26 ± 0.09 0.86 ± 0.02 0.75 ± 0.02 0.73 ± 0.01 
50-59
f
 Men (n = 15) 1.21 ± 0.02 0.89 ± 0.02 0.79 ± 0.02 0.77 ± 0.02 
 Women (n = 15) 1.18 ± 0.03 0.91 ± 0.04 0.74 ± 0.02 0.74 ± 0.02 
a
p < 0.01, 
b
p < 0.05 Significant gender effect. 
c
p < 0.01, 
d
p < 0.05 Significantly lower than 20-29 
group for 5%:35%. 
e
p < 0.01, 
f
p < 0.05 Significantly lower than 20-29 group for 5%:65%. 
 
 Differences in content and area values can be thought to affect periosteal and 
endosteal circumferences, and as a result cortical thickness. Figure 13 presents the 
periosteal circumferences (PeriC) from 5% to 85%, and Figures 14 and 15 show the 
endosteal circumferences (EndoC) and cortical thickness values from 15% to 85% of 
the tibia length, respectively.  There were significant (p < 0.01) site, site*gender, gender 
effects for PeriC, and there was a trend for a site*age interaction (p = 0.055). Only sites 
25% vs. 55% were not significantly different from each other. Men had 9.7-13.0% 
higher PeriC values than women, and gender effects were significant at all sites.  
Correcting for BFLBM made the site*gender interaction nonsignificant, and made the 
site*age and age*gender interactions significant (p < 0.05). In this analysis, PeriC 
appeared to peak in 30s, with a trend for 30s > 20s.  The gender effect was <1% in 20s, 
but was approximately 6%, 7%, and 4.5% in 30s, 40s, and 50s.  The age effect became 
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a trend (p = 0.057) after correcting for BFLBM.  Correcting for FM also made the 
site*age interaction significant (p < 0.05). 
 Site, site*age, site*gender, age, and gender effects were all significant (p < 0.05) 
for EndoC. All sites were significantly different from each other (p < 0.01, except 25% 
vs. 45%, p < 0.05).  Twenties had 4.1-8.7% and 1.8-13.1% lower EndoC values than 
30s and 50s, respectively (p < 0.05).  The difference between 20s and 30s peaked at the 
55% site, and the peak difference between 20s and 50s was at 35% site.  Differences 
between 20s and 30s were smaller at more distal sites, whereas the smallest difference 
between 20s and 50s was at the 85% site.  Age differences were significant (p < 0.05) at 
sites 25%, 35%, and 55%-85%, and a trend (p < 0.10) existed at sites 15% and 45%. 
Women had 6.5-12.0% lower EndoC values than men, and the largest differences were 
closest to the midshaft, but differences were significant at all sites. Site*gender 
interaction and gender effects were not significant for EndoC after correcting for 
BFLBM, however, site*age*gender became significant (p < 0.05).  Correcting for FM 
did not affect the EndoC results. 
 Cortical thickness had significant (p < 0.01) site, site*gender, age, and gender 
effects. There was a trend (p = 0.067) for a difference between the 35% and 55% sites, 
but all other sites were significantly different from each other.  The 50s group had 
significantly (p < 0.05) lower values than all other age groups.  The age effect was 
significant (p < 0.05) at sites 35%-55%, and there was a trend (p < 0.10) for the age 
effect at sites 25%, 65%, and 75%.  Gender differences were significant (p < 0.01) at all 
sites.  Site*gender effects were no longer significant after using BFLBM as a covariate. 
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Figure 13. Periosteal Circumference at Each Tibia Site from 5% to 85% of the Limb Length. 
Mean ± SE. Significant (p < 0.01) site, site*gender, gender effects. Only sites 25% vs 55% were 
not significantly different from each other. *p < 0.01 Gender effect significant at all sites.  
 
Figure 14. Endosteal Circumference at Each Tibia Site from 15% to 85% of the Limb Length. 
Mean ± SE. p < 0.05 Significant site, site*age, site*gender, age, and gender effects. p < 0.01 
(except 25% vs. 45%, p < 0.05) All sites were significantly different from each other.  *p < 0.01 
Gender effect significant at all sites. †p<0.05 Significant age effect. 
* 
* 
† † 
63 
 
 
Figure 15. Cortical Thickness at Each Tibia Site from 15% to 85% of the Limb Length. Mean ± 
SE. Significant (p < 0.01) site, site*gender, age, and gender effects.  Trend (p=0.067) for a 
difference between the 35% and 55% sites. All other sites significantly different from each 
other.  †p < 0.05: Age effect. *p < 0.01: Gender effect significant at all sites. 
 
 The 95% tibia site was drastically different from all other tibia sites in terms of 
shape and the relative make up of cortical and trabecular bone.  There was no cortical 
shell as this site, and for many subjects, portions of the epicondyle appeared.  This may 
have been a result of normal variations in the shape of the tibial plateau or epicondyles, 
or it may be been indicative of arthritic changes. Positioning error may have also played 
a larger role at this site than for other sites.  For some subjects, tibia length required that 
the 95% site be measured separately, with the entire set-up being shifted to allow the 
gantry to access the site. In these instances, scout views could not be used.  For some 
subjects, obtaining a 95% measure was not possible due to holder limits on thigh size.  
Due to these measurement issues, only trabecular vBMD values were used from this site 
and were not compared to other trabecular rich sites.  Table 7 shows the trabecular 
* 
† 
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vBMD values for each group.  The 20s group had significantly (p < 0.01) greater values 
than all other group.  There was also a significant (p < 0.01) age*gender interaction 
effect, as the gender difference was not significant for the 20s and 30s groups, but 40s 
men had significantly greater trabecular vBMD values than 40s women, and 50s women 
had higher values than 50s men. 
Table 7. Trabecular Volumetric Bone Mineral Density (vBMD) (mg/cm3) at the 
Tibia 95% Site for Each Group (Mean ± SE). 
Age & Gender 
Group 
20-29† 
M = 14 
W = 15 
30-39 
M = 15 
W = 13 
40-49 
M = 9 
W = 12 
50-59 
M = 13 
W = 14 
Men 242.71 ± 6.65 209.35 ± 8.20 236.36 ± 12.58 178.02 ± 6.13 
Women 240.59 ± 7.61 214.37 ± 10.54 193.53 ± 10.01 210.09 ± 9.36 
†p < 0.01 Significant age effect, 20s > all other groups.  p < 0.01 Significant age*gender 
interaction effect. 
 
Possible Effects of Menopause on Bone Variables 
 Although there was generally a lack of age*gender interaction effects, secondary 
analyses were performed to determine if correcting for age resulted in differences in 
bone characteristics between pre- and postmenopausal women.  There were no 
significant differences in DXA aBMD or BMC values between menopausal groups that 
were distinct from age differences. Also, there were no significant differences between 
menopause groups for total area, PeriC, EndoC, cortical vBMD, area, or thickness, 
trabecular BMC, vBMD, or area, or any strength estimates.  There were significant (p < 
0.05) site*menopause interaction effects for total BMC and vBMD, and there was a 
trend (p = 0.061) for an interaction effect for cortical BMC.  Group differences in total 
BMC after correcting for age ranged from <1% to 9.6%.  Group differences in total 
vBMD after correcting for age ranged from <1% to 7%. Postmenopausal women had 
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lower values than premenopausal women, and group differences in both variables 
peaked in the diaphysis.  Finally there was a trend (p = 0.061) for a menopause effect on 
5%:35% Total BMC ratio.  The main menopause effect was not significant for any 
variable. 
Bone Strength Estimations by pQCT 
Bone strength was estimated using moments of inertia (Imax, Imin), strength 
strain index (SSI) and bone strength index (BSI). An SSI:Total BMC ratio was 
calculated at each site to determine the bone strength relative to bone mass. Figures 16 
and 17 show the SSI and SSI:ToC ratios at each tibia site.  Strength and strength to 
mass ratios were greatest at the most proximal sites.  Site, gender and site*gender 
effects were significant (p < 0.01) for SSI. SSI of the 15% and 25% sites were not 
significantly different from each other, but all other sites were significantly different.  
Men had 28.1-31.2% higher SSI values than women.  Correcting for BFLBM made the 
site*gender, age*gender, and site*age*gender interactions a trend (p = 0.056, 0.061, 
and 0.064), as gender differences were reduced to 9.4-14% higher in men. Correcting 
for FM did not affect the SSI results. 
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Figure 16. Strength Strain Index (SSI) at Each Tibia Site from 15% to 85% of the Limb Length. 
Mean ± SE. p < 0.01; Site, gender and site*gender effects. 15% and 25% sites were not 
significantly different from each other, but all other sites were significantly different. *p < 0.01: 
Gender was significant at all sites. 
 
Strength to mass ratio, as represented as SSI:Total BMC, had significant (p < 
0.01) site, site*age, site*gender, age, and gender effects.  All sites were significantly 
different.  The 20s group had significantly lower (p < 0.05) SSI:Total BMC than 30s 
(1.3-11.3%) and 50s (3.6-10%), and there was a trend (p = 0.075) to have lower 
SSI:Total BMC than 40s (1.2-9.2%). Women had 4.8-12.5% lower SSI:Total BMC than 
men.  Site*gender became a trend when correcting for BFLBM (p = 0.096), and gender 
was no longer significant.  Gender differences were reduced to being 4.8% lower (at 
85% site) to 1.2% greater (at 15% site) in women. Correcting for fat mass did not 
remove any significant effects. 
 
* 
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Figure 17. Strength Strain Index to Total BMC Ratio at Each Tibia Site from 15% to 85% of 
the Limb Length. Mean ± SE.  p < 0.01; Significant site, site*age, site*gender, age, and gender 
effects.  All sites were significantly different from each other (p < 0.01, except 15% vs. 65%, 
which was p < 0.05). * p < 0.01 Gender significant at all sites. 
 
Figures 18, 19, and 20 show the Imax, Imin, and Imax/Imin ratios. Imax refers 
to the maximum cross-sectional moment of inertia, and Imin refers to the minimum 
cross-sectional moment of inertia.  The Imax/Imin ratio is simply being used as an 
indicator of the symmetry of direction-specific strength. There were significant (p < 
0.01) site, site*age, site*gender, and gender effects for Imax.  The 15% and 25% sites 
were not significantly different from each other; all other sites were significantly 
different from the other sites.  Imax values were highest in the 40s age group. Imax 
values lowest in the 20s group, and were 12.2%-14.2% lower than the 40s age group. 
The 50s group had 6.2% (65)-16.4% (85) lower Imax values than the 40s group.  Imax 
values were 36.5% (15) – 46.7% (65) lower in women, and gender difference were 
significant at all sites.  Correcting for BFLBM made the age*site interaction 
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nonsignificant, and made the age*gender and age*gender*site interactions significant.  
In this analysis, gender differences were smallest in 20s (<1%) and largest in 40s (33%), 
followed by 30s (23%). Further, when correcting for BFLBM, Imax was lowest in 20s 
men and highest in 40s men, but lowest in 40s women and highest in 50s women.  Age 
and gender interactions varied by site.  Correcting for FM made the age*site interaction 
a trend. 
Imin had significant (p < 0.01) site, site*gender, and gender effects. When 
correcting for BFLBM, site, gender and site*gender effects were no longer significant. 
Age*site interaction effects became a trend (p=0.087). Using FM as a covariate did not 
affect the Imin results.  Gender effects were significant (p < 0.01) at all sites, where 
men had 38.2% (85 site) -62.9% (25 site) greater values than women.  Correcting for 
BFLBM reduced these differences to 0.3-18.4%. 
Imax/Imin ratio had significant (p < 0.01) site, site*gender, and gender, which 
remained significant when using BFLBM as a covariate. The 15% and 25% sites were 
significantly (p < 0.01) different from all other sites, and 45% was different (p < 0.01) 
from 55%, but the other sites were not significantly different from each other.  Gender 
effects were not significant at sites 15-35%, but were significant (p < 0.01) at sites 45-
85%. 
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Figure 18. Maximum Moment of Inertia (Imax) at Each Tibia Site from 15% to 85% of the 
Limb Length. Mean ± SE. p < 0.01 Significant site, site*age, site*gender, and gender effects. 
The 15% and 25% sites were the only not significantly different from each other. All other sites 
were significantly different from the other sites.  *p < 0.01: Gender significant at all sites.  
 
Figure 19. Minimum Moment of Inertia (Imin) at Each Tibia Site from 15% to 85% of the 
Limb Length. Mean ± SE. p < 0.01; Significant site, site*gender, and gender effects. *p < 0.01: 
Gender significant at all sites.  
* 
* 
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Figure 20. Ratio of Maximum (Imax) and Minimum (Imin) Moments of Inertia at Each Tibia 
Site from 15% to 85% of Limb Length.  *p < 0.01 Gender significant at sites 45%-85%. ‡p < 
0.01 Significantly different from 55%. ‡‡p < 0.01 Significantly different from all other sites. 
 
Bone strength index, as a measure of compressive strength, is typically 
measured at the most distal sites. However, there is discrepancy between manuals and 
studies in how it has been calculated. Some report the BSI as Total BMD
2
 * Total Area, 
and some report the BSI as (Total vBMD * Total Area)
2 
(BSI2).  Thus, for the sake of 
completeness, BSI is shown for the 5% and 15% sites using both formulas in Table 8. 
Both formulas had significant (p < 0.05) site and gender effects. However, Total 
vBMD
2
*Total Area (BSI1) was also significant (p < 0.05) for site*gender and age. 
Women had 33.2% and 42.1% lower BSI1 values than men at the 5% and 15% sites, 
respectively, and had 30.8% and 29.1% lower BSI2 values. 
 
 
 
* 
‡‡ 
‡‡ 
‡ 
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Table 8. Bone Strength Index (BSI) of the 5% and 15% Tibia Sites Using 2 
Formulas.  Mean ± SE.   
Site Groups Men Women 
abcd
BSI = Tot.vBMD
2
 * Tot.Area (mg
2
/mm
4
) 
5% 20s: M=15; W=15 1.468E8 ± 9.280E6 1.013E8 ± 6.792E6 
 30s: M=15; W=14 1.275E8 ± 9.290E6 1.030E8 ± 1.612E7 
 40s: M=10; W=15 1.431E8 ± 9.534E6 8.645E7 ± 3.582E6 
 50s: M=15; W=15 1.156E8 ± 7.181E6 7.778E8 ± 5.832E6 
15% 20s: M=15; W=15 1.976E8 ± 7.228E6 1.474E8 ± 7.422E6 
 30s: M=15; W=14 1.869E8 ± 1.010E7 1.372E8 ± 6.850E6 
 40s: M=10; W=15 2.008E8 ± 1.102E7 1.281E6 ± 7.952E6 
 50s: M=15; W=15 1.715E8 ± 6.735E6 1.236E8 ± 6.658E6 
ad
BSI = (Tot.BMC * Tot.Area)
2
 
5% 20s: M=15; W=15 1.493E11 ± 1.211E10 8.426E10 ± 6.370E9 
 30s: M=15; W=14 1.455E11 ± 1.317E10 1.575E11 ± 7.907E10 
 40s: M=10; W=15 1.583E11 ± 1.510E10 7.485E10 ± 3.701E9 
 50s: M=15; W=15 1.231E11 ± 9.915E9 6.839E10 ± 6.489E9 
15% 20s: M=15; W=15 9.066E10 ± 4.622E9 5.855E10 ± 3.778E9 
 30s: M=15; W=14 9.397E10 ± 6.667E9 5.575E10 ± 4.106E9 
 40s: M=10; W=15 1.042E11 ± 7.986E9 5.195E10 ± 4.091E9 
 50s: M=15; W=15 8.444E10 ± 5.602E9 4.983E10 ± 2.880E9 
a
p < 0.05 Significant gender effect. 
b
p < 0.05 Significant site*gender effect. 
c
p < 0.05 
Significant age effect. 
d
p < 0.01 Significant site effect.  Tot.BMC: Total BMC; Tot.Area: Total 
Area; 20s: 20-29 Age Group; 30s: 30-39 Age Group; 40s: 40-49 Age Group; 50s: 50-59 Age 
Group. 
 
 As the number of significant effects at various sites is very large, Table 9 was 
created to summarize which effects for significant for each variable without correcting 
for BFLBM or FM. Table 10 summarizes the range of gender differences for each 
variable, and Table 11 summarizes the range of age group differences for each variable. 
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Table 9. Summary of Significant (S), Non-Significant (NS), and Trend (T) for 
Effects for Each Bone Variable. 
 Site Site*Gender Site*Age Gender Age Age*Gender 
Total BMC S S S S T NS 
Total vBMD S S S NS S NS 
Total Area S S NS S S NS 
Trab. BMC S T NS S T NS 
Trab. vBMD S NS NS NS NS S 
Trab. Area S S NS S S NS 
Cort. BMC S S NS S T NS 
Cort. vBMD S T S S NS NS 
Cort. Area S S NS S T NS 
Cort. Thk S S NS S S NS 
PeriC S S T S NS NS 
EndoC S S S S S NS 
SSI S S NS S S NS 
Imax S S S S NS NS 
Imin S S NS S NS NS 
Imax/Imin S S NS S NS NS 
SSI:Tot.BMC S S S S S NS 
BSI1 S S NS S S NS 
BSI2 S NS NS S NS NS 
S: Significant, p < 0.05; NS: Non-Significant; T: Trend, 0.05<p<0.10. BMC: Bone Mineral 
Content; vBMD: Volumetric Bone Mineral Density; Trab: Trabecular; Cort: Cortical; PeriC: 
Periosteal Circumference; EndoC: Endosteal Circumference; SSI: Strength Strain Index; Imax: 
Maximum Moment of Inertia of a Cross-Sectional Slice; Imin: Minimum Moment of Inertia of 
a Cross-Sectional Slice; BSI1 = Total Area * Total vBMD
2
; BSI2 = (Total Area * Total vBMD)
2
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Table 10. Range of Gender Differences and Site(s) of Peak Gender Difference for 
Each Bone Variable. 
Variable Range M vs. W (M > W is 
Positive, W > M is negative) 
Site(s) (± 0.2%) of Peak 
Difference 
Total BMC 21-28% 5% 
Total vBMD 
-
1.2-10% 5% 
Total Area 14-25% 35, 65% 
Trabecular BMC 18-25% 5% 
Trabecular Area 12-17% 85% 
Cortical BMC 21-25% 15, 25, 85% 
Cortical vBMD -1- -2% 65% 
Cortical Area 23-26% 15, 25, 85% 
Cortical Thickness 12-19% 15% 
Periosteal Circ. 10-14% 65% 
Endosteal Circ 7-12% 65% 
SSI 28-32% 35, 55% 
Imax 37-47% 65% 
Imin 28-39% 25% 
Imax/Imin 1-24% 75% 
SSI:Tot.BMC 5-13% 55% 
BSI1 33%, 42% 15% 
BSI2 31%, 29% 5% 
BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; Circ: Circumference; 
SSI: Strength Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice; 
Imin: Minimum Moment of Inertia of a Cross-Sectional Slice: BSI: Bone Strength Index; BSI1 
= Total Area * Total vBMD
2
; BSI2=(Total Area * Total vBMD)
2 
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Table 11. Summary of Decade Differences for Bone Variables with a Significant 
Age and/or Age*Site Interaction Effect. 
Base Decade 20s vs. 30s vs. 40s vs. 
Comparison 
Decade 
30s 40s 50s 40s 50s 50s 
Total BMC 
-
5-6% 
-
5-4% 3-14% 
-
3-1% 5-8% 4-10% 
Total vBMD 1-16% 1-12% 5-17% 
-
5-2% 2-5% 3-7% 
Total Area 
-
3-
-
23% 
-
3-
-
9% 
-
2-
-
7% 
-
1-13% 0-14% 
-
3-4% 
Trab. Area -12-
-
28% 
-
10-
-
15% 
-
10-
-
15% 
-
2-14% 
-
2-14% 0-1% 
Cort. vBMD 
-
1-1% 0-1% 
-
1-1% 
-
1-1% 
-
2-2% 0-1% 
Cort. Thk 
-
1-9% 0-5% 8-10% 
-
7-0% 1-9% 5-9% 
EndoC 
-
4-
-
9% 
-
4-
-
9% 
-
2-13% 
-
4-5% 
-
8-5% 
-
7-0% 
SSI 
-
3-
-
8% 
-
6-
-
9% 
-
3-4% 
-
3-1% 2-7% 1-9% 
Imax 
-
5-
-
19% 
-
14-
-
16% 
-
7-5% 
-
8-4% 2-12% 9-16% 
SSI:Tot.BMC 
-
2-
-
13% 
-
2-
-
10% 
-
3-
-
11% 
-
1- 2% 
-
4-2% 
-
4-2% 
BSI1 6-7% 5-8% 15-22% 0-1% 9-16% 10-16% 
A negative percent denotes that the 20s group was lower than the comparison decade. 
Percentages rounded to the nearest whole number. BMC: Bone Mineral Content; vBMD: 
Volumetric Bone Mineral Density; Trab: Trabecular; Cort: Cortical; Thk: Thickness; EndoC: 
Endosteal Circumference; SSI: Strength Strain Index; Imax: Maximum Moment of Inertia of a 
Cross-Sectional Slice; BSI1 = Total Area * Total vBMD
2
. 
 
Prediction of DXA-Based Bone Results 
 The choice of pQCT variables to predict DXA-based aBMD values were first 
based on correlation coefficients.  All stepwise linear regression models utilized a body 
composition variable, age, and a pQCT variable.  Age was negatively related to bone 
variables, and generally, was more strongly related to BMD variables than BMC from 
both DXA and pQCT (Table 12).  Age was not related to cortical BMC, and was only 
related negatively to cortical vBMD at the 15% sites (r = -0.19, p < 0.05). The total 
BMC ratios 5%:35% and 5%:65% were inversely correlated with age (r= -0.23 and -
0.27, respectively, p < 0.05). Age was not related to SSI nor Imax values, but were 
significantly correlated with SSI:Total BMC ratios at sites 25%-45% and 85% (r = 0.19-
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0.29, p < 0.05). There was a trend (p < 0.10) for age to SSI:Total BMC correlations at 
sites 55-75%.   
Total BFLBM was positively related to BMC and BMD, but generally, was 
more strongly related to BMC than BMD.  Correlations between total BFLBM and 
lumbar spine and hip (total, femoral neck, trochanter) BMC ranged from r = 0.61-0.74 
(p < 0.01).  The correlation between total BFLBM and lumbar spine aBMD was r = 
0.19 (p < 0.05), and the range of correlations between total BFLBM and hip aBMD 
variables was r = 0.41-0.50 (p < 0.01).  Leg BFLBM consistently had stronger 
correlations with lower limb bone variables (DXA-based BMC correlations: r = 0.64-
0.78, p < 0.01; aBMD: r = 0.23-0.52, p < 0.05) than total BFLBM, indirectly providing 
evidence to support the importance of muscle contractions over gravitational loading.  
This is further supported by the lack of significant correlations between bone and fat 
variables. Only leg FM was negatively (p < 0.05) correlated with trochanter aBMD (r = 
-0.19) and BMC (r = -0.20).   
Ranges of correlations between bone-free lean tissue mass values and selected 
pQCT-based bone variables are shown in Table 13. Correlations between both lean and 
fat mass and cortical bone variables were similar to the total bone correlations.  Total 
and leg FM were not related to total BMC values; only leg FM was related to 5% total 
BMC (r = -0.19, p < 0.05). Total vBMD was only inversely related (p < 0.05) to total 
body FM at the 65% - 85% sites (r = -0.20- -0.28) and leg FM at the 85% site (r = -
0.26). SSI was not related to fat mass values. Total and leg FM were not related to 
PeriC, but FCSA was significantly (p < 0.05) negatively related to PeriC at most sites (r 
= -0.20 - -0.28).  FCSA was also negatively related (r = -0.25 - -0.32, p < 0.05) to Total 
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BMC and SSI at all sites. For Total vBMD, there was a trend for a negative relationship 
with FCSA at the 5% and 15% sites (r = -0.18, p = 0.053 and 0.054), and the 
relationship was significant at the 85% site (-0.25, p < 0.01).  Correlations between soft 
tissue masses and BMC values are also reflected in soft tissue mass to total bone area 
correlations. 
Table 12. Correlations between Age and Bone Mineral Density (BMD) and Bone 
Mineral Content (BMC) Variables. 
Site  Age 
Lumbar Spine (DXA) 
aBMD -0.19 
BMC NS 
Total Hip (DXA) 
aBMD -0.38 
BMC -0.20 
Femoral Neck (DXA) 
aBMD -0.51 
BMC -0.34 
Trochanter (DXA) 
aBMD -0.28 
BMC NS 
Total (pQCT sites 5-85%; range) 
vBMD 
-
0.29-
-
0.41 
BMC -0.20, -0.26 (sig. at 5% and 85% only) 
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Table 13. Correlations between Total and Leg Bone-Free Lean Body Mass 
(BFLBM) and Calf Muscle Cross-Sectional Area (MCSA) and pQCT Variables 
 Total 
BFLBM 
Leg 
BFLBM 
MCSA 
Tot.vBMD 
5%-25% 0.21-0.37 0.25-0.42 0.30 (5%) 
35%-75% NS NS NS 
85% NS 0.22 NS 
Tot.BMC 0.71-0.82 0.73-0.85 0.63-0.70 
SSI 0.73-0.78 0.76-0.80 0.62-0.71 
PeriC 0.61-0.77 0.62-0.78 0.55-0.67 
Tot: total; vBMD: volumetric bone mineral density; SSI: strength strain index; PeriC: periosteal 
circumference. 
 
 Bone mineral content and bone area values were consistently correlated with 
bone strength estimators. However, correlations between total vBMD and bone strength 
were negative but not consistently significant.  Cortical vBMD values were often 
inversely correlated with bone strength, and were stronger than the total vBMD 
relationships to bone strength.  From the 15% to 85% sites, total BMC to SSI 
correlations ranged from 0.90-0.95, and total BMC to Imax correlations ranged from 
0.85-0.93.  Cortical vBMD to SSI correlations from the 25% site to the 75% site ranged 
from -0.28- -0.43, and cortical vBMD to Imax correlations ranged from -0.36 - -0.44. At 
the 85% site, SSI was not related to cortical vBMD, and the Imax correlation was r = -
0.19 (p < 0.05). 
 Correlations between BMC and vBMD from pQCT to DXA aBMD values are 
shown in Table 14. Relationships followed a curvilinear pattern throughout the tibia, as 
the strongest correlations were at the 5% and 85% sites, and the weakest correlations 
were at the 35% site for total BMC and 45% site for total vBMD. For total vBMD, the 
5% site was the strongest correlation, and for total BMC, the 85% site was the strongest 
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correlation site. Correlations between aBMD and Imax and SSI followed a similar 
pattern as total BMC, where the 85% site was the strongest correlation site, and for 
Imax the 45% and 55% sites had the weakest correlations.  SSI:aBMD correlations were 
weakest at the 25% site. For cortical BMC, correlations with aBMD were lower at the 
15% and 85% sites, and highest at the 65% site. Cortical vBMD was only correlated 
between the 25% and 35% sites and trochanter aBMD, and the relationship was 
negative (-0.20, p < 0.05). Trabecular BMC was correlated at the 5% and 85% sites, but 
trabecular vBMD was not related to hip aBMD variables. Strength to mass ratios 
(SSI:Total BMC) were only related to trochanter aBMD at sites 35-75%, and were not 
related to lumbar spine, total hip, or femoral neck aBMD. 
Table 14. Correlation Ranges Between DXA aBMD Values and pQCT BMC, 
vBMD, Strength, and Mass Ratios  
pQCT Variable L1-L4 Spine Total Hip Femoral Neck Trochanter 
Total BMC 0.30-0.47
a
 0.52-0.72
a
 0.45-0.67
a
 0.59-0.76
a
 
Total vBMD 0.28-0.35
*b
 0.36-0.74
b
 0.31-0.70
b
 0.32-0.71
b
 
Cortical BMC 0.27-0.35 0.53-0.61 0.49-0.55 0.57-0.67 
Cortical vBMD NS NS NS -0.20
#
 
Trabecular BMC 0.20, 0.22 0.34, 0.33 0.33, 0.26 0.33, 0.35 
Trabecular vBMD NS NS NS NS 
SSI 0.22-0.33 0.41-0.54 0.37-0.49 0.50-0.61 
Imax 0.21-0.30 0.39-0.45 0.34-0.40 0.49-0.54 
SSI:Total BMC NS NS NS 0.20-0.25 
BSI1 0.37 (15%) 0.22, 0.57 0.20, 0.52 0.21, 0.63 
BSI2 0.39, 0.38 0.61, 0.64 0.56, 0.59 0.62, 0.67 
Total BMC 5:15 NS 0.22 0.20 0.24 
Total BMC 5:35 0.23 0.33 0.34 0.34 
Total BMC 5:65 0.23 0.34 0.33 0.36 
Total BMC 5:85 NS NS NS NS 
BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength Strain 
Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice. BSI: Bone Strength 
Index; BSI1 = Total Area * Total vBMD
2
; BSI2=(Total Area * Total vBMD)
2
 a. Strongest 
correlation at 85%. b. Strongest correlation at 5%. # Only at 25% and 35% sites. 
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Correlations between DXA BMC and pQCT total BMC values are shown in 
Table 15.  They were strongest at the ends of the tibia, and weakest at the 35% site, but 
the correlations did not directly decline from the ends. Correlations increased and 
decreased along the tibia. DXA BMC values were far more strongly correlated with 
total vBMD values at the 5% site than any other site. Volumetric BMD and DXA BMC 
values were not related at tibia sites 45%-65% for any DXA site. Values were 
correlated (p < 0.05) between DXA BMC and 5%-25% and 85% total vBMD for all 
DXA sites.  Total hip and femoral neck BMC were significantly related (r = 0.21, 0.19, 
p < 0.05) to total vBMD the 75% site, and total hip BMC was related to the 35% site (r 
= 0.20, p < 0.05).  For cortical BMC, correlations with DXA BMC were lower at the 
15% and 85% tibia sites, and highest at the 65% site.  Relationships between cortical 
vBMD and DXA BMC were significant and negative between tibia sites 25% and 75% 
for the hip variables, but relationships were not significant between hip variables and 
the tibia at the 15% and 85% sites, or between the lumbar spine and any tibia site.  DXA 
BMC values and pQCT trabecular vBMD values were not related. 
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Table 15. Correlation Ranges Between DXA BMC Values and pQCT BMC, 
vBMD, Strength, and Mass Ratios. 
pQCT Variable L1-L4 Spine Total Hip Femoral Neck Trochanter 
Total BMC 0.64-0.74 0.79-0.89 0.72-0.87 0.78-0.86 
Total vBMD 0.25-0.47 0.21-0.66 0.19-0.67 0.27-0.56 
Cortical BMC 0.57-0.67 0.69-0.84 0.64-0.75 0.66-0.81 
Cortical vBMD NS -0.24- -0.32
*
 -0.22- -0.30
*
 -0.28- -0.39
*
 
Trabecular BMC 0.32, 0.27 0.39, 0.36 0.39, 0.34 0.36, 0.33 
Trabecular vBMD NS NS NS NS 
SSI 0.62-0.67 0.75-0.81 0.66-0.76 0.75-0.80 
Imax 0.63-0.69 0.74-0.79 0.67-0.74 0.78-0.80 
SSI:Total BMC 0.21-0.50 0.22-0.54 0.22-0.46 0.26-0.59 
BSI1 0.57, 0.63 0.69, 0.79 0.67, 0.74 0.64, 0.75 
BSI2 0.27, 0.69 0.27, 0.82 0.26, 0.76 0.25, 0.81 
Total BMC 5:15 0.26 0.29 0.26 0.27 
Total BMC 5:35 0.37 0.37 0.39 0.34 
Total BMC 5:65 0.39 0.44 0.45 0.43 
Total BMC 5:85 NS NS NS NS 
BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength Strain 
Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice. BSI: Bone Strength 
Index; BSI1 = Total Area * Total vBMD
2
; BSI2=(Total Area * Total vBMD)
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 Tables 16 through 21 show significant predictors of total hip, femoral neck, and 
trochanter aBMD and BMC.  Each model used age, a pQCT bone variable, and either 
total BFLBM or MCSA.  To be concise, tables are limited to the sites near slices most 
commonly used in previous literature (5%, 15%, 35%, and 65%), and the 85% site 
because of the divergence in pQCT bone values seen between groups and the stronger 
correlations with DXA values.  
 When adding age and a lean mass variable into the stepwise regression, total 
BMC and vBMD each predicted hip, femoral neck, and trochanter aBMD. With the 
exception of the 5% tibia site, tibia BMC was generally a stronger predictor of hip 
aBMD than tibia vBMD.  Prediction was strongest by total vBMD and BMC at the 5% 
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and 85% sites, but up to 40% of the variance in total hip, femoral neck, and trochanter 
aBMD was still predicted from total BMC and vBMD in the diaphyseal sites.  In the 
diaphyseal sites, however, cortical BMC was sometimes a stronger predictor of hip 
aBMD than total BMC. 
 For any given site, total slice BMC was the best pQCT predictor of total hip, 
femoral neck, and trochanter BMC, and the 5% and 85% sites gave the strongest 
predictive values.  However, cortical BMC predicted femoral neck and trochanter BMC 
slightly better than total BMC at the 35% site, and cortical BMC predicted trochanter 
BMC slightly better than total BMC at the 85% site.  Total BMC predicted hip BMC 
values much more strongly than total vBMD. Total and cortical BMC and strength 
estimates of the diaphyseal sites, along with lean tissue and age, were still able to 
account for over 60% of the variance in total hip BMC. Within the diaphyseal sites, 
cortical BMC was a stronger predictor than total vBMD, and SSI was typically a 
slightly stronger predictor than Imax.  Cortical vBMD was not a predictor of hip values. 
Lean tissue significantly predicted total hip and femoral neck BMC with age and 
a pQCT variable more often than it predicted total hip and femoral neck aBMD when 
the pQCT variable and age were included in the stepwise model.  Total bone free lean 
mass always predicted DXA values better than MCSA, but MCSA was often a 
significant predictor when total BFLBM was a significant predictor.  Fat mass values 
were not added to stepwise regression procedures as leg fat mass values were only 
correlated with trochanter values, and correlations between FCSA and hip values were 
weak. 
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Table 16. Selected Best Total Hip aBMD Predictors Using a pQCT Variable, a 
Lean Mass Variable, and Age 
Best Predictors using Total BFLBM Best Predictors using MCSA 
 β SEE R2  β SEE R2 
Total BFLBM 
Age 
 0.383 
-0.355 
0.127 0.289 Age 
MCSA 
-0.394 
 0.367 
0.128 0.278 
5% Tot.vBMD 
Total BFLBM 
 0.686 
 0.150 
0.099 0.563 5% Tot.vBMD 
MCSA 
Age 
 0.640 
 0.163 
-0.137 
0.098 0.572 
85% Tot.BMC 
Age 
Total BFLBM 
 0.815 
-0.180 
-0.199 
0.099 0.561 85% Tot.BMC 
Age 
 
 0.664 
-0.266 
0.101 0.546 
85% Tot.vBMD 
Total BFLBM 
Age 
 0.486 
 0.312 
-0.162 
0.109 0.468 85% Tot.vBMD 
MCSA 
Age 
 0.494 
 0.304 
-0.192 
0.110 0.463 
5% Tot.BMC 
Age 
 0.581 
-0.268 
0.110 0.459 5% Tot.BMC 
Age 
 0.581 
-0.268 
0.110 0.459 
5% BSI1 
Age 
 0.549 
-0.255 
0.114 0.429 5% BSI1 
Age 
 0.549 
-0.255 
0.114 0.429 
15% BSI1 
Age 
 0.582 
-0.144 
0.110 0.465 15% BSI1 
Age 
 0.582 
-0.144 
0.110 0.465 
35% Cort.BMC 
Age 
 0.511 
-0.341 
0.117 0.403 35% Cort.BMC 
Age 
 0.511 
-0.341 
0.117 0.403 
35% Tot.BMC 
Age 
 0.497 
-0.353 
0.118 0.389 35% Tot.BMC 
Age 
 0.497 
-0.353 
0.118 0.389 
Total BFLBM 
35% Tot.vBMD 
Age 
 0.393 
 0.313 
-0.254 
0.120 0.377 35% Tot.vBMD 
MCSA 
Age 
 0.316 
 0.380 
-0.294 
0.121 0.350 
65% Tot.BMC 
Age 
 0.567 
-0.336 
0.111 0.463 65% Tot.BMC 
Age 
 0.567 
-0.336 
0.111 0.463 
Total BFLBM 
65% Tot.vBMD 
Age 
 0.428 
 0.376 
-0.243 
0.116 0.416 65% Tot.vBMD 
MCSA 
Age 
 0.366 
 0.405 
-0.290 
0.118 0.399 
Total BFLBM 
Age 
5:35% Tot.BMC 
 0.344 
-0.315 
 0.180 
0.125 0.318 Age 
MCSA 
5:35% Tot.BMC 
-0.347 
 0.332 
 0.197 
0.126 0.313 
BFLBM: Bone-Free Lean Body Mass; MCSA: Muscle Cross-Sectional Area at the 65% Tibia 
Site; BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength 
Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice. BSI: Bone 
Strength Index; BSI1 = Total Area * Total vBMD
2 
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Table 17. Selected Best Total Hip BMC Predictors Using a pQCT Variable, a Lean 
Mass Variable, and Age 
Best Predictors using Total BFLBM Best Predictors using MCSA 
 β SEE R2  β SEE R2 
5% Tot.BMC 
Total BFLBM 
 0.728 
 0.194 
3.353 0.781 5% Tot.BMC  0.874 3.460 0.765 
Total BFLBM 
5% Tot.vBMD 
 0.576 
 0.450 
3.749 0.726 5% Tot.vBMD 
MCSA 
 0.530 
 0.442 
4.433 0.617 
Total BFLBM 
5% BSI1 
 0.533 
 0.427 
3.989 0.690 5% BSI1 
MCSA 
 0.538 
 0.399 
4.470 0.610 
15% Tot.BMC 
Total BFLBM 
Age 
 0.540 
 0.355 
-0.115 
3.801 0.713 15% Tot.BMC 
MCSA 
Age 
 0.679 
 0.171 
-0.128 
4.106 0.674 
15% BSI1 
Total BFLBM 
 0.528 
 0.407 
3.804 0.713 15% BSI1 
MCSA 
 0.650 
 0.263 
4.120 0.669 
35% Tot.BMC 
Total BFLBM 
Age 
 0.521 
 0.338 
-0.154 
3.994 0.692 35% Tot.BMC 
Age 
MCSA 
 0.661 
-0.176 
 0.177 
4.191 0.661 
35% SSI 
Total BFLBM 
Age 
 0.493 
 0.344 
-0.204 
4.149 0.658 35% SSI 
Age 
MCSA 
 0.646 
-0.240 
 0.174 
4.321 0.629 
35% Imax 
Total BFLBM 
Age 
 0.493 
 0.339 
-0.201 
4.169 0.664 35% Imax 
Age 
MCSA 
 0.649 
-0.235 
 0.168 
4.332 0.637 
65% Tot.BMC 
Total BFLBM 
Age 
 0.658 
 0.228 
-0.138 
3.573 0.753 65% Tot.BMC 
Age 
 0.834 
-0.139 
3.708 0.732 
65% SSI 
Total BFLBM 
Age 
 0.507 
 0.344 
-0.198 
4.055 0.682 65% SSI 
Age 
MCSA 
 0.645 
-0.233 
 0.193 
4.227 0.655 
65% Imax 
Total BFLBM 
Age 
 0.494 
 0.346 
-0.210 
4.134 0.670 65% Imax 
Age 
MCSA 
 0.632 
-0.249 
 0.207 
4.263 0.649 
85% Tot.BMC 
Total BFLBM 
 0.747 
 0.200 
3.081 0.815 85% Tot.BMC  0.892 3.220 0.796 
85% SSI 
Total BFLBM 
Age 
 0.572 
 0.317 
-0.146 
3.740 0.730 85% SSI 
Age 
MCSA 
 0.688 
-0.166 
 0.184 
3.918 0.703 
85% Imax 
Total BFLBM 
Age 
 0.557 
 0.291 
-0.167 
3.996 0.692 85% Imax 
Age 
MCSA 
 0.678 
-0.189 
 0.166 
4.098 0.676 
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BFLBM: Bone-Free Lean Body Mass; MCSA: Muscle Cross-Sectional Area at the 65% Tibia 
Site; BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength 
Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice. BSI: Bone 
Strength Index; BSI1 = Total Area * Total vBMD
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Table 18. Selected Best Femoral Neck aBMD Predictors Using a pQCT Variable, a 
Lean Mass Variable, and Age. 
Best Predictors using Total BFLBM Best Predictors using MCSA 
 β SEE R2  β SEE R2 
5% Tot.BMC 
Age 
 0.505 
-0.408 
0.112 0.500 5% Tot.BMC 
Age 
 0.505 
-0.408 
0.112 0.500 
5% Tot.vBMD 
Age 
Total BFLBM 
 0.531 
-0.288 
 0.165 
0.103 0.582 5% Tot.vBMD 
Age 
MCSA 
 0.542 
-0.300 
 0.150 
0.104 0.579 
5% BSI1 
Age 
Total BFLBM 
 0.382 
-0.408 
 0.166 
0.115 0.482 5% BSI1 
Age 
MCSA 
 0.397 
-0.423 
 0.169 
0.115 0.485 
15% Tot.BMC 
Age 
 0.459 
-0.450 
0.117 0.462 15% Tot.BMC 
Age 
 0.459 
-0.450 
0.117 0.462 
15% Tot.vBMD 
Age 
MCSA 
 0.301 
-0.386 
 0.267 
0.118 0.450 15% Tot.vBMD 
Age 
MCSA 
 0.327 
-0.405 
 0.261 
0.118 0.450 
15% BSI1 
Age 
 0.505 
-0.389 
0.113 0.496 15% BSI1 
Age 
 0.505 
-0.389 
0.113 0.496 
Age 
35% Tot.BMC 
-0.483 
 0.424 
0.120 0.434 Age 
35% Tot.BMC 
-0.483 
 0.424 
0.120 0.434 
Age 
Total BFLBM 
35% Tot.vBMD 
-0.420 
 0.356 
 0.197 
0.123 0.411 Age 
MCSA 
35% Tot.vBMD 
-0.455 
 0.331 
 0.199 
0.124 0.394 
Age 
35% Cort.BMC 
-0.473 
 0.427 
0.119 0.436 Age 
35% Cort.BMC 
-0.473 
 0.427 
0.119 0.436 
Age 
35% SSI 
-0.524 
 0.394 
0.122 0.410 Age 
35% SSI 
-0.524 
 0.394 
0.122 0.410 
65% Tot.BMC 
Age 
 0.501 
-0.467 
0.112 0.504 65% Tot.BMC 
Age 
 0.501 
-0.467 
0.112 0.504 
Age 
Total BFLBM 
65% Tot.vBMD 
-0.405 
 0.381 
 0.264 
0.120 0.439 Age 
MCSA 
65% Tot.vBMD 
-0.446 
 0.349 
 0.254 
0.122 0.417 
65% Cort.BMC 
Age 
 0.495 
-0.448 
0.113 0.496 65% Cort.BMC 
Age 
 0.495 
-0.448 
0.113 0.496 
Age  -0.519 0.120 0.427 Age  -0.519 0.120 0.427 
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65% SSI  0.415 65% SSI  0.415 
85% Tot.BMC 
Age 
 0.580 
-0.354 
0.104 0.568 85% Tot.BMC 
Age 
 0.580 
-0.354 
0.104 0.568 
85% Tot.vBMD 
Age 
Total BFLBM 
 0.394 
-0.327 
 0.292 
0.113 0.503 85% Tot.vBMD 
Age 
MCSA 
 0.402 
-0.353 
 0.271 
0.114 0.492 
Age 
85% SSI 
-0.475 
 0.463 
0.116 0.468 Age 
85% SSI 
-0.475 
 0.463 
0.116 0.468 
BFLBM: Bone-Free Lean Body Mass; MCSA: Muscle Cross-Sectional Area at the 65% Tibia 
Site; BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength 
Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice. BSI: Bone 
Strength Index; BSI1 = Total Area * Total vBMD
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Table 19. Selected Best Femoral Neck BMC Predictors Using a pQCT Variable, a 
Lean Mass Variable, and Age. 
Best Predictors using Total BFLBM Best Predictors using MCSA 
 β SEE R2  β SEE R2 
5% Tot.BMC 
Age 
Total BFLBM 
 0.620 
-0.204 
 0.220 
0.540 0.734 5% Tot.BMC 
Age 
 0.789 
-0.186 
0.558 0.713 
Total BFLBM 
5% Tot.vBMD 
Age 
 0.537 
 0.414 
-0.142 
0.573 0.701 5% Tot.vBMD 
MCSA 
Age 
 0.472 
 0.429 
-0.171 
0.649 0.616 
Total BFLBM 
5% BSI1 
Age 
 0.506 
 0.367 
-0.222 
0.599 0.673 5% BSI1 
MCSA 
Age 
 0.457 
 0.403 
-0.251 
0.649 0.616 
15% Tot.BMC 
Age 
Total BFLBM 
 0.475 
-0.258 
 0.348 
0.585 0.688 15% Tot.BMC 
Age 
MCSA 
 0.594 
-0.273 
 0.194 
0.621 0.648 
15% Cort.BMC 
Total BFLBM 
Age 
 0.371 
 0.428 
-0.248 
0.623 0.646 15% Cort.BMC 
Age 
MCSA 
 0.497 
-0.266 
 0.275 
0.665 0.596 
15% SSI 
Age 
Total BFLBM 
 0.424 
-0.298 
 0.365 
0.614 0.656 15% SSI 
Age 
MCSA 
 0.568 
-0.323 
 0.183 
0.650 0.614 
15% BSI1 
Total BFLBM 
Age 
 0.430 
 0.413 
-0.212 
0.593 0.679 15% BSI1 
MCSA 
Age 
 0.535 
 0.295 
-0.226 
0.628 0.639 
35% Tot.BMC 
Age 
Total BFLBM 
 0.430 
-0.292 
 0.356 
0.615 0.654 35% Tot.BMC 
Age 
MCSA 
 0.559 
-0.317 
 0.212 
0.640 0.626 
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35% Cort.BMC 
Age 
Total BFLBM 
 0.433 
-0.283 
 0.358 
0.612 0.658 35% Cort.BMC 
Age 
MCSA 
 0.557 
-0.305 
 0.222 
0.636 0.630 
Total BFLBM 
Age 
35% SSI 
 0.341 
-0.336 
 0.432 
0.623 0.646 35% SSI 
Age 
MCSA 
 0.567 
-0.372 
 0.196 
0.643 0.623 
65% Tot.BMC 
Age 
Total BFLBM 
 0.566 
-0.278 
 0.248 
0.567 0.707 65% Tot.BMC 
Age 
 0.756 
-0.279 
0.588 0.681 
65% Cort.BMC 
Age 
Total BFLBM 
 0.522 
-0.258 
 0.296 
0.577 0.696 65% Cort.BMC 
Age 
MCSA 
 0.625 
-0.272 
 0.181 
0.596 0.676 
65% SSI 
Age 
Total BFLBM 
 0.465 
-0.332 
 0.325 
0.606 0.665 65% SSI 
Age 
MCSA 
 0.582 
-0.365 
 0.203 
0.624 0.645 
85% Tot.BMC 
Age 
Total BFLBM 
 0.697 
-0.144 
 0.184 
0.488 0.782 85% Tot.BMC 
Age 
 0.837 
-0.119 
0.503 0.767 
Total BFLBM 
85% Cort.BMC 
Age 
 0.504 
 0.319 
-0.258 
0.625 0.644 85% Cort.BMC 
MCSA 
Age 
 0.429 
 0.392 
-0.289 
0.667 0.594 
85% SSI 
Age 
Total BFLBM 
 0.528 
-0.284 
 0.298 
0.567 0.706 85% SSI 
Age 
MCSA 
 0.625 
-0.304 
 0.192 
0.585 0.688 
85% Imax 
Age 
Total BFLBM 
 0.501 
-0.304 
 0.284 
0.602 0.669 85% Imax 
Age 
MCSA 
 0.606 
-0.326 
 0.182 
0.612 0.658 
BFLBM: Bone-Free Lean Body Mass; MCSA: Muscle Cross-Sectional Area at the 65% Tibia 
Site; BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength 
Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice; BSI: Bone 
Strength Index; BSI1 = Total Area * Total vBMD
2 
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Table 20. Selected Best Trochanter aBMD Predictors Using a pQCT Variable, a 
Lean Mass Variable, and Age 
Best Predictors using Total BFLBM Best Predictors using MCSA 
 β SEE R2  β SEE R2 
5% Tot.BMC 
Age 
 0.667 
-0.154 
0.100 0.508 5% Tot.BMC 
Age 
 0.667 
-0.154 
0.100 0.508 
5% Tot.vBMD 
Total BFLBM 
 0.614 
 0.267 
0.094 0.571 5% Tot.vBMD 
MCSA 
 0.651 
 0.207 
0.096 0.548 
5% BSI1 
Total BFLBM 
Age 
 0.448 
 0.265 
-0.164 
0.106 0.453 5% BSI1 
MCSA 
Age 
 0.488 
 0.228 
-0.182 
0.107 0.444 
15% Tot.BMC 
Age 
 0.597 
-0.210 
0.108 0.420 15% Tot.BMC 
Age 
 0.597 
-0.210 
0.108 0.420 
15% BSI1  0.669 0.106 0.448 15% BSI1  0.669 0.106 0.448 
35% Tot.BMC 
Age 
 0.574 
-0.252 
0.110 0.408 35% Tot.BMC 
Age 
 0.574 
-0.252 
0.110 0.408 
35% Cort.BMC 
Age 
 0.584 
-0.239 
0.109 0.419 35% Cort.BMC 
Age 
 0.584 
-0.239 
0.109 0.419 
65% Tot.BMC 
Age 
 0.639 
-0.234 
0.102 0.485 65% Tot.BMC 
Age 
 0.639 
-0.234 
0.102 0.485 
65% Cort.BMC 
Age 
 0.642 
-0.208 
0.102 0.486 65% Cort.BMC 
Age 
 0.642 
-0.208 
0.102 0.486 
85% Tot.BMC  0.760 0.092 0.578 85% Tot.BMC  0.760 0.092 0.578 
85% Tot.vBMD 
Total BFLBM 
 0.510 
 0.409 
0.101 0.498 85% Tot.vBMD 
MCSA 
 0.541 
 0.344 
0.106 0.452 
85% SSI 
Age 
 0.591 
-0.244 
0.108 0.427 85% SSI 
Age 
 0.591 
-0.244 
0.108 0.427 
BFLBM: Bone-Free Lean Body Mass; MCSA: Muscle Cross-Sectional Area at the 65% Tibia 
Site; BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength 
Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice; BSI: Bone 
Strength Index; BSI1 = Total Area * Total vBMD
2 
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Table 21. Selected Best Trochanter BMC Predictors Using a pQCT Variable, a 
Lean Mass Variable, and Age. 
Best Predictors using Total BFLBM Best Predictors using MCSA 
 β SEE R2  β SEE R2 
5% Tot.BMC 
Total BFLBM 
0.682 
0.230 
0.156 0.755 5% Tot.BMC 0.856 1.724 0.732 
Total BFLBM 
5% Tot.vBMD 
0.622 
0.331 
1.984 0.649 MCSA 
5% Tot.vBMD 
0.456 
0.423 
2.356 0.504 
Total BFLBM 
5% BSI1 
0.569 
0.358 
1.975 0.652 5% BSI1 
MCSA 
0.486 
0.401 
2.259 0.544 
15% Tot.BMC 
Total BFLBM 
0.529 
0.372 
1.849 0.695 15% Tot.BMC 0.791 2.039 0.625 
15% SSI 
Total BFLBM 
0.520 
0.357 
1.909 0.675 15% SSI 0.786 2.059 0.618 
15% BSI1 
Total BFLBM 
0.460 
0.452 
1.892 0.680 15% BSI1 
MCSA 
0.608 
0.267 
2.089 0.610 
35% Tot.BMC 
Total BFLBM 
0.501 
0.365 
1.948 0.661 35% Tot.BMC 0.777 2.095 0.604 
35% Cort.BMC 
Total BFLBM 
0.484 
0.382 
1.960 0.657 35% Cort.BMC 
MCSA 
0.670 
0.158 
2.096 0.608 
35% Imax 
Total BFLBM 
0.520 
0.332 
1.967 0.654 35% Imax 
Age 
0.788 
-0.122 
2.040 0.628 
65% Tot.BMC 
Total BFLBM 
0.610 
0.276 
1.812 0.707 65% Tot.BMC 
 
0.822 1.898 0.675 
65% Cort.BMC 
Total BFLBM 
0.572 
0.319 
1.832 0.700 65% Cort.BMC 0.809 1.958 0.655 
65% SSI 
Total BFLBM 
0.487 
0.374 
1.968 0.654 65% SSI 0.771 2.120 0.595 
85% Tot.BMC 
Total BFLBM 
0.626 
0.289 
1.709 0.739 85% Tot.BMC 
Age 
0.872 
0.135 
1.781 0.717 
Total BFLBM 
85% Cort.BMC 
0.542 
0.359 
2.002 0.642 85% Cort.BMC 
MCSA 
0.506 
0.365 
2.444 0.550 
85% SSI 
Total BFLBM 
0.541 
0.351 
1.858 0.692 85% SSI 
MCSA 
0.703 
0.151 
1.985 0.648 
85% Imax 
Total BFLBM 
0.568 
0.295 
1.908 0.675 85% Imax 0.801 1.992 0.642 
BFLBM: Bone-Free Lean Body Mass; MCSA: Muscle Cross-Sectional Area at the 65% Tibia 
Site; BMC: Bone Mineral Content; vBMD: Volumetric Bone Mineral Density; SSI: Strength 
Strain Index; Imax: Maximum Moment of Inertia of a Cross-Sectional Slice; BSI: Bone 
Strength Index; BSI1 = Total Area * Total vBMD
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DISCUSSION 
The basic rationale behind the current study was that previous investigations 
measuring bone characteristics using pQCT have used a variety of tibia sites and have 
focused on a variety of different bone variables from the pQCT output (23,47,55,80).  
This variety limits direct comparisons among studies and has inhibited the development 
of standardized testing procedures and reference databases, which is a major strength of 
DXA (24).  My study focused on measuring the tibia at 10 sites along the length of the 
tibia in generally healthy, non-elderly adult Caucasian men and women not taking 
exogenous hormones or medications known to significantly affect bone health.  The 
primary findings were that most tibia sites have significantly different amounts of 
volumetric bone mineral density, bone mineral content, area, circumferences, cortical 
thicknesses, general shape, and estimated strength.  Many of the gender differences 
were accounted for by differences in content, leading to differences in area and, 
subsequently, strength.  In addition, a major proportion of gender differences were 
explained by differences in muscle mass.  There were multiple age effects that led to the 
40-49 year old decade having the highest estimated bone strength, with the magnitude 
of age differences depended on the measurement site. The BSI results suggested that 
estimated compressive strength also does not peak during the 30s, but with variability in 
BSI values in the 40s and 50s may suggest the importance of loading modalities on the 
development of peak strength.  Most of the analyses was performed with the Total 
vBMD
2
 * Total Area version of BSI, as it is the more common version in literature (48), 
it exhibited more significant effects, and was more strongly related to hip aBMD and 
BMC variables.   
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This study builds on the findings and ideas proposed by Capozza et al. (14), who 
tested the tibia at 18 sites: every 5% of the limb length from 5-95%, distal to proximal, 
except for the 50% site.  Their study, however, was a small study (n=22) of healthy men 
and women ages 20-40 years, with no other information about the participants. Physical 
activity, body size, body composition, nutrition, hormone status and ethnicity of the 
participants were not reported, so there is no indication of the application of their 
findings.  Ethnicity is important because some authors from Capozza et al. (14) reported 
their institutional affiliations as being from South American, whereas other authors‟ 
affiliations were in Europe, and differences in aBMD and fracture risk between 
ethnicities are well established (15, 53), but differences in pQCT-related variables are 
far less established.  Further, because this group did not report DXA values, there is no 
indication of their bone health status (above normal, normal, osteopenic).  
Gender and Bone 
 Women have been shown to have greater fragility fracture risk than men after 
middle age (15, 55, 59). This is probably mostly due to differences in bone size, as 
suggested by the pQCT results. A previous study has also reported bone size and 
strength differences without large differences in vBMD between men and women (23). 
In fact, data from this study suggests that women had greater cortical vBMD, and at 
some sites, total vBMD, than men. Differences in content or area translated to larger 
differences in estimated bone strength as Imax, Imin, or SSI. Gender differences in 
fracture risk may also be related to different relative contributions of cortical and 
trabecular bone or with the efficiency of the bone architecture that is not represented by 
density.   
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This study utilized recently suggested techniques for bone analysis to assess the 
relative amounts of cortical and trabecular bone within the tibia and to assess relative 
bone strength (14).  Total BMC ratios were calculated between a trabecular rich site 
(5%) and a cortical rich site (15%, 35%, 65%, 85%).  The reported cortical rich sites 
were selected because they were on or near sites that Capozza et al. (14) proposed for 
inclusion in ratios and gave ratio values for (5%, 35%), because they were on or near 
sites that were commonly measured in previous studies (15%, 35%, 65%), or because 
the repeated measures ANOVAs from this study suggested that it was a site sensitive 
for detecting age and gender differences (85%). Men had higher bone content ratio 
values than women for 5%:35%, 5%:65%, and 5%:85%, suggesting that men either 
have higher relative amounts of trabecular bone or lower relative amounts of cortical 
bone.  This is somewhat difficult to discern considering men had higher cortical and 
trabecular BMC values.  The 20-29 year old men were the only group that had 5%:35% 
ratios similar to those reported by Capozza et al., and 5%:15% ratios were much lower 
than the 1.5:1.0 presented by Capozza et al (14).  It is clear that these ratios are not 
consistent between genders, age groups, or perhaps even ethnic groups, so caution is 
needed in trying to use or interpret the ratios.  Much larger samples are needed to 
determine healthy ranges of ratio values and the physiological significance, if any, of 
these ratios.   
Men had greater SSI:Total BMC ratios than women at all sites except for the 
15% site.  Dividing SSI values by total BMC values to assess strength-to-weight ratios 
is a slight departure from Capozza et al. (14), where they divided cross-sectional 
moment of inertia by total BMC.  SSI is defined by using the equation  
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SSI = (Ʃ(d2*A*(cort.vBMDmeas/cort.vBMDmax)))/dmax,  
where d is distance, A is area, cort.vBMDmeas is the measured cortical vBMD, 
cort.vBMDmax is a theoretical maximum cortical vBMD under physiological conditions 
(1200 mg/cm
3
), and dmax is the maximum distance of the outer cortical shell to the 
center of mass (64).  Substituting vBMD for elastic modulus is thought to give a section 
modulus (cross-sectional moment of inertia divided by the maximum radius) that takes 
bone material properties into account (i.e. comparing resistance to torsion and bending 
of a cardboard tube and a bone of the same dimensions) (64). Dividing a cortical 
density-weighted section modulus by total bone content gives a strength-to-weight ratio, 
which is indicative of the efficiency of whole-bone tissue arrangement. Thus, it appears 
from these data that men have a more effective arrangement of bone mass that may be 
protective from fracture.  The method proposed by Capozza et al. (14) may be just as 
effective of an assessment of whole-bone architecture efficiency, but further studies are 
needed to determine if either assessment are beneficial for assessing bone health.   
In addition to gender differences in bone content, area, estimated strength, and 
strength-to-weight ratios, the ratio of Imax to Imin was also greater in men at sites 45% 
to 85%, suggesting differences in whole bone shape, not just difference in content.  This 
may be related to loading patterns from different types of physical activities 
(56,63,101). While this may not affect hip fracture risk, it may be related to stress 
fracture risk in the tibia caused by excessive or prolonged unaccustomed loading 
(23,42,65,81,95).  Interestingly, this was the only bone variable for which most sites 
were not significantly different from each other. 
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Muscle mass accounted for a much larger proportion of gender differences in 
BMC and bone strength than of gender differences in vBMD.  The majority of loading 
onto bone is thought to come from muscular contractions (27), and these data support 
that theory, especially since leg BFLBM was more strongly related to bone 
characteristics than total body BFLBM.  Calf MCSA was a weaker predictor of bone 
characteristics than total body BFLBM, but this may suggest the importance of the thigh 
musculature inserting force on the tibia.  Leg and total BFLBM are also better 
indicators of general training and fitness status.  Calf MCSA was included in the 
regression tables to show the ability to predict DXA hip values without using any DXA-
based body composition measures.   
Total and leg fat mass did not account for gender differences in bone 
characteristics, and since women had greater fat mass values than men, some gender 
differences in bone characteristics were slightly amplified when controlling for fat mass 
values. Total and leg fat mass were not correlated with bone characteristics. The finding 
that calf FCSA was negatively related to some bone characteristics may be indicative of 
the negative effects of inactivity on bone health (64,67). Previous studies have reported 
fat mass as a predictor of aBMD in untrained postmenopausal women (66,84), since fat 
mass is a source of gravitational loading and also a potential source of estrogen 
production (50).  
The general lack of age*gender interaction effects in this study was surprising, 
as it does not support previous findings in postmenopausal women not taking hormone 
replacement therapy having greater bone or body composition differences from men or 
premenopausal women not taking hormonal contraceptives (28,61,77,80).  This may 
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simply be a power issue related to sample size, as correcting for BFLBM caused 
age*gender interactions to become significant for PeriC and Imax and age*gender*site 
interactions to become a trend for total BMC and Imax.  The main finding was that 
gender effects were greatest in 40-49 year olds for these variables. This enhanced 
gender difference is not likely due to menopausal status, as there were 14 (out of 15) 
postmenopausal woman in the 50s group, and only 4 postmenopausal women in the 40s 
group. Two women in this latter group were perimenopausal. Despite these results, 
secondary analysis comparing only premenopausal women to postmenopausal women 
found site*menopause interactions for tibia total BMC and vBMD when using age as a 
covariate. While a trend for this effect also occurred for cortical BMC, there were no 
menopause effects for any other bone variable when accounting for age. 
Aging and Bone 
Significant age effects were not seen as consistently as gender effects.  The trend 
for age effects for total and cortical BMC and cortical area likely did not meet 
significance because of the number of sites that were not different between age groups, 
but sample size is also a possible issue.  Other potential reasons for fewer age group 
differences are the lack of age group differences in lean tissue values and the significant 
age group differences in fat mass values.  Since BFLBM was a significant predictor of 
many bone characteristics, and it is thought to be the primary source of bone loading, 
maintaining lean tissue may have prevented some age-related bone loss.  Although fat 
mass was not related to bone characteristics, correcting for fat mass made some age 
differences in bone characteristics (total and cortical BMC, cortical area, and the 
age*site for PeriC) significant when they were previously a trend.  Essentially, some 
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age effects were reduced because of increased fat mass in older age groups, but not 
nearly to the extent that lean mass affected gender effects. Further, decreases in lean 
mass equivalent to the increases seen in fat mass would have likely caused a greater 
detrimental effect on bone characteristics between age groups.   
Most significant age pairwise comparisons were found between the 20s group 
and 50s group.  The 40s participants, however, had the highest estimate bone strength, 
suggesting that while the accumulation of bone mass may peak around age 30, there 
may be additional arrangements of whole bone architecture to strengthen the bone, such 
that peak bone strength may occur when a person is in their 5
th
 decade, not 4
th
.  This 
suggestion is supported by significant age and age*site effects in endosteal 
circumference between 20s and 30s.  However, prolonged increases in endosteal 
circumference without increases in periosteal circumference can decrease cortical 
thickness to a degree that decreases strength. 
Although age group differences were less common than gender differences in 
this study, age was a more consistent predictor of DXA aBMD values than lean tissue 
values. Further, while bone variables did not have a linear decrease along age groups, 
age was always a negative predictor of hip bone variables. Lean tissue predicted aBMD 
more often when a vBMD variable was used in the prediction model.  The fact that 
MCSA remained in the model when it substituted total BLFBM suggests that over 50% 
of the variability in hip aBMD can be explained by using age and pQCT measures.  
When predicting hip BMC values, total BLFBM was a more important contributor to 
the model than age, but age was a more important contributor than MCSA. 
Interestingly, cortical vBMD was negatively related to the pQCT bone strength 
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estimates.  This finding seems to conflict with long-standing methods of using bone 
density as a surrogate of bone strength (14, 46), however, cortical and trabecular vBMD 
were not correlated with hip aBMD or BMC, but hip aBMD and BMC were related to 
pQCT tibia strength estimates.  Bone strength index, SSI, and Imax were not able to 
predict DXA variables better than total BMC.  Bone content ratios and SSI:Total BMC 
ratios did not predict DXA variables better than single variable predictors. However, 
there were age and gender differences in bone content ratios, suggesting that they may 
be indicative of relative cortical or bone losses.  The relatively weak correlations 
between the generated T-scores for ratios and hip T-scores suggest that the ratios could 
not be used as a substitute for hip T-scores for fracture risk determination. 
Physical Activity and Diet as Predictors of Bone Health 
Calcium and vitamin D were not significant predictors of bone characteristics, 
which is interesting considering such a high proportion of the sample was not ingesting 
recommended amounts according to Institute of Medicine (75). Protein and 
phosphorous, however, were consistent correlates of bone characteristics. While 
correlations were weaker and less consistent, the proportion of calories ingested as 
protein was also related to bone health. Higher protein intakes have previously been 
associated with increased BMD and IGF-1 levels and with reduced rates of bone 
resorption (20, 89).  Phosphorous is the 2
nd
 most abundant mineral in the body, second 
to calcium (29).  The relationship between phosphorous and protein intake was 0.96, so 
it is unclear whether protein or phosphorous alone or the combination of both were 
related to better bone health.  It should be noted that a potential limitation of the Block 
2005 Food Frequency Questionnaire is an inadequate separation of „energy bars‟ and 
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„protein bars‟ and representation of protein supplement usage in the form of powders 
and shakes.  Since many of protein bars and powder also contain calcium, it is possible 
that calcium and protein intakes are being underestimated in some subjects. Also, since 
information about sun exposure was not obtained, I cannot state for certain that the 
participants were vitamin D deficient. 
Bone-specific physical activity was not strongly related to bone variables.  This 
may have been partly due to how activities are scored, and due to the fact that the 
BPAQ is not particularly specific about frequency or intensity of the activities during 
the years the activity was performed.  Also, women had higher past and total bone-
specific physical activity levels, which was somewhat unexpected.  Again, this was 
likely due to how activities are scored.  Gymnastics is considered the bone loading 
standard to which other physical activities are compared to when scoring the 
questionnaire (99).  A wide range of physical activity levels were included to 
adequately reflect the general healthy population.  At a minimum, participants only had 
to report that they engaged in a minimum of 75 minutes per week of moderate or 
vigorous occupational, home, or leisure physical activity.  At a maximum, participants 
were included if they reported more than 15 hours per week of moderate or vigorous 
exercise per week.  The terms physical activity and exercise are used exclusively 
intentionally, such that individuals with more physical demanding occupations such as 
fire fighters or construction worker were not excluded for having either „too much‟ 
physical activity or not enough exercise outside of work.  Specific sports or physical 
activities were not excluded, as this would have limited to applicability of the findings.  
While some physical activities have been positively associated with bone characteristics 
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(32,56,81,101), some physical activities have been negatively associated with bone 
health (6,25,78) but the reasons for the negative association are unclear.  
Recommendations 
In the interest of deciding ideal sites for bone characterization, the 5% and 85% 
sites were sites with higher amounts of group divergence.  Also, the 35% and 65% sites, 
near already commonly used sites (38% and 66%) were sites at which several group 
differences peaked.  More group differences peaked at the 65% than the 35% site, and 
the 65% site has the added benefit of being a site for assessing calf MCSA.  The 15% 
site does not appear to add anything to the above four sites.  The „ideal‟ site(s) also 
partly depends on the chosen outcome variable.   
Limitations 
There are several limitations to this study. Because of the cross-sectional design, 
Rates of bone change in different age groups or between genders cannot be addressed.  
While certain tibia sites had larger gender and age group differences, longitudinal 
studies are needed to confirm that the same sites will show the greatest changes with 
prolonged exercise training, prolonged unloading, aging or menopause.  pQCT results 
were used to predict DXA values, but the design of the study prohibited the prediction 
for fracture.  Large, long-term prospective studies are needed to determine if pQCT 
values can be used to asses fracture risk. 
Cortical bone values, SSI, Imax, Imin, and Imax/Imin were not reported at the 
5% site because this site is particularly influenced by partial volume effects (4,30) when 
performing cortical-based analyses because of the thin cortical shell relative to the 
resolution of the scan.  All participants‟ cortical shells were less than 2 mm at this site, 
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even when using the 480 threshold.  Another issue unique to the 5% site for this study is 
that the SSI, Imax, and Imin values are calculated based on the cortical bone, assuming 
a hollow tube shape, and the 5% site strongly violates this assumption (see Figure 1).  
The Stratec software gives a „total bone‟ Imax and Imin value, but they assume a solid, 
homogenous rod, and all sites strongly violate this assumption.  Therefore, it is difficult 
to have high confidence in the accuracy of the non-BSI estimated strength values at this 
site.  It should be noted that while the 85% site also has a thin cortex in many people, 
for any given person the thickness is greater at the 85% site than at the 5% site, and 
therefore, is less prone to partial volume effects.  Partial volume effects occur at the 
border between soft tissue and the cortical shell, and between cortical bone and 
trabecular bone when a voxel contains both bone and soft tissue, or both cortical and 
trabecular bone.  Cortical shells that are thin relative to the scan resolution are more 
prone to under or over estimations in cortical values.  When reporting cortical bone 
values (not strength values, all were reported with the 480 threshold) using the 710 
threshold, approximately 1/3 had a cortical thickness of 2 mm, but this threshold was set 
a priori and the resulting values were used for consistency of analysis technique with 
other sites.  It should also be noted that using the 710 threshold did not cause streaking 
or popping points in the cortical analysis, and for the purposes of characterizing purely 
cortical bone, is still appropriate.  Using a 650 cortical threshold, also commonly used, 
may be more appropriate for this site to further reduce the chances of partial volume 
effects.  All subjects had a cortical thickness value greater than 2 mm with the 480 
threshold, but using the lower threshold would have automatically lowered the cortical 
density value and raised the cortical area value. 
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Tibia limb length became a limitation, as some tibias were too long to allow the 
gantry to move to the 95% site from a scout view.  There are likely minute differences 
in actual measurement site between scout view-based and manual scans.  Also, it is 
expected that the there is some variation in the shape and contour of the tibia condyles, 
particularly in those with arthritic changes of the knee.  In particular, there may be 
differences in the distance from the tibial plateau that is palpable by the tester to the 
articular surfaces, as well as differences in the distance from the medial malleolus to the 
tibia endplate.  Other sites, however, were all collected using a scout view.  It simply 
suggests the need to consistently use either a scout view or manual scanning for site 
determination for the most precise results. 
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CHAPTER V 
CONCLUSIONS 
The purpose of this study was to examine the effects of age and gender on tibia 
morphology, and to relate indicators of tibia mass and shape on hip and spine aBMD 
and BMC as assessed by DXA. Further purposes of this study were to determine which 
tibia site or sites are most sensitive for detecting age, gender, or menopause-related 
morphology changes.  The following research questions were investigated: 1. What 
effects do age and gender have on bone mass, bone shape, and bone strength indicators 
throughout the adult tibia?  2. What tibia site(s) and characteristics are most sensitive to 
age-related changes?  3. What tibia site(s) and characteristics are most sensitive to 
menopause-related changes?  4. What are the relationships between pQCT-assessed 
bone mass, bone shape, and bone strength indicators at individual tibia sites or as ratios 
between multiple tibia sites and DXA-assessed bone mass and aBMD? 
Research Hypothesis 1.  
A. Men will have greater periosteal circumference, cortical thickness, total and 
cortical area, total vBMD and SSI than women at any tibia site and any age.  
Men did, in fact have greater periosteal circumference, total and cortical area, 
and SSI than women at any tibia site and any age.  However, men did not have 
greater total vBMD at every site.  The magnitude of gender difference varied by 
site, and much of the gender difference was accounted for by differences in bone-
free lean body mass. 
B. With age, women would develop a greater endosteal circumference than 
men.  
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Findings did not support this hypothesis. Men had greater endosteal 
circumferences than women at all sites for all age groups. 
C. Men and premenopausal women would have similar cortical vBMD, 
trabecular content and vBMD.  
Cortical vBMD were similar between men and all women, and in fact, women 
had slightly, but significantly, greater values than men. Men had greater trabecular 
BMC than women, but gender differences widely varied between age groups and by 
site.  There was an interaction of age and gender for trabecular vBMD. Gender 
differences in trabecular content and vBMD were generally large. 
D. Trends for increases in bone size would begin at age 40 for both genders, but 
rates of change would be more rapid for women.  
The evidence from this sample does not fully support this hypothesis. Only 
trabecular vBMD had significant age and gender interaction effects, suggesting that 
for most bone size-related variables, including total and cortical area and periosteal 
and endosteal circumferences, changes occurred at a similar rate between genders in 
this sample.  The 20-29 year age group had the smallest total and trabecular area and 
periosteal and endosteal circumference mean values.  Also, cortical area values were 
highest in 30-somethings and 40-somethings, but this was not significant.  
An interesting point to consider is that when correcting for BFLBM, some 
age*gender interaction effects became significant, as gender differences were 
largest in 40-49 year olds, and became smaller between 50-59 year olds. In these 
cases, it was predominantly because while men had higher values in the 40s group 
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(compared to other male age groups), women had lower values in the 40s group. In 
the 50s group there was a reconvergence of values between gender groups. 
Research Hypothesis 2.  
A. Sites closest to the bone ends will be most sensitive to age related changes.  
This finding somewhat depended on the variable being tested, but this 
hypothesis is supported for total BMC, vBMD and area, and trabecular area and 
content. 
B. There will be decreases in cortical area and thickness, and decreases in 
trabecular content.  
Cortical thickness did decrease with age, but cortical area did not. There was a 
trend for decreases in trabecular content with age, but it was not significant. 
Trabecular loss appeared to decline in 40-49 yr olds at the 5% site, and 50-59 yr 
olds at the 85% site. 
C. There will be increases in total and trabecular bone area. SSI (measure of 
torsional strength at diaphyseal sites) will not significantly change with 
decreased cortical content when total bone area increases.  
The 20-29 year age group had the smallest total and trabecular area mean values.  
The hypothesis that SSI would not change significantly with decreased cortical 
content when total area increases could not be adequately tested because there were 
no significant decreases in cortical content.  
D. The ratio of total bone mass between the 5% site and more proximal sites until 
75% would decrease. 
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The data support this hypothesis, and the ratio continued to decrease until the 
85% site. 
Research Hypothesis 3. 
A. Menopause-related changes will be most evident with trabecular content and 
vBMD loss in the distal and proximal tibia sites (5%, 15%, and 95%), and 
cortical area and thickness loss in the diaphyseal sites.  
Trabecular vBMD was the only variable to have a significant age*gender 
interaction effect, and trabecular content was the only variable to have a significant 
site*age*gender interaction.  However, the only bone variables where a direct 
significant site*menopause group interactions were found were tibia total BMC and 
total vBMD, and group differences peaked in the diaphyseal shaft. 
B. There will be a change in the ratio of cortical content in diaphyseal sites to 
trabecular content in epiphyseal sites.  
There were significant findings in bone mass ratios.  The 5:35%, 5:65% and 
5:85% total BMC ratios were each significantly greater in men than women, and the 
20-29 year age group had the highest ratios. This suggests men had higher relative 
amounts of trabecular bone or lower relative amounts of cortical bone.  Also, the 
relative amount of trabecular bone was greater in younger adults. 
Research Hypothesis 4. 
A. Total BMC will be the strongest predictor of hip aBMD and BMC variables at 
all pQCT sites, but correlations will be strongest at non-diaphyseal sites.  
When adding age and a lean mass variable into the stepwise regression, total 
BMC and vBMD each predicted hip, femoral neck, and trochanter aBMD. With the 
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exception of the 5% tibia site, tibia BMC was generally a stronger predictor of hip 
aBMD than tibia vBMD.  Prediction was strongest by total vBMD and BMC at the 
5% and 85% sites, but up to 40% of the variance in total hip, femoral neck, and 
trochanter aBMD was still predicted from total BMC and vBMD in the diaphyseal 
sites.  In the diaphyseal sites, however, cortical BMC was sometimes a stronger 
predictor of hip aBMD than total BMC. 
 For any given site, total slice BMC was the best pQCT predictor of total hip, 
femoral neck, and trochanter BMC, and the 5% and 85% sites gave the strongest 
predictive values.  However, cortical BMC predicted femoral neck and trochanter 
BMC slightly better than total BMC at the 35% site, and cortical BMC predicted 
trochanter BMC slightly better than total BMC at the 85% site.  Total BMC 
predicted hip BMC values much more strongly than total vBMD. Total and cortical 
BMC and strength estimates of the diaphyseal sites, along with lean tissue and age, 
were still able to account for over 60% of the variance in total hip BMC. 
B. Total area, cortical BMC and area will be strongly related to hip aBMD and 
BMC.  
Yes, total area, cortical BMC and area were strongly related to hip BMC 
variables. Cortical area was strongly related to hip aBMD variables, and total area 
and cortical BMC were moderately correlated with hip aBMD variables. 
C. Volumetric BMD will only be correlated to hip aBMD and BMC variables at 
the tibia 5%, 15%, 85%, and 95% sites, and will not be related at sites 25-75%.  
Cortical vBMD at the ends of the tibia was not correlated to hip variables, and 
cortical vBMD throughout the diaphysis was negatively related to hip variables. 
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Total vBMD was correlated with hip variables throughout the tibia, but correlations 
were strongest at the 5% and 85% sites.  Trabecular vBMD was not related to hip 
variables. 
D. Trabecular bone variables will not be related to hip aBMD or BMC variables 
at sites 35-75%. 
Because this section of bone contains little, if any trabecular bone in this region 
of the tibia, trabecular bone was not quantified at these sites. It was only quantified 
at the 5%, 15%, 85%, and 95% sites.  Trabecular vBMD was not related to hip 
variables for any site. 
Clinical Significance 
 Peripheral Quantitative Computed Tomography is a bone assessment technique 
that can give bone content, density, and area measures of the total, cortical, and 
trabecular bone tissue. In addition, pQCT is able to provide estimates of bone strength. 
However, because of the heterogeneity of site selection between studies and a lack of 
evidence to support current site selections, reference databases and screening 
recommendations cannot yet be developed. In determining what sites are most sensitive 
for detecting normal aging and gender differences in bone characteristics, including 
strength, progress can be made towards developing reference databases at the most 
sensitive sites and engaging in fracture outcomes research using pQCT.  These steps are 
critical for collecting evidence for effective use of pQCT for fracture risk prediction.   
 It should be noted that results do not suggest 4%, 14%, 38%, and 66% sites 
currently used in the literature are inappropriate, per se, but does suggest a need for 
caution when directly comparing studies that used different sites for measurement.  
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Results of this study suggest that the 85% site may be a new useful site for pQCT 
testing. It is a site of appreciable cortical and trabecular bone, and predicts DXA 
variables well. Additionally, it may be a sensitive site to loading or unloading induced 
changes, and as a result may be able to predict hip fracture. As a slightly speculative 
hypothesis, the 85% site may be a useful site for predicting healing time for total knee 
replacements because a clinician will be able to better assess bone quality near the site 
of implantation.  Based on the results of this study, the 14% site does not appear to be of 
benefit beyond the 4%, 38%, 66%, or 85% sites.  Therefore, for research laboratories 
looking to limit the number of scans for research protocols, the 14% site is expendable.   
 Until large, publicly available, reference datasets at pQCT site(s) are developed, 
it is recommended that laboratories develop reference datasets at each tibia site using 
their own unique participant scans (as opposed to repeated scans from a single 
individual) for BMC, vBMD, SSI, BSI, and moments of inertia. Similar to DXA scan 
comparisons, individual pQCT scans could be compared to a young adult reference 
database and an age-, body size-, and ethnicity-matched database.  Scans that are added 
to the laboratory reference database should all be analyzed with standardized methods 
for consistency. 
Future Research Directions 
 Long-term longitudinal studies are needed to confirm which sites are most 
sensitive for detecting change due to aging, menopause, or other pathological 
conditions. Further, prospective studies are needed to determine fracture risk 
probabilities with pQCT.  Drastic departures from the most commonly used sites are 
likely not necessary. Some commonly used sites in the literature are 4%, 14%, 38%, and 
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66%. In the interest of selecting sites for useful, yet efficient screening, the 5%, 35%, 
65%, and 85% were best because of the ability to assess cortical and trabecular bone 
characteristics and bone strength that differ with age and gender groups, and be able to 
assess the calf musculature. The 85% site seems to be an under-utilized, but potentially 
powerful site for assessment.  While mass ratios and strength to mass ratios did not 
predict DXA variables better than a single variable or single-site bone mass value, they 
may still be beneficial in determining the relative bone losses (i.e. cortical vs. 
trabecular) or gains due to unloading or an intervention. Strength to mass ratios may 
reflect the efficiency of whole bone remodeling not captured when using density values. 
Longitudinal studies are also needed to confirm this. 
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Bone Density Research Laboratory 
OU Department of Health and Exercise Science 
Health Status Questionnaire 
 
Instructions  Complete each question accurately.  All information provided is confidential. 
(NOTE: The following codes are for office use only: RF; MC; SLA; SEP) 
 
Part 1.  Information about the individual 
 
1._______________________________________________ 
  Date 
  
2. __________________________________________________________________________________ 
  Legal name        Nickname 
  
3.__________________________________________________________________________________ 
  Mailing address         
     
   __________________________________________________________________________________ 
  Home phone                                     Business phone 
 
4.Gender (circle one): Female  Male (RF) 
 
5. Year of birth: ___________________________  Age  __________ 
 
6.  Number of hours worked per week:     Less than 20          20-40          41-60          Over 60 
 More than 25% of time spent on job (circle all that apply) 
 Sitting at desk          Lifting or carrying loads          Standing            Walking           Driving 
 
Part 2.  Medical history 
7.  (RF) Circle any who died of heart attack before age 50: 
  Father          Mother          Brother          Sister          Grandparent  
  
8.Date of:  Last medical physical exam: _______________ (year) 
Last physical fitness test:  _________________ (year) 
                 
 9. Circle operations you have had: 
  Back (SLA) Heart (MC) Kidney (SLA) Eyes (SLA) Joint (SLA) Neck (SLA) 
  Ears (SLA)  Hernia (SLA) Lung (SLA) Other ____________________________ 
 
10.  Please circle any of the following for which you have been diagnosed or treated by a physician or 
health professional: 
  Alcoholism (SEP)   Diabetes (SEP)   Kidney problem (MC) 
  Anemia, sickle cell (SEP)  Emphysema (SEP)  Mental illness (SEP) 
  Anemia, other (SEP)   Epilepsy (SEP)   Neck strain (SLA) 
  Asthma (SEP)   Eye problems (SLA)  Obesity (RF) 
  Back strain  (SLA)   Gout (SLA)   Osteoporosis 
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  Bleeding trait (SEP)   Hearing loss (SLA)  Phlebitis (MC) 
  Bronchitis, chronic (SEP)  Heart problems (SLA)  Rheumatoid arthritis  
  Cancer (SEP)   High blood pressure (RF)  Stroke (MC) 
  Cirrhosis, liver (MC)   Hypoglycemia (SEP)  Thyroid problem (SEP) 
  Concussion (MC)   Hyperlipidemia (RF)  Ulcer (SEP) 
  Congenital defect (SEP)  Infectious mononucleosis (MC) Other _____________ 
 
11.  Circle all medicine taken in last 6 months: 
  Blood thinner (MC)  Epilepsy medication (SEP)  Nitroglycerin (MC) 
  Diabetic pill (SEP)  Heart-rhythm medication (MC)  Estrogen 
  Digitalis (MC)  High-blood-pressure medication (MC) Thyroid 
  Diuretic (MC)  Insulin (MC)    Corticosteroids 
Asthma   Other ______________________ 
 
12.  Any of these health symptoms that occurs frequently is the basis for medical attention.   Circle the  
number indicating how often you have each of the following:  
  1 = Practically never   2 = Infrequently   3 = Sometimes 4 = Fairly often  5 = Very often 
  
  a. Cough up blood (MC)  d.  Leg pain (MC)  g.   Swollen joints (MC)   
   1    2    3    4    5       1    2    3    4    5        1    2    3    4    5  
  b. Abdominal pain (MC)  e.  Arm or shoulder pain (MC) h.   Feel faint (MC) 
   1    2    3    4    5          1    2    3    4    5        1    2    3    4    5  
  c. Low back pain (SLA)  f.   Chest pain (RF) (MC) I.    Dizziness (MC) 
   1    2    3    4    5         1    2    3    4    5         1    2    3    4    5  
         j.    Breathless with slight exertion (MC) 
                  1    2    3    4    5   
Part 3.  Health-related behavior 
 
13. (RF) Do you now smoke?     Yes No 
 
14. If you are a smoker, indicate number smoked per day:   
  Cigarettes:       40 or more 20-39  10-19  1-9 
  Cigars or pipes only: 5 or more or any inhaled  Less than 5, none inhaled 
 
15. Weight now: ________lb.          One year ago: ________lb..          Age 21: ________lb. 
 
16. Thinking about the things you do at work, how would you rate yourself as to the amount of physical 
activity you get compared with others of your age and sex? 
 
1. Much more active 
2. Somewhat more active 
3. About the same 
4. Somewhat less active 
5. Much less active 
6. Not applicable 
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17. Now, thinking about the things you do outside of work, how would you rate yourself as to the 
amount of physical activity you get compared with others of your age and sex? 
 
1. Much more active 
2. Somewhat more active 
3. About the same 
4. Somewhat less active 
5. Much less active 
6. Not applicable  
 
18. Do you regularly engage in strenuous exercise or hard physical labor? 
1.  Yes (answer question # 19) 2.  No (stop) 
 
19. Do you exercise or labor at least three times a week?     1.  Yes  2.  No 
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Bone Density Research Laboratory 
Department of Health and Exercise Science 
University of Oklahoma 
 
MENSTRUAL HISTORY QUESTIONNAIRE 
Name: ______________________________      Date: _____________________________ 
We are asking you to give us as complete a menstrual history as possible.   All information you 
provide will be strictly confidential. 
SECTION A: CURRENT MENSTRUAL STATUS  
1. At what age did you experience your final menstrual period? 
 
 
2. Have you had a hysterectomy (surgical removal of the uterus)?  If yes, at what age did you 
have this surgery? 
 
 
3. Have you had your ovaries removed?  If yes, at what age did you have this surgery? 
 
 
4. Are you currently on estrogen and /or progesterone replacement therapy?  If no, skip to 
question 5. 
 
If yes, how long have you been on hormone replacement therapy? 
 
What is the brand name, dosage, and type (i.e., pills, cream, patch) of hormone 
medication you are taking? 
 
5. Have you taken estrogen and/or progesterone replacement in the past?  If no, skip to 
SECTION B 
 
If yes, what was the type (i.e., pills, cream, patch) and dosage of the medication? 
 
 
At what age did you start taking hormone replacement? 
 
 
How long did you continue taking the hormone replacement? 
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At what age and why did you stop taking hormone replacement?  
 
 
6. If you answered yes to questions 4 or 5, did you experience any side effects (i.e., weight 
gain, mood swings, headaches) while taking hormone replacement? 
If yes, please list the side effects. 
 
SECTION B:  PAST MENSTRUAL HISTORY 
1. At what age did you experience your first menstrual period? 
 
 
2. Were your periods regular (occurring monthly) during the first two years after menstruation 
began?  If no, at what age did your periods eventually become regular? 
 
 
3. Did you perform any form of athletic training prior to your first menstrual period?  If yes, 
indicate type of training (i.e., gymnastics, track, basketball, etc.) and the number of years 
you trained for each activity. 
 
4. Has there been any time in the past where your periods were irregular or absent?  If no, skip 
to question 5.  
 
If yes, did these periods coincide with unusual bouts of training, or with a period of stress?  
How long did this occur? 
 
5. Have you ever consulted a doctor about menstrual problems (specifically, about irregular or 
missing periods)?  If no, skip to question 6.  
If yes, what was the diagnosis (i.e., shortened luteal phase, amenorrhea)? 
Have you ever been tested to determine if you were ovulating normally? 
 
6. Have you ever consulted a physician about any problems relating to your hormonal system?  
If so, please explain. 
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Appendix C 
Sample DXA Scans 
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Appendix D 
Descriptive Statistics 
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Gender = men, Decade = 20s 
Descriptive Statistics
a
 
 
N Minimum Maximum Mean 
Std. 
Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 337.01 479.26 399.599 9.354 36.229 
t5tod 15 332.80 448.90 387.000 9.129 35.355 
t5toa 15 307.80 1238.40 984.488 56.188 217.614 
t5trc 15 195.63 694.40 296.888 29.864 115.664 
t5trd 15 210.50 380.30 298.693 10.612 41.102 
t5tra 15 624.64 1076.96 865.344 29.981 116.117 
t15toc 15 223.81 340.57 299.627 8.030 31.100 
t15tod 15 545.00 746.30 659.200 15.380 59.567 
t15toa 15 354.12 570.88 457.859 16.197 62.730 
t15trc 15 17.37 71.39 37.787 3.700 14.328 
t15trd 15 102.80 232.40 171.000 8.855 34.295 
t15tra 15 164.00 327.36 217.077 14.168 54.872 
t15coc 15 197.70 282.71 248.615 6.102 23.635 
t15cod 15 1095.40 1168.70 1138.047 5.652 21.890 
t15coa 15 171.36 250.72 218.549 5.472 21.193 
t15cth 15 2.67 4.11 3.377 .102 .394 
t15peri 15 66.77 84.70 75.689 1.343 5.202 
t15endo 15 47.18 67.16 54.471 1.705 6.603 
t25toc 15 311.36 398.01 348.470 6.396 24.773 
t25tod 15 727.30 968.00 876.427 18.122 70.185 
t25toa 15 343.68 484.96 399.904 10.777 41.739 
t25coc 15 297.09 373.47 329.251 5.933 22.978 
t25cod 15 1135.00 1202.70 1170.547 4.231 16.388 
t25coa 15 251.84 319.84 281.333 5.185 20.083 
t25cth 15 4.26 6.09 5.197 .140 .543 
t25peri 15 39.03 78.07 68.801 2.325 9.004 
t25endo 15 29.88 51.30 37.715 1.533 5.936 
t35toc 15 311.33 464.01 392.501 8.812 34.129 
t35tod 15 859.60 1016.30 944.267 11.463 44.396 
t35toa 15 331.52 506.88 416.171 11.655 45.139 
t35coc 15 299.02 436.04 376.611 8.083 31.304 
t35cod 15 1132.30 1207.30 1166.813 5.932 22.975 
t35coa 15 247.68 376.64 323.051 7.415 28.718 
t35cth 15 5.11 6.84 6.100 .123 .476 
t35peri 15 64.55 79.81 72.218 1.012 3.918 
t35endo 15 25.48 41.90 33.892 1.240 4.802 
Valid N (listwise) 15      
a. gender = men, decade = 20s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 15 390.66 516.82 438.701 8.826 34.183 
t45tod 15 823.20 1002.30 928.800 12.584 48.737 
t45toa 15 390.08 575.52 474.037 12.798 49.566 
t45coc 15 379.69 477.10 419.369 7.303 28.286 
t45cod 15 1116.00 1190.90 1156.253 5.307 20.555 
t45coa 15 324.80 413.44 362.763 6.360 24.633 
t45cth 15 5.59 6.78 6.368 .082 .319 
t45peri 15 70.01 85.04 77.083 1.039 4.026 
t45endo 15 28.64 45.13 37.073 1.307 5.061 
t55toc 15 354.00 548.49 449.133 12.045 46.651 
t55tod 15 746.00 937.20 871.153 13.696 53.044 
t55toa 15 422.08 666.72 517.621 16.930 65.570 
t55coc 15 337.56 509.85 427.397 10.961 42.453 
t55cod 15 1110.10 1184.60 1148.627 5.462 21.156 
t55coa 15 284.96 447.20 372.309 9.887 38.293 
t55cth 15 4.98 6.69 6.070 .131 .507 
t55peri 15 72.83 91.53 80.504 1.304 5.052 
t55endo 15 34.33 52.52 42.640 1.504 5.825 
t65toc 15 394.73 540.38 460.047 10.236 39.645 
t65tod 15 613.40 841.00 768.620 16.293 63.103 
t65toa 15 475.52 784.16 603.168 20.452 79.210 
t65coc 15 364.38 486.90 424.989 9.177 35.542 
t65cod 15 1071.30 1166.60 1129.653 6.476 25.081 
t65coa 15 323.52 434.24 376.203 7.908 30.628 
t65cth 15 4.29 6.01 5.403 .116 .449 
t65peri 15 77.30 99.27 86.890 1.459 5.650 
t65endo 15 43.71 66.31 52.946 1.869 7.240 
t75toc 15 340.40 533.34 446.866 12.565 48.663 
t75tod 15 455.70 702.40 606.845 17.879 69.245 
t75toa 15 570.08 955.52 743.595 27.155 105.171 
t75coc 15 281.88 438.28 371.719 11.551 44.737 
t75cod 15 1054.30 1130.90 1097.920 4.919 19.052 
t75coa 15 252.16 400.48 338.613 10.565 40.916 
t75cth 15 2.75 4.84 4.077 .149 .577 
t75peri 15 84.64 109.58 96.446 1.742 6.746 
t75endo 15 53.03 89.62 68.830 2.382 9.226 
Valid N (listwise) 15      
a. gender = men, decade = 20s 
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Descriptive Statistics
a
 
 
N Minimum Maximum Mean 
Std. 
Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 15 433.28 614.99 533.147 12.787 49.524 
t85tod 15 314.80 530.40 453.487 16.392 63.487 
t85toa 15 826.24 1587.68 1197.184 51.307 198.711 
t85trc 15 98.05 267.14 174.669 10.750 41.637 
t85trd 15 166.70 277.10 219.600 7.949 30.787 
t85tra 15 485.12 1299.84 806.251 54.625 211.560 
t85coc 15 154.93 361.05 301.476 13.149 50.925 
t85cod 15 976.10 1064.20 1022.827 6.025 23.336 
t85coa 15 158.72 361.60 294.475 12.632 48.925 
t85cth 15 1.66 3.26 2.668 .115 .444 
t85peri 15 100.79 134.21 119.062 2.594 10.047 
t85endo 15 82.07 119.38 102.289 2.725 10.553 
t15imax 15 10053.36 17244.26 13807.877 578.267 2239.618 
t15imin 15 8727.70 16663.83 12207.506 593.041 2296.838 
t15irat 15 1.00 1.45 1.143 .036 .140 
t15ssi 15 1495.71 2118.02 1782.273 50.758 196.585 
t15ssitoc 15 5.37 8.35 5.987 .200 .774 
t25imax 15 10032.99 16873.23 14207.997 598.692 2318.724 
t25imin 15 7788.27 16042.06 10668.482 617.636 2392.095 
t25irat 15 1.03 1.81 1.362 .061 .235 
t25ssi 15 1421.62 2264.05 1768.328 58.935 228.256 
t25ssitoc 15 4.41 5.80 5.066 .115 .446 
t35imax 15 11984.09 25191.31 18494.226 958.874 3713.702 
t35imin 15 8584.78 16390.71 11619.836 624.378 2418.205 
t35irat 15 1.08 2.32 1.628 .093 .360 
t35ssi 15 1576.73 2488.56 1911.526 67.496 261.412 
t35ssitoc 15 4.24 6.82 4.882 .167 .648 
t45imax 15 16367.71 33848.19 23557.139 1209.746 4685.327 
t45imin 15 9002.50 19584.86 14409.925 1019.248 3947.530 
t45irat 15 1.02 2.71 1.735 .135 .525 
t45ssi 15 1680.86 2825.90 2173.440 80.086 310.171 
t45ssitoc 15 4.30 5.47 4.935 .098 .380 
Valid N (listwise) 15      
a. gender = men, decade = 20s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 15 18506.92 41977.78 28205.893 1522.860 5898.012 
t55imin 15 9355.46 25355.16 18068.968 1400.051 5422.375 
t55irat 15 1.06 3.06 1.703 .167 .648 
t55ssi 15 1837.68 3505.40 2503.933 109.377 423.616 
t55ssitoc 15 4.61 7.79 5.579 .204 .792 
t65imax 15 23341.51 56629.11 35210.039 2137.491 8278.465 
t65imin 15 10933.78 29327.92 20646.498 1589.869 6157.536 
t65irat 15 1.10 3.43 1.856 .181 .701 
t65ssi 15 2123.73 4028.36 2893.269 123.307 477.565 
t65ssitoc 15 5.38 7.47 6.262 .160 .621 
t75imax 15 30005.42 67459.31 45101.439 2509.716 9720.089 
t75imin 15 13162.76 36977.80 26271.495 2023.132 7835.555 
t75irat 15 1.03 3.15 1.864 .171 .662 
t75ssi 15 2414.99 4513.25 3341.465 132.548 513.356 
t75ssitoc 15 6.28 11.00 7.511 .299 1.1567 
t85imax 15 46650.99 94549.74 71839.292 3929.395 15218.480 
t85imin 15 21216.69 55513.29 37960.109 2661.088 10306.351 
t85irat 15 1.10 3.44 2.008 .158 .612 
t85ssi 15 3223.76 5642.90 4210.721 170.120 658.870 
t85ssitoc 15 6.48 9.18 7.869 .174 .674 
toc515r 15 1.14 1.84 1.344 .042 .163 
toc535r 15 .86 1.32 1.024 .0314 .122 
toc585r 15 .69 .94 .752 .0176 .068 
toc565r 15 .77 1.03 .871 .019 .074 
tcsa65 15 8926.40 13955.52 11111.691 360.787 1397.321 
fcsa65 15 360.80 2632.48 1314.891 163.210 632.111 
mcsa65 15 7199.04 11780.96 9101.419 360.601 1396.602 
Valid N (listwise) 15      
a. gender = men, decade = 20s 
 
 
 
 
 
 
154 
 
Gender = Men, Decade = 30s 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 295.67 536.81 376.949 15.806 61.218 
t5tod 15 262.30 428.90 334.247 11.577 44.836 
t5toa 15 917.12 1488.96 1134.357 41.023 158.881 
t5trc 15 190.29 407.31 259.566 13.008 50.381 
t5trd 15 227.00 343.40 266.713 7.900 30.595 
t5tra 15 778.24 1357.12 976.245 42.502 164.609 
t15toc 15 227.16 394.50 303.981 10.592 41.023 
t15tod 15 501.40 734.60 610.707 17.506 67.800 
t15toa 15 404.00 628.32 500.192 16.406 63.539 
t15trc 15 18.83 235.39 49.634 13.766 53.317 
t15trd 15 92.60 1063.80 204.707 62.110 240.551 
t15tra 15 172.32 360.96 254.069 13.999 54.219 
t15coc 15 190.05 318.61 250.941 8.220 31.836 
t15cod 15 1120.00 1159.60 1141.133 3.206 12.415 
t15coa 15 164.32 277.92 219.989 7.333 28.400 
t15cth 15 2.46 4.28 3.203 .125 .482 
t15peri 15 71.25 88.86 79.134 1.292 5.004 
t15endo 15 48.09 70.10 59.012 1.663 6.440 
t25toc 15 277.47 438.25 357.069 10.359 40.120 
t25tod 15 754.40 957.70 848.793 16.579 64.212 
t25toa 15 357.28 522.08 421.355 11.165 43.243 
t25coc 15 260.35 408.16 336.938 9.718 37.639 
t25cod 15 1153.60 1201.10 1180.220 3.972 15.384 
t25coa 15 218.88 345.60 285.653 8.579 33.225 
t25cth 15 3.94 6.35 5.037 .157 .606 
t25peri 15 67.01 81.00 72.678 .957 3.707 
t25endo 15 32.40 48.15 40.318 1.223 4.737 
t35toc 15 356.86 507.16 419.781 11.530 44.656 
t35tod 15 834.70 1034.00 936.640 12.182 47.180 
t35toa 15 397.60 534.08 448.128 10.546 40.843 
t35coc 15 343.02 488.68 404.475 11.031 42.721 
t35cod 15 1145.30 1214.00 1176.100 5.432 21.039 
t35coa 15 287.36 420.48 344.373 10.459 40.509 
t35cth 15 5.10 7.30 6.212 .172 .664 
t35peri 15 70.69 81.92 74.971 .874 3.386 
t35endo 15 27.93 43.50 35.938 .937 3.631 
Valid N (listwise) 15      
a. gender = men, decade = 30s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 15 401.72 556.83 455.687 11.762 45.554 
t45tod 15 843.40 994.60 920.547 10.796 41.814 
t45toa 15 437.92 580.48 495.019 11.157 43.210 
t45coc 15 380.06 522.37 435.481 11.047 42.784 
t45cod 15 1135.20 1201.50 1165.680 5.423 21.004 
t45coa 15 323.04 458.88 374.048 10.601 41.057 
t45cth 15 5.55 7.37 6.357 .157 .607 
t45peri 15 74.18 85.41 78.802 .882 3.414 
t45endo 15 33.32 44.82 38.863 .840 3.252 
t55toc 15 406.32 573.13 469.339 12.971 50.238 
t55tod 15 758.70 899.70 840.473 10.268 39.770 
t55toa 15 481.12 641.92 558.187 12.699 49.181 
t55coc 15 387.29 555.02 446.518 12.521 48.493 
t55cod 15 1115.40 1186.60 1153.447 5.426 21.013 
t55coa 15 329.76 489.44 387.595 11.960 46.320 
t55cth 15 5.15 7.33 5.965 .159 .615 
t55peri 15 77.76 89.81 83.676 .956 3.689 
t55endo 15 40.31 52.81 46.198 .822 3.184 
t65toc 15 392.09 596.32 471.819 14.626 56.645 
t65tod 15 646.70 811.10 725.833 13.168 51.000 
t65toa 15 546.24 740.48 650.453 16.542 64.069 
t65coc 15 360.59 548.17 433.906 13.400 51.898 
t65cod 15 1107.10 1157.50 1131.493 4.504 17.442 
t65coa 15 311.52 487.20 383.861 12.619 48.872 
t65cth 15 4.52 6.58 5.189 .156 .602 
t65peri 15 82.85 96.46 90.305 1.163 4.503 
t65endo 15 49.75 64.33 57.704 1.206 4.670 
t75toc 15 409.68 628.84 463.746 16.001 61.973 
t75tod 15 455.00 659.80 546.867 15.518 60.101 
t75toa 15 671.84 953.12 850.507 21.630 83.771 
t75coc 15 339.34 516.32 389.980 13.749 53.250 
t75cod 15 1065.60 1126.30 1093.793 4.838 18.737 
t75coa 15 308.64 477.28 356.715 12.925 50.057 
t75cth 15 3.23 5.11 3.931 .140 .540 
t75peri 15 91.88 109.44 103.259 1.346 5.212 
t75endo 15 65.95 87.95 78.362 1.560 6.042 
Valid N (listwise) 15      
a. gender = men, decade = 30s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 15 403.76 695.07 496.298 22.601 87.534 
t85tod 15 248.50 446.60 354.893 13.830 53.563 
t85toa 15 1056.96 1625.12 1405.835 43.709 169.284 
t85trc 15 117.21 308.85 170.014 14.148 54.796 
t85trd 15 101.30 918.10 208.000 51.473 199.354 
t85tra 15 732.32 1335.52 1034.635 40.504 156.872 
t85coc 15 211.50 437.54 283.725 14.112 54.655 
t85cod 15 918.10 1041.40 1005.253 7.919 30.672 
t85coa 15 208.48 420.16 282.219 13.581 52.597 
t85cth 15 1.68 3.28 2.299 .106 .409 
t85peri 15 114.65 141.66 130.197 2.029 7.858 
t85endo 15 99.17 131.08 115.753 2.120 8.211 
t15imax 15 10951.22 23501.35 15587.448 785.076 3040.585 
t15imin 15 8774.28 19781.43 13838.322 726.703 2814.510 
t15irat 15 1.01 1.33 1.134 .027 .103 
t15ssi 15 1482.78 2599.30 1860.613 76.576 296.576 
t15ssitoc 15 5.35 6.78 6.121 .121 .469 
t25imax 15 10982.90 23248.08 15715.268 872.571 3379.455 
t25imin 15 8441.35 17555.36 11658.973 648.572 2511.909 
t25irat 15 1.01 1.85 1.364 .055 .213 
t25ssi 15 1487.32 2622.51 1905.035 74.867 289.957 
t25ssitoc 15 4.68 5.98 5.325 .100 .389 
t35imax 15 16172.70 31254.24 21856.252 1120.244 4338.688 
t35imin 15 8652.26 17341.07 12043.560 648.415 2511.301 
t35irat 15 1.45 2.33 1.836 .067 .258 
t35ssi 15 1708.34 2679.51 2077.643 70.897 274.584 
t35ssitoc 15 4.52 5.48 4.944 .077 .297 
t45imax 15 18749.86 37486.99 27321.229 1408.202 5453.944 
t45imin 15 11332.27 21204.90 14798.270 812.907 3148.375 
t45irat 15 1.33 2.66 1.884 .097 .370 
t45ssi 15 1927.74 2943.17 2314.608 74.725 289.408 
t45ssitoc 15 4.71 5.67 5.07 .077 .299 
Valid N 
(listwise) 
15 
     
a. gender = men, decade = 30s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 15 20686.87 45033.76 31873.772 1757.103 6805.229 
t55imin 15 14067.53 30578.71 19827.988 1153.324 4466.804 
t55irat 15 1.16 2.66 1.649 .104 .401 
t55ssi 15 2188.88 3383.93 2700.845 89.948 348.366 
t55ssitoc 15 5.27 6.25 5.747 .078 .304 
t65imax 15 24807.09 54851.57 40096.465 2056.650 ###### 
t65imin 15 16026.59 37697.96 24077.359 1515.495 ##### 
t65irat 15 1.11 2.89 1.7510 .114 .442 
t65ssi 15 2444.11 4042.50 3172.868 119.010 460.915 
t65ssitoc 15 6.14 7.36 6.713 .104 .402 
t75imax 15 36626.99 71844.81 54149.617 3037.970 11766.007 
t75imin 15 22748.97 49557.28 31521.603 2077.406 8045.760 
t75irat 15 1.01 2.67 1.794 .134 .518 
t75ssi 15 2416.89 4973.14 3734.407 166.358 644.300 
t75ssitoc 15 5.77 8.90 8.039 .206 .799 
t85imax 15 60706.46 125153.25 83057.482 4293.844 16629.988 
t85imin 15 24087.57 64587.17 42575.600 2950.693 11427.986 
t85irat 15 1.60 2.95 2.016 .104 .402 
t85ssi 15 3453.00 6686.97 4524.957 222.922 863.372 
t85ssitoc 15 8.09 10.25 9.117 .171 .662 
toc515r 15 1.14 1.36 1.239 .019 .073 
toc535r 15 .79 1.06 .895 .019 .073 
toc585r 15 .67 .97 .764 .019 .073 
toc565r 15 .69 .90 .797 .015 .057 
tcsa65 15 8726.72 15114.08 11937.045 557.301 2158.418 
fcsa65 15 828.96 4315.20 2196.107 291.428 1128.693 
mcsa65 15 6789.76 10727.04 8985.216 311.296 1205.642 
Valid N 
(listwise) 
15 
     
a. gender = men, decade = 30s 
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Gender = men, Decade = 40s 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 10 323.67 509.99 394.339 17.910 56.637 
t5tod 10 315.50 413.00 360.580 10.020 31.685 
t5toa 10 933.60 1312.16 1094.736 41.026 129.735 
t5trc 10 83.16 374.58 234.204 26.117 82.569 
t5trd 10 256.30 754.30 377.970 59.888 189.382 
t5tra 10 745.44 1168.48 923.456 39.687 125.500 
t15toc 10 251.92 393.71 320.811 12.2516 38.740 
t15tod 10 486.90 709.30 623.630 21.453 67.841 
t15toa 10 428.32 635.68 517.728 20.905 66.109 
t15trc 10 30.59 275.74 88.301 30.764 97.286 
t15trd 10 108.10 1112.90 352.700 124.987 395.244 
t15tra 10 169.28 333.44 260.256 19.354 61.201 
t15coc 10 201.90 312.03 264.762 9.323 29.482 
t15cod 10 1065.50 1179.30 1140.390 10.623 33.594 
t15coa 10 171.20 274.40 232.320 8.206 25.951 
t15cth 10 2.34 3.72 3.336 .137 .4337 
t15peri 10 73.37 89.38 80.512 1.627 5.144 
t15endo 10 50.17 67.38 59.550 2.117 6.694 
t25toc 10 265.21 451.47 367.339 15.217 48.119 
t25tod 10 695.30 921.20 847.520 20.556 65.002 
t25toa 10 375.04 537.76 433.312 15.022 47.502 
t25coc 10 245.44 428.29 345.861 14.821 46.867 
t25cod 10 1102.70 1215.50 1170.580 11.527 36.451 
t25coa 10 201.92 365.28 297.856 14.117 44.641 
t25cth 10 3.46 5.82 5.186 .229 .725 
t25peri 10 68.65 82.21 73.785 1.283 4.056 
t25endo 10 35.19 47.50 41.199 1.443 4.562 
t35toc 10 348.43 529.65 426.950 16.005 50.613 
t35tod 10 888.80 1017.70 944.040 14.351 45.383 
t35toa 10 363.84 558.40 450.103 17.724 56.047 
t35coc 10 336.72 503.79 408.363 15.369 48.601 
t35cod 10 1098.20 1232.20 1172.320 11.157 35.282 
t35coa 10 273.28 429.12 348.624 13.393 42.351 
t35cth 10 5.39 7.37 6.274 .203 .642 
t35peri 10 67.62 83.77 75.320 1.453 4.594 
t35endo 10 27.75 42.56 35.898 1.580 4.995 
Valid N (listwise) 10      
a. gender = men, decade = 40s 
 
159 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 10 393.41 577.90 463.571 17.568 55.554 
t45tod 10 829.30 1032.00 928.970 21.020 66.472 
t45toa 10 394.56 619.52 500.896 20.724 65.535 
t45coc 10 371.00 480.42 433.025 12.954 40.964 
t45cod 10 1103.70 1216.40 1166.840 10.325 32.649 
t45coa 10 314.40 471.52 377.952 14.383 45.483 
t45cth 10 5.40 7.57 6.425 .221 .700 
t45peri 10 70.41 88.23 79.185 1.638 5.179 
t45endo 10 28.43 48.42 38.816 2.063 6.524 
t55toc 10 395.49 584.41 474.102 18.375 58.106 
t55tod 10 761.00 974.70 856.630 22.534 71.258 
t55toa 10 437.76 699.52 556.480 25.010 79.089 
t55coc 10 366.32 558.98 448.863 18.793 59.430 
t55cod 10 1079.40 1204.50 1156.320 10.965 34.675 
t55coa 10 313.92 481.12 388.048 15.462 48.895 
t55cth 10 5.18 7.00 6.032 .207 .654 
t55peri 10 74.17 93.76 83.435 1.869 5.912 
t55endo 10 34.30 54.46 45.534 2.192 6.930 
t65toc 10 368.88 586.31 476.782 19.882 62.873 
t65tod 10 649.20 887.30 743.420 21.831 69.037 
t65toa 10 532.96 839.52 644.080 28.693 90.734 
t65coc 10 331.35 546.54 438.549 20.343 64.328 
t65cod 10 1041.40 1191.60 1135.180 11.921 37.698 
t65coa 10 278.08 477.76 386.320 17.275 54.628 
t65cth 10 4.02 6.33 5.291 .219 .691 
t65peri 10 81.84 102.71 89.772 1.964 6.210 
t65endo 10 42.49 67.42 56.530 2.196 6.945 
t75toc 10 381.81 573.40 474.984 18.990 60.053 
t75tod 10 491.10 731.20 584.260 22.246 70.349 
t75toa 10 645.60 1086.24 819.280 37.007 117.027 
t75coc 10 294.93 493.55 399.237 19.898 62.924 
t75cod 10 1021.90 1154.20 1104.520 10.905 34.485 
t75coa 10 255.52 447.36 361.408 17.458 55.207 
t75cth 10 2.92 5.12 4.110 .209 .662 
t75peri 10 90.07 116.83 101.244 2.237 7.074 
t75endo 10 57.89 89.60 75.420 2.700 8.537 
Valid N (listwise) 10      
a. gender = men, decade = 40s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 10 436.31 661.13 536.755 25.424 80.396 
t85tod 10 320.80 517.90 403.690 16.931 53.542 
t85toa 10 992.16 1559.36 1337.888 55.977 177.014 
t85trc 10 111.63 369.24 208.352 28.901 91.392 
t85trd 10 132.90 935.40 328.420 99.431 314.427 
t85tra 10 585.60 1100.00 922.928 49.212 155.621 
t85coc 10 192.96 458.89 318.412 23.830 75.356 
t85cod 10 947.30 1063.70 1029.360 10.516 33.254 
t85coa 10 203.68 436.64 308.240 21.445 67.816 
t85cth 10 1.77 3.45 2.631 .174 .550 
t85peri 10 110.41 137.43 125.451 3.032 9.586 
t85endo 10 89.99 122.43 108.918 3.054 9.657 
t15imax 10 12910.29 25363.50 16835.977 1173.365 3710.504 
t15imin 10 9800.46 20222.11 14002.965 1056.606 3341.282 
t15irat 10 1.01 1.52 1.220 .054 .169 
t15ssi 10 1622.20 2662.60 2015.251 103.159 326.217 
t15ssitoc 10 5.49 6.76 6.268 .152 .479 
t25imax 10 10337.97 29428.87 17472.245 1535.475 4855.599 
t25imin 10 8010.17 15883.78 11929.051 772.672 2443.404 
t25irat 10 1.11 2.10 1.474 .096 .302 
t25ssi 10 1539.55 2633.74 1976.084 106.733 337.518 
t25ssitoc 10 4.50 5.83 5.371 .137 .432 
t35imax 10 11524.64 38732.16 23381.534 2107.104 6663.248 
t35imin 10 8009.74 15727.17 12154.654 873.286 2761.573 
t35irat 10 1.13 2.72 1.966 .166 .526 
t35ssi 10 1637.79 2934.20 2140.774 117.989 373.115 
t35ssitoc 10 4.56 5.54 4.990 .108 .343 
t45imax 10 15902.79 49848.26 29995.201 2778.344 8785.895 
t45imin 10 8971.16 22997.69 14566.379 1514.411 4788.988 
t45irat 10 1.10 3.43 2.221 .254 .804 
t45ssi 10 1785.60 3340.59 2378.775 142.261 449.868 
t45ssitoc 10 4.42 5.78 5.103 .136 .430 
Valid N 
(listwise) 
10 
     
a. gender = men, decade = 40s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 10 19692.48 59352.15 35031.980 3474.576 10987.575 
t55imin 10 10182.21 28331.48 18389.669 2265.674 7164.690 
t55irat 10 1.04 3.72 2.172 .313 .991 
t55ssi 10 1969.02 3921.03 2689.296 181.897 575.208 
t55ssitoc 10 4.72 6.71 5.630 .188 .594 
t65imax 10 20279.79 74365.59 42869.511 4502.625 14238.552 
t65imin 10 11894.23 35325.56 21912.098 2537.354 8023.817 
t65irat 10 1.00 3.70 2.194 .315 .997 
t65ssi 10 2258.41 4680.82 3186.757 214.810 679.290 
t65ssitoc 10 5.50 7.98 6.638 .208 .658 
t75imax 10 29857.98 99201.93 55097.875 5916.792 18710.538 
t75imin 10 17263.65 39881.90 28924.545 2999.577 9485.494 
t75irat 10 1.04 3.32 2.078 .267 .846 
t75ssi 10 2843.22 5662.99 3784.535 252.931 799.838 
t75ssitoc 10 6.45 9.88 7.921 .268 .845 
t85imax 10 45304.05 144779.68 89404.685 8503.699 26891.058 
t85imin 10 25972.17 58672.88 40957.319 3545.051 11210.435 
t85irat 10 1.34 3.00 2.135 .183 .578 
t85ssi 10 3080.58 6893.57 4820.431 340.040 1075.300 
t85ssitoc 10 7.06 10.51 8.922 .325 1.029 
toc515r 10 1.06 1.37 1.230 .030 .093 
toc535r 10 .75 1.00 .924 .024 .076 
toc585r 10 .65 .79 .737 .014 .045 
toc565r 10 .69 .94 .830 .024 .076 
tcsa65 10 9372.80 14679.52 11945.184 496.259 1569.307 
fcsa65 10 851.68 3397.60 1741.712 275.991 872.760 
mcsa65 10 7666.72 10943.84 9462.240 329.386 1041.611 
Valid N 
(listwise) 
10 
     
a. gender = men, decade = 40s 
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Gender = men, Decade = 50s 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 259.70 459.32 347.125 13.746 53.238 
t5tod 15 264.90 417.40 330.060 11.446 44.332 
t5toa 15 823.04 1279.04 1059.104 38.040 147.328 
t5trc 15 78.50 327.45 204.431 16.971 65.727 
t5trd 15 217.20 801.20 345.127 53.025 205.366 
t5tra 15 639.36 1259.84 919.367 43.145 167.101 
t15toc 15 232.18 368.42 288.440 9.419 36.478 
t15tod 15 514.30 757.20 595.267 15.866 61.447 
t15toa 15 352.48 600.96 489.504 20.254 78.442 
t15trc 15 13.45 267.91 79.153 22.685 87.859 
t15trd 15 84.60 1110.90 330.880 102.349 396.396 
t15tra 15 134.56 342.56 257.813 15.651 60.617 
t15coc 15 206.27 290.45 237.371 6.515 25.231 
t15cod 15 1047.40 1159.90 1137.913 7.509 29.082 
t15coa 15 178.56 261.76 208.725 5.898 22.845 
t15cth 15 2.51 3.62 3.054 .074 .287 
t15peri 15 66.55 86.90 78.185 1.656 6.415 
t15endo 15 43.84 68.17 58.998 1.843 7.137 
t25toc 15 270.45 441.27 343.335 11.919 46.164 
t25tod 15 713.50 958.20 825.500 19.488 75.478 
t25toa 15 309.76 515.36 419.787 18.212 70.536 
t25coc 15 260.59 412.49 319.455 11.169 43.257 
t25cod 15 1110.30 1205.90 1173.153 6.073 23.519 
t25coa 15 218.40 354.24 272.523 9.807 37.984 
t25cth 15 3.95 5.65 4.760 .139 .537 
t25peri 15 62.39 80.48 72.386 1.592 6.167 
t25endo 15 31.52 55.21 42.478 1.816 7.035 
t35toc 15 297.32 513.20 398.634 15.033 58.224 
t35tod 15 727.50 999.60 898.920 19.788 76.639 
t35toa 15 342.24 553.28 446.955 19.833 76.811 
t35coc 15 284.37 492.88 375.427 14.294 55.361 
t35cod 15 1109.00 1212.80 1172.147 7.253 28.091 
t35coa 15 240.80 420.64 320.608 12.627 48.905 
t35cth 15 4.37 7.01 5.647 .180 .695 
t35peri 15 65.58 83.38 74.682 1.674 6.485 
t35endo 15 28.68 55.59 39.202 1.908 7.389 
Valid N (listwise) 15      
163 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 259.70 459.32 347.125 13.746 53.238 
t5tod 15 264.90 417.40 330.060 11.446 44.332 
t5toa 15 823.04 1279.04 1059.104 38.040 147.328 
t5trc 15 78.50 327.45 204.431 16.971 65.727 
t5trd 15 217.20 801.20 345.127 53.025 205.366 
t5tra 15 639.36 1259.84 919.367 43.145 167.101 
t15toc 15 232.18 368.42 288.440 9.419 36.478 
t15tod 15 514.30 757.20 595.267 15.866 61.447 
t15toa 15 352.48 600.96 489.504 20.254 78.442 
t15trc 15 13.45 267.91 79.153 22.685 87.859 
t15trd 15 84.60 1110.90 330.880 102.349 396.396 
t15tra 15 134.56 342.56 257.813 15.651 60.617 
t15coc 15 206.27 290.45 237.371 6.515 25.231 
t15cod 15 1047.40 1159.90 1137.913 7.509 29.082 
t15coa 15 178.56 261.76 208.725 5.898 22.845 
t15cth 15 2.51 3.62 3.054 .074 .287 
t15peri 15 66.55 86.90 78.185 1.656 6.415 
t15endo 15 43.84 68.17 58.998 1.843 7.137 
t25toc 15 270.45 441.27 343.335 11.919 46.164 
t25tod 15 713.50 958.20 825.500 19.488 75.478 
t25toa 15 309.76 515.36 419.787 18.212 70.536 
t25coc 15 260.59 412.49 319.455 11.169 43.257 
t25cod 15 1110.30 1205.90 1173.153 6.073 23.519 
t25coa 15 218.40 354.24 272.523 9.807 37.984 
t25cth 15 3.95 5.65 4.760 .139 .537 
t25peri 15 62.39 80.48 72.386 1.592 6.167 
t25endo 15 31.52 55.21 42.478 1.816 7.035 
t35toc 15 297.32 513.20 398.634 15.033 58.224 
t35tod 15 727.50 999.60 898.920 19.788 76.639 
t35toa 15 342.24 553.28 446.955 19.833 76.811 
t35coc 15 284.37 492.88 375.427 14.294 55.361 
t35cod 15 1109.00 1212.80 1172.147 7.253 28.091 
t35coa 15 240.80 420.64 320.608 12.627 48.905 
t35cth 15 4.37 7.01 5.647 .180 .695 
t35peri 15 65.58 83.38 74.682 1.674 6.485 
t35endo 15 28.68 55.59 39.202 1.908 7.389 
Valid N (listwise) 15      
a. gender = men, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 15 331.78 555.14 432.378 15.601 60.422 
t45tod 15 715.20 955.80 866.353 18.017 69.779 
t45toa 15 392.16 615.68 502.336 20.788 80.513 
t45coc 15 315.37 521.79 405.519 14.706 56.958 
t45cod 15 1084.30 1205.20 1158.700 7.433 28.787 
t45coa 15 271.36 450.40 350.144 12.792 49.542 
t45cth 15 4.48 7.15 5.733 .166 .644 
t45peri 15 70.20 87.96 79.208 1.660 6.431 
t45endo 15 34.62 59.79 43.189 1.837 7.114 
t55toc 15 342.65 560.85 448.244 16.088 62.309 
t55tod 15 680.70 875.60 805.053 15.594 60.397 
t55toa 15 255.20 667.36 531.477 28.945 112.105 
t55coc 15 325.80 527.59 416.399 15.474 59.932 
t55cod 15 1066.20 1183.30 1149.227 7.023 27.199 
t55coa 15 279.68 458.40 362.432 13.454 52.108 
t55cth 15 4.22 6.64 5.457 .159 .615 
t55peri 15 73.21 92.72 83.641 1.737 6.729 
t55endo 15 41.22 65.09 49.354 1.849 7.160 
t65toc 15 347.67 550.26 448.818 15.098 58.475 
t65tod 15 580.70 775.60 694.900 14.061 54.459 
t65toa 15 469.28 825.28 651.403 28.181 109.143 
t65coc 15 326.93 505.10 405.248 13.607 52.699 
t65cod 15 1059.70 1160.30 1127.080 6.279 24.319 
t65coa 15 284.80 450.88 359.819 12.411 48.069 
t65cth 15 3.88 5.80 4.795 .117 .454 
t65peri 15 76.79 101.84 90.173 1.977 7.656 
t65endo 15 48.15 74.79 60.049 2.041 7.905 
t75toc 15 346.73 537.03 432.175 14.037 54.365 
t75tod 15 431.60 637.50 538.160 14.084 54.545 
t75toa 15 570.88 1086.72 814.048 38.770 150.155 
t75coc 15 292.74 452.82 359.709 10.682 41.369 
t75cod 15 1031.90 1125.10 1096.927 6.233 24.139 
t75coa 15 263.20 417.28 328.117 10.057 38.951 
t75cth 15 3.26 4.39 3.729 .082 .319 
t75peri 15 84.70 116.86 100.811 2.439 9.447 
t75endo 15 60.11 94.46 77.379 2.526 9.782 
Valid N (listwise) 15      
a. gender = men, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 15 351.77 575.00 464.904 17.731 68.671 
t85tod 15 263.20 452.20 360.747 12.383 47.959 
t85toa 15 983.68 1928.00 1314.955 72.953 282.547 
t85trc 15 76.82 354.54 179.036 25.776 99.831 
t85trd 15 100.20 934.10 293.567 84.232 326.231 
t85tra 15 620.64 1537.44 957.259 69.083 267.558 
t85coc 15 229.50 354.00 280.542 8.935 34.605 
t85cod 15 985.80 1062.40 1029.093 6.012 23.284 
t85coa 15 216.32 344.64 272.608 8.429 32.644 
t85cth 15 1.87 2.82 2.351 .089 .345 
t85peri 15 108.66 150.38 124.427 3.191 12.360 
t85endo 15 92.44 138.02 109.667 3.534 13.685 
t15imax 15 8721.40 21420.25 14258.125 986.723 3821.563 
t15imin 15 7370.14 18625.43 12735.761 878.205 3401.275 
t15irat 15 1.02 1.25 1.124 .020 .079 
t15ssi 15 1284.13 2501.29 1799.058 90.482 350.434 
t15ssitoc 15 4.81 7.03 6.198 .146 .566 
t25imax 15 9888.28 25724.03 15699.348 1164.101 4508.544 
t25imin 15 5495.97 19292.58 11300.194 1028.002 3981.433 
t25irat 15 1.02 1.88 1.452 .079 .304 
t25ssi 15 1205.96 2566.56 1859.877 108.227 419.161 
t25ssitoc 15 4.45 6.21 5.366 .165 .640 
t35imax 15 13628.48 34131.00 20682.889 1491.283 5775.714 
t35imin 15 5941.24 23938.24 12715.937 1287.586 4986.798 
t35irat 15 1.08 2.50 1.741 .109 .423 
t35ssi 15 1377.74 2780.18 2056.456 121.948 472.304 
t35ssitoc 15 4.26 5.99 5.111 .154 .597 
t45imax 15 18977.33 42573.47 26820.110 1782.487 6903.543 
t45imin 15 7113.59 27990.56 15475.545 1759.563 6814.757 
t45irat 15 1.04 2.70 1.957 .159 .616 
t45ssi 15 1612.15 2973.22 2332.002 128.153 496.334 
t45ssitoc 15 4.61 6.32 5.350 .145 .561 
Valid N 
(listwise) 
15 
     
a. gender = men, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 15 17406.03 49600.64 32023.119 2286.458 8855.413 
t55imin 15 10478.52 32433.64 18706.152 1730.123 6700.739 
t55irat 15 1.02 2.62 1.818 .131 .508 
t55ssi 15 1832.95 3517.98 2706.631 141.029 546.202 
t55ssitoc 15 5.16 7.04 5.995 .137 .532 
t65imax 15 23411.28 57883.88 39940.232 2691.033 10422.325 
t65imin 15 11838.51 38356.26 22567.580 2147.190 8316.033 
t65irat 15 1.15 2.56 1.884 .123 .475 
t65ssi 15 2071.37 4097.60 3106.765 166.826 646.113 
t65ssitoc 15 5.96 8.29 6.863 .176 .683 
t75imax 15 24584.00 78244.83 48514.652 3742.649 14495.217 
t75imin 15 16032.25 58173.61 29034.347 2774.050 10743.851 
t75irat 15 1.06 2.59 1.779 .144 .556 
t75ssi 15 2352.37 4957.00 3494.009 194.013 751.409 
t75ssitoc 15 6.78 9.64 8.009 .210 .812 
t85imax 15 41350.55 111762.61 75359.590 5058.9270 19593.138 
t85imin 15 19878.82 82926.56 41639.405 4074.205 15779.330 
t85irat 15 1.21 3.22 1.944 .148 .571 
t85ssi 15 2464.90 5656.34 4285.824 219.289 849.303 
t85ssitoc 15 7.01 10.40 9.163 .199 .769 
toc515r 15 1.08 1.35 1.203 .024 .093 
toc535r 15 .71 1.05 .875 .026 .099 
toc585r 15 .58 .87 .750 .020 .077 
toc565r 15 .66 .95 .775 .021 .082 
tcsa65 15 7880.00 14082.72 11441.653 489.955 1897.588 
fcsa65 15 728.80 3273.76 1534.347 169.735 657.379 
mcsa65 15 6305.76 12051.04 9154.347 388.258 1503.718 
Valid N (listwise) 14      
a. gender = men, decade = 50s 
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Gender = women, Decade = 20s 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 200.88 364.75 287.249 11.194 43.355 
t5tod 15 257.80 422.40 347.420 11.839 45.852 
t5toa 15 719.20 908.96 827.179 17.083 66.162 
t5trc 15 105.78 258.87 175.374 11.916 46.151 
t5trd 15 169.10 880.00 417.080 69.085 267.567 
t5tra 15 113.60 783.36 654.517 42.441 164.374 
t15toc 15 187.52 278.22 240.163 7.895 30.577 
t15tod 15 469.90 747.20 609.807 17.007 65.869 
t15toa 15 309.92 451.20 395.179 10.831 41.948 
t15trc 15 14.49 239.29 82.179 23.093 89.439 
t15trd 15 65.00 1128.90 403.860 113.997 441.508 
t15tra 15 114.56 245.28 204.576 8.998 34.849 
t15coc 15 162.57 229.46 200.446 5.803 22.471 
t15cod 15 1125.90 1185.40 1156.220 4.348 16.838 
t15coa 15 141.28 202.24 173.344 4.952 19.179 
t15cth 15 2.21 3.33 2.823 .078 .300 
t15peri 15 62.41 75.30 70.374 .981 3.801 
t15endo 15 41.46 56.91 52.635 1.110 4.297 
t25toc 15 223.64 324.25 271.919 8.394 32.507 
t25tod 15 724.20 947.80 848.753 17.828 69.048 
t25toa 15 269.60 379.84 321.205 9.594 37.158 
t25coc 15 212.20 306.76 257.261 7.938 30.743 
t25cod 15 1166.80 1215.60 1194.307 4.218 16.335 
t25coa 15 174.56 262.72 216.544 6.786 26.282 
t25cth 15 3.42 5.06 4.405 .139 .542 
t25peri 15 58.21 69.09 63.434 .945 3.662 
t25endo 15 26.41 42.99 35.740 1.3023 5.046 
t35toc 15 260.83 390.73 316.031 10.346 40.070 
t35tod 15 853.90 1027.90 952.127 14.773 57.217 
t35toa 15 6.91 399.84 312.151 24.090 93.301 
t35coc 15 251.90 380.58 304.557 9.930 38.460 
t35cod 15 1164.80 1217.00 1195.407 3.911 15.147 
t35coa 15 208.48 326.24 254.944 8.685 33.637 
t35cth 15 4.31 6.44 5.345 .153 .5914 
t35peri 15 58.81 70.88 64.504 1.002 3.880 
t35endo 15 24.93 37.30 30.920 1.037 4.0175 
Valid N (listwise) 15      
a. gender = women, decade = 20s 
168 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 15 274.22 433.87 350.057 11.339 43.914 
t45tod 15 843.40 1017.40 939.620 14.287 55.335 
t45toa 15 304.16 459.20 373.568 11.955 46.302 
t45coc 15 257.84 432.99 337.153 11.782 45.634 
t45cod 15 1153.50 1205.60 1184.287 4.110 15.919 
t45coa 15 217.44 375.36 284.992 10.585 40.997 
t45cth 15 4.54 6.92 5.611 .174 .673 
t45peri 15 61.82 75.96 68.396 1.085 4.201 
t45endo 15 26.49 39.12 32.989 .985 3.815 
t55toc 15 298.33 450.44 365.105 11.660 45.160 
t55tod 15 772.70 963.10 874.747 14.285 55.325 
t55toa 15 355.52 516.80 417.803 12.790 49.536 
t55coc 15 278.37 434.04 349.260 11.481 44.467 
t55cod 15 1135.50 1197.30 1175.180 4.416 17.102 
t55coa 15 235.04 382.24 297.525 10.486 40.611 
t55cth 15 4.32 6.28 5.359 .158 .611 
t55peri 15 66.84 80.59 72.344 1.089 4.217 
t55endo 15 30.58 44.59 38.675 1.058 4.099 
t65toc 15 300.11 430.45 365.647 11.507 44.566 
t65tod 15 668.00 840.70 759.720 16.081 62.280 
t65toa 15 375.02 599.84 470.292 14.812 57.368 
t65coc 15 268.22 402.92 338.833 10.628 41.161 
t65cod 15 1124.40 1180.90 1160.647 4.164 16.127 
t65coa 15 231.20 355.84 292.160 9.659 37.410 
t65cth 15 3.65 5.34 4.626 .135 .524 
t65peri 15 71.83 86.82 77.732 1.117 4.326 
t65endo 15 40.21 56.11 48.667 1.192 4.618 
t75toc 15 298.88 438.79 370.693 11.790 45.663 
t75tod 15 477.70 687.80 587.527 17.002 65.850 
t75toa 15 528.80 797.28 633.621 18.030 69.828 
t75coc 15 244.02 379.41 310.077 9.447 36.589 
t75cod 15 1080.20 1142.20 1118.907 4.160 16.113 
t75coa 15 218.08 345.92 277.365 8.979 34.776 
t75cth 15 2.78 4.32 3.567 .113 .438 
t75peri 15 81.52 100.10 89.110 1.247 4.831 
t75endo 15 56.81 77.90 66.699 1.415 5.482 
Valid N (listwise) 15      
a. gender = women, decade = 20s 
 
169 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 15 312.94 514.13 416.265 16.793 65.038 
t85tod 15 299.20 492.10 398.667 14.329 55.495 
t85toa 15 908.64 1285.60 1045.621 25.311 98.028 
t85trc 15 82.33 368.96 183.602 22.356 86.584 
t85trd 15 107.00 936.20 380.053 87.448 338.685 
t85tra 15 279.52 932.96 708.699 36.443 141.142 
t85coc 15 151.63 308.30 235.755 10.094 39.095 
t85cod 15 968.00 1060.20 1033.627 6.584 25.500 
t85coa 15 156.64 295.68 227.787 9.321 36.102 
t85cth 15 1.42 2.65 2.123 .083 .321 
t85peri 15 106.30 126.60 113.968 1.364 5.282 
t85endo 15 92.15 112.84 100.626 1.380 5.344 
t15imax 15 6631.74 12608.47 9701.024 542.583 2101.413 
t15imin 15 6268.81 11520.77 8331.675 411.348 1593.145 
t15irat 15 1.01 1.41 1.165 .036 .138 
t15ssi 15 1090.73 1653.76 1371.950 50.941 197.294 
t15bsi 15 3.52E10 7.74E10 5.855E10 3.778E9 1.463E10 
t15bsitoatod2 15 88110430.23 1.79E8 1.474E8 7.422E6 2.875E7 
t15ssitoc 15 4.71 6.49 5.720 .124 .481 
t25imax 15 5887.02 15221.84 9528.402 672.930 2606.247 
t25imin 15 3912.05 10230.35 6714.798 401.995 1556.921 
t25irat 15 1.01 2.26 1.458 .103 .401 
t25ssi 15 966.16 1641.35 1272.689 56.734 219.728 
t25ssitoc 15 3.76 5.39 4.665 .110 .427 
t35imax 15 7683.47 19769.17 12010.856 846.637 3279.011 
t35imin 15 4009.09 12332.12 7165.312 555.134 2150.026 
t35irat 15 1.03 3.24 1.804 .152 .590 
t35ssi 15 1062.92 1770.99 1372.528 61.343 237.580 
t35ssitoc 15 3.84 4.85 4.325 .074 .286 
t45imax 15 9487.45 23566.75 15219.099 1005.871 3895.722 
t45imin 15 4784.17 14469.80 9081.812 682.022 2641.461 
t45irat 15 1.08 3.56 1.763 .151 .586 
t45ssi 15 1126.80 2152.98 1571.827 72.400 280.404 
t45ssitoc 15 3.92 4.99 4.471 .088 .341 
Valid N 
(listwise) 
15 
     
a. gender = women, decade = 20s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 15 11657.16 27418.01 17686.172 1268.448 4912.676 
t55imin 15 6541.04 16434.30 11680.639 701.089 2715.308 
t55irat 15 1.07 2.92 1.551 .117 .454 
t55ssi 15 1364.09 2471.08 1799.108 84.116 325.780 
t55ssitoc 15 4.30 5.52 4.904 .094 .366 
t65imax 15 14917.31 32037.84 21525.483 1341.699 5196.377 
t65imin 15 8847.70 21612.28 14552.304 896.152 3470.782 
t65irat 15 1.12 2.35 1.510 .087 .337 
t65ssi 15 1747.32 2715.33 2109.493 89.975 348.473 
t65ssitoc 15 5.05 6.58 5.753 .106 .409 
t75imax 15 20337.19 46943.78 29707.012 2058.480 7972.457 
t75imin 15 12354.40 30377.65 19770.402 1051.043 4070.670 
t75irat 15 1.01 2.26 1.532 .105 .405 
t75ssi 15 1999.84 3255.22 2529.265 105.714 409.427 
t75ssitoc 15 5.89 7.70 6.808 .128 .496 
t85imax 15 31963.56 69898.09 47229.940 3072.061 11898.0425 
t85imin 15 20745.61 44878.13 28188.023 1768.563 6849.617 
t85irat 15 1.11 2.23 1.697 .082 .317 
t85ssi 15 2328.62 4480.10 3163.260 172.296 667.298 
t85ssitoc 15 6.25 8.91 7.577 .206 .796 
toc515r 15 1.06 1.31 1.195 .023 .090 
toc535r 15 .73 1.14 .911 .027 .106 
toc585r 15 .54 .88 .696 .023 .089 
toc565r 15 .65 .97 .787 .023 .087 
tcsa65 15 7377.28 14818.40 10302.197 562.211 2177.433 
fcsa65 15 929.12 4817.28 2788.043 282.179 1092.876 
mcsa65 15 4917.60 9708.32 6988.608 327.531 1268.522 
Valid N 
(listwise) 
15 
     
a. gender = women, decade = 20s 
 
 
 
 
 
 
 
 
171 
 
gender = women, decade = 30s 
Descriptive Statistics
a
 
 
N Minimum Maximum Mean 
Std. 
Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 14 212.80 375.60 272.991 12.330 46.134 
t5tod 14 272.00 387.60 311.036 8.528 31.910 
t5toa 14 684.48 3956.00 1103.017 221.075 827.187 
t5trc 14 72.61 762.92 215.278 44.272 165.649 
t5trd 14 211.40 756.80 356.336 56.447 211.207 
t5tra 14 567.52 3608.48 965.703 204.740 766.065 
t15toc 14 203.33 294.73 234.221 8.314 31.110 
t15tod 14 498.10 650.00 583.579 13.476 50.424 
t15toa 14 316.80 481.60 402.674 13.583 50.821 
t15trc 14 23.62 187.65 53.555 15.284 57.187 
t15trd 14 99.30 1162.40 282.764 98.768 369.557 
t15tra 14 153.92 289.28 219.726 10.345 38.708 
t15coc 14 172.77 247.28 195.784 6.642 24.852 
t15cod 14 1136.10 1196.60 1167.207 4.931 18.449 
t15coa 14 147.36 215.36 167.749 5.669 21.213 
t15cth 14 2.31 3.23 2.683 .0768 .287 
t15peri 14 63.10 77.79 71.002 1.204 4.506 
t15endo 14 45.26 62.00 54.145 1.254 4.690 
t25toc 14 228.73 360.50 275.128 10.316 38.560 
t25tod 14 745.50 965.80 851.621 18.586 69.541 
t25toa 14 263.20 382.24 323.337 10.163 38.028 
t25coc 14 216.79 349.56 261.071 10.280 38.466 
t25cod 14 1173.10 1236.40 1208.479 5.293 19.806 
t25coa 14 177.28 282.72 216.057 8.448 31.608 
t25cth 14 3.52 5.53 4.315 .149 .558 
t25peri 14 57.51 69.31 63.641 1.002 3.747 
t25endo 14 29.57 41.82 36.259 .995 3.724 
t35toc 14 265.12 438.98 323.279 12.442 46.554 
t35tod 14 859.10 1078.30 950.986 16.625 62.206 
t35toa 14 277.44 437.44 340.091 11.718 43.846 
t35coc 14 250.45 426.52 310.061 12.633 47.270 
t35cod 14 1176.30 1232.60 1203.379 5.489 20.538 
t35coa 14 204.00 348.32 257.669 10.372 38.809 
t35cth 14 4.31 6.47 5.300 .176 .658 
t35peri 14 59.05 74.14 65.251 1.111 4.156 
t35endo 14 23.77 36.68 31.957 1.072 4.010 
Valid N (listwise) 14      
a. gender = women, decade = 30s 
172 
 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 14 293.57 484.16 359.689 13.541 50.666 
t45tod 14 872.20 1079.20 936.793 14.853 55.574 
t45toa 14 324.48 511.84 384.194 13.662 51.118 
t45coc 14 275.26 468.99 341.501 13.733 51.389 
t45cod 14 1150.80 1223.70 1185.107 6.156 23.032 
t45coa 14 227.20 387.04 288.171 11.399 42.650 
t45cth 14 4.55 6.69 5.545 .175 .655 
t45peri 14 63.86 80.20 69.347 1.204 4.507 
t45endo 14 24.60 68.99 36.822 2.704 10.11819 
t55toc 14 316.50 501.71 370.334 14.243 53.291 
t55tod 14 797.20 983.30 866.900 12.832 48.011 
t55toa 14 351.84 569.76 427.497 15.677 58.657 
t55coc 14 295.58 485.52 351.131 14.385 53.825 
t55cod 14 1142.00 1213.90 1175.600 6.283 23.506 
t55coa 14 245.76 400.96 298.526 11.673 43.676 
t55cth 14 4.51 6.14 5.261 .142 .535 
t55peri 14 66.49 84.62 73.141 1.314 4.917 
t55endo 14 33.04 46.06 40.084 1.036 3.878 
t65toc 14 301.42 479.68 373.374 14.163 52.991 
t65tod 14 668.40 859.20 747.679 16.803 62.872 
t65toa 14 406.24 712.16 502.423 22.361 83.669 
t65coc 14 274.07 448.01 343.171 13.685 51.204 
t65cod 14 1126.60 1195.60 1157.914 5.832 21.821 
t65coa 14 231.20 379.20 296.269 11.449 42.837 
t65cth 14 3.78 5.46 4.567 .132 .493 
t65peri 14 71.45 94.60 79.219 1.709 6.393 
t65endo 14 41.56 64.69 50.522 1.704 6.377 
t75toc 14 310.07 445.65 364.806 12.558 46.989 
t75tod 14 465.10 640.90 565.014 16.467 61.613 
t75toa 14 500.80 936.16 654.983 34.072 127.487 
t75coc 14 258.02 375.98 305.739 10.238 38.306 
t75cod 14 1078.00 1159.50 1119.864 6.434 24.074 
t75coa 14 223.68 335.52 272.971 8.842 33.083 
t75cth 14 2.84 4.11 3.447 .098 .368 
t75peri 14 79.33 108.46 90.351 2.278 8.525 
t75endo 14 56.24 87.63 68.691 2.513 9.402 
Valid N (listwise) 14      
a. gender = women, decade = 30s 
 
173 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 14 317.54 489.45 393.892 15.238 57.016 
t85tod 14 297.30 446.80 361.714 11.831 44.266 
t85toa 14 839.20 1429.60 1098.937 48.381 181.025 
t85trc 14 73.19 264.90 150.827 17.017 63.673 
t85trd 14 96.30 986.30 316.129 86.470 323.543 
t85tra 14 593.44 1130.40 804.063 45.658 170.836 
t85coc 14 183.09 311.45 230.992 10.015 37.473 
t85cod 14 965.50 1081.80 1031.764 9.518 35.615 
t85coa 14 177.28 296.48 223.520 8.757 32.765 
t85cth 14 1.64 2.74 2.071 .090 .337 
t85peri 14 101.56 129.10 114.981 1.917 7.177 
t85endo 14 87.83 117.19 101.972 2.172 8.127 
t15imax 14 6565.02 13593.37 9707.443 596.708 2232.676 
t15imin 14 5819.77 12160.20 8441.939 527.430 1973.461 
t15irat 14 1.01 1.33 1.155 .027 .102 
t15ssi 14 1062.82 1726.81 1378.835 58.265 218.007 
t15bsi 14 4.13E10 8.69E10 5.576E10 4.106E9 1.536E10 
t15bsitoatod2 14 1.03E8 1.89E8 1.372E8 6.850E6 2.563E7 
t15ssitoc 14 5.14 6.67 5.877 .105 .393 
t25imax 14 6536.18 13191.02 9297.870 535.776 2004.692 
t25imin 14 4282.03 10448.11 7117.377 544.112 2035.880 
t25irat 14 1.03 1.77 1.349 .068 .256 
t25ssi 14 997.99 1738.25 1322.049 61.214 229.042 
t25ssitoc 14 4.06 5.26 4.796 .101 .380 
t35imax 14 8149.29 18939.10 11718.633 706.678 2644.145 
t35imin 14 4226.74 13464.30 7897.258 812.311 3039.390 
t35irat 14 1.00 2.46 1.625 .135 .506 
t35ssi 14 1080.30 2127.39 1434.547 72.232 270.269 
t35ssitoc 14 3.77 4.85 4.422 .086 .323 
t45imax 14 9820.15 25684.02 15179.587 1018.625 3811.346 
t45imin 14 6353.86 17503.88 9973.924 866.673 3242.794 
t45irat 14 1.18 1.96 1.572 .076 .285 
t45ssi 14 1280.20 2626.39 1643.748 92.375 345.636 
t45ssitoc 14 3.96 5.42 4.544 .104 .388 
Valid N 
(listwise) 
14 
     
a. gender = women, decade = 30s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 14 11380.30 31579.58 17815.924 1407.339 5265.780 
t55imin 14 8445.41 20561.71 12613.265 924.102 3457.670 
t55irat 14 1.09 2.23 1.429 .075 .282 
t55ssi 14 1408.03 2964.87 1873.156 105.426 394.468 
t55ssitoc 14 4.39 5.91 5.024 .098 .368 
t65imax 14 14400.95 41914.92 22248.204 1976.192 7394.232 
t65imin 14 10305.46 26272.24 16233.000 1308.285 4895.153 
t65irat 14 1.02 2.24 1.403 .097 .364 
t65ssi 14 1629.44 3684.13 2207.998 142.976 534.967 
t65ssitoc 14 4.89 7.68 5.862 .182 .680 
t75imax 14 19528.55 51428.13 29713.006 2364.854 8848.475 
t75imin 14 14534.34 36456.53 21877.959 1944.736 7276.534 
t75irat 14 1.04 1.79 1.390 .060 .225 
t75ssi 14 1902.57 3694.85 2581.529 145.145 543.084 
t75ssitoc 14 5.93 8.29 7.021 .180 .674 
t85imax 14 32211.41 57226.90 45604.141 2385.494 8925.701 
t85imin 14 19043.37 51937.27 32966.147 2587.574 9681.813 
t85irat 14 1.02 2.23 1.456 .099 .369 
t85ssi 14 2498.22 4137.63 3273.479 140.619 526.148 
t85ssitoc 14 7.35 9.34 8.305 .133 .499 
toc515r 14 1.05 1.27 1.162 .018 .067 
toc535r 14 .70 1.00 .845 .021 .080 
toc585r 14 .63 .77 .692 .011 .040 
toc565r 14 .61 .84 .731 .018 .067 
tcsa65 14 7878.08 15632.16 10669.909 562.356 2104.143 
fcsa65 14 1075.04 5936.64 3095.223 344.788 1290.080 
mcsa65 14 5667.04 9036.32 6996.743 282.130 1055.632 
Valid N 
(listwise) 
14 
     
a. gender = women, decade = 30s 
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Gender = women, Decade = 40s 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 227.57 328.00 272.445 6.692 25.919 
t5tod 15 273.00 363.20 316.087 7.028 27.218 
t5toa 15 753.92 1015.84 864.768 20.885 80.887 
t5trc 15 76.58 205.15 176.174 8.314 32.199 
t5trd 15 221.20 699.80 279.787 30.714 118.956 
t5tra 15 671.68 889.12 747.008 18.870 73.083 
t15toc 15 119.61 288.89 224.921 9.899 38.340 
t15tod 15 404.30 655.00 561.647 15.087 58.430 
t15toa 15 295.84 464.64 398.453 11.381 44.079 
t15trc 15 16.03 199.30 42.195 11.477 44.448 
t15trd 15 80.80 1088.80 203.533 64.022 247.955 
t15tra 15 177.44 257.28 222.069 6.229 24.125 
t15coc 15 59.57 242.16 183.213 10.453 40.483 
t15cod 15 917.00 1194.20 1141.727 17.094 66.205 
t15coa 15 64.96 204.16 159.243 8.339 32.297 
t15cth 15 1.13 3.11 2.531 .123 .476 
t15peri 15 60.98 76.41 70.656 1.034 4.003 
t15endo 15 49.47 58.86 54.751 .778 3.015 
t25toc 15 218.98 323.27 273.946 7.526 29.150 
t25tod 15 739.80 932.60 821.220 12.789 49.532 
t25toa 15 279.52 384.00 334.005 8.795 34.064 
t25coc 15 205.12 303.19 255.532 7.183 27.821 
t25cod 15 1140.60 1235.50 1193.873 7.113 27.547 
t25coa 15 173.28 259.36 214.240 6.408 24.817 
t25cth 15 3.62 4.76 4.143 .103 .398 
t25peri 15 59.27 69.47 64.707 .857 3.317 
t25endo 15 32.49 45.55 38.678 .805 3.117 
t35toc 15 249.49 365.89 320.151 8.415 32.592 
t35tod 15 840.20 1019.80 932.007 12.824 49.666 
t35toa 15 280.00 404.80 343.915 9.024 34.951 
t35coc 15 236.09 352.73 306.827 8.461 32.768 
t35cod 15 1142.50 1240.10 1193.053 7.274 28.172 
t35coa 15 202.56 299.84 257.419 7.607 29.460 
t35cth 15 4.24 5.91 5.222 .122 .471 
t35peri 15 59.32 71.32 65.660 .867 3.356 
t35endo 15 26.49 37.70 32.848 .753 2.916 
Valid N (listwise) 15      
a. gender = women, decade = 40s 
176 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 15 272.31 405.69 352.337 10.175 39.406 
t45tod 15 803.00 977.70 922.247 12.485 48.352 
t45toa 15 313.92 445.76 382.283 10.556 40.884 
t45coc 15 257.87 390.91 336.057 10.107 39.146 
t45cod 15 1131.10 1231.50 1183.653 7.309 28.308 
t45coa 15 220.48 345.60 284.352 9.443 36.573 
t45cth 15 4.37 6.27 5.450 .142 .551 
t45peri 15 62.81 74.84 69.217 .959 3.715 
t45endo 15 30.90 41.39 34.973 .733 2.838 
t55toc 15 274.43 426.57 362.899 10.967 42.477 
t55tod 15 746.00 946.60 855.720 14.058 54.447 
t55toa 15 344.48 494.72 424.245 11.387 44.103 
t55coc 15 251.87 408.94 343.795 10.949 42.404 
t55cod 15 1125.90 1233.80 1171.927 7.547 29.229 
t55coa 15 218.08 347.68 293.707 9.942 38.504 
t55cth 15 4.04 5.80 5.177 .144 .558 
t55peri 15 65.79 78.85 72.922 .987 3.822 
t55endo 15 34.56 45.75 40.462 .789 3.054 
t65toc 15 293.43 421.99 363.054 9.398 36.399 
t65tod 15 619.40 928.50 748.787 22.246 86.160 
t65toa 15 135.04 581.28 466.933 27.195 105.324 
t65coc 15 261.38 381.81 334.560 9.256 35.848 
t65cod 15 1101.20 1201.10 1155.813 7.665 29.688 
t65coa 15 232.64 346.72 289.611 8.245 31.933 
t65cth 15 3.59 6.10 4.564 .1698 .658 
t65peri 15 72.30 85.47 78.209 1.083 4.196 
t65endo 15 34.09 60.33 49.530 1.701 6.590 
t75toc 15 301.63 410.96 359.537 8.668 33.572 
t75tod 15 459.50 721.90 558.760 21.692 84.013 
t75toa 15 517.12 840.48 652.501 22.496 87.126 
t75coc 15 247.72 360.26 300.927 8.587 33.256 
t75cod 15 1057.00 1160.20 1114.927 7.930 30.712 
t75coa 15 215.68 327.20 270.091 7.940 30.752 
t75cth 15 2.74 4.81 3.430 .153 .593 
t75peri 15 80.61 102.77 90.365 1.552 6.012 
t75endo 15 52.89 83.82 68.813 2.242 8.683 
Valid N (listwise) 15      
a. gender = women, decade = 40s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 15 302.76 446.73 377.359 10.938 42.364 
t85tod 15 270.40 470.00 343.707 14.556 56.376 
t85toa 15 812.00 1629.28 1119.861 51.635 199.980 
t85trc 15 81.16 203.22 119.722 9.413 36.458 
t85trd 15 107.20 183.30 145.520 6.683 25.884 
t85tra 15 502.40 1117.12 818.165 41.983 162.600 
t85coc 15 111.76 277.71 216.069 11.938 46.235 
t85cod 15 898.70 1157.80 1030.967 16.434 63.647 
t85coa 15 120.80 257.12 208.096 9.626 37.281 
t85cth 15 1.43 2.89 2.028 .113 .438 
t85peri 15 83.70 124.26 110.175 3.182 12.324 
t85endo 15 65.53 113.26 97.435 3.503 13.567 
t15imax 15 7074.95 13299.84 9960.475 490.032 1897.885 
t15imin 15 6299.50 13006.81 8670.790 491.508 1903.603 
t15irat 15 1.02 1.32 1.158 .027 .106 
t15ssi 15 1118.55 1888.55 1321.522 50.682 196.290 
t15bsi 15 1.43E10 8.34E10 5.196E10 4.091E9 1.584E10 
t15bsitoatod2 15 48357559.68 1.80E8 1.281E8 7.953E6 3.080E7 
t15ssitoc 15 5.35 9.35 5.978 .254 .985 
t25imax 15 5988.95 12918.46 9525.097 505.461 1957.641 
t25imin 15 5363.71 9817.63 7301.765 365.021 1413.720 
t25irat 15 1.08 1.59 1.312 .045 .175 
t25ssi 15 1007.23 1670.13 1331.198 50.905 197.155 
t25ssitoc 15 4.46 5.34 4.842 .071 .275 
t35imax 15 7594.70 17755.34 12139.957 741.135 2870.404 
t35imin 15 5399.22 10096.35 7832.132 380.468 1473.548 
t35irat 15 1.14 1.99 1.558 .071 .273 
t35ssi 15 1104.28 1719.11 1431.042 49.829 192.988 
t35ssitoc 15 4.11 4.78 4.459 .054 .209 
t45imax 15 8409.89 22967.42 14974.589 1017.457 3940.593 
t45imin 15 6559.44 14260.04 10175.442 610.128 2363.017 
t45irat 15 1.02 2.26 1.501 .093 .360 
t45ssi 15 1149.96 2071.00 1627.368 65.649 254.258 
t45ssitoc 15 4.15 5.10 4.601 .072 .281 
Valid N 
(listwise) 
15 
     
a. gender = women, decade = 40s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 15 9972.83 23568.81 17512.671 973.843 3771.678 
t55imin 15 7856.40 17610.33 12523.006 826.946 3202.748 
t55irat 15 1.08 2.49 1.448 .099 .385 
t55ssi 15 1267.84 2389.71 1838.111 75.951 294.156 
t55ssitoc 15 4.55 5.60 5.050 .079 .306 
t65imax 15 15029.08 29121.72 21722.264 1108.741 4294.134 
t65imin 15 9599.38 22013.99 14504.053 944.081 3656.410 
t65irat 15 1.08 2.29 1.553 .095 .366 
t65ssi 15 1702.48 2708.90 2131.692 77.933 301.833 
t65ssitoc 15 4.68 6.84 5.871 .141 .545 
t75imax 15 20634.44 42991.67 30320.136 1807.312 6999.688 
t75imin 15 11363.82 25988.75 19748.777 1168.827 4526.848 
t75irat 15 1.05 2.84 1.613 .138 .534 
t75ssi 15 2038.00 3119.37 2581.371 86.428 334.736 
t75ssitoc 15 5.94 8.08 7.178 .155 .602 
t85imax 15 28163.37 62681.32 46479.991 2396.694 9282.354 
t85imin 15 19356.21 34690.06 28265.798 1136.992 4403.550 
t85irat 15 1.03 2.58 1.677 .104 .404 
t85ssi 15 2431.33 3561.90 3041.365 91.634 354.897 
t85ssitoc 15 6.50 8.83 8.080 .164 .637 
toc515r 15 .94 2.45 1.257 .089 .345 
toc535r 15 .72 1.01 .855 .021 .081 
toc585r 15 .63 .81 .725 .014 .053 
toc565r 15 .63 .86 .753 .016 .061 
tcsa65 15 7601.28 19048.16 12353.771 809.790 3136.302 
fcsa65 15 1097.60 9609.12 4172.597 585.053 2265.901 
mcsa65 15 6013.28 9718.40 7609.707 291.796 1130.120 
Valid N 
(listwise) 
15 
     
a. gender = women, decade = 40s 
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Gender = women, Decade = 50s 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t5toc 15 202.56 332.09 262.357 10.793 41.803 
t5tod 15 233.40 376.50 298.107 10.095 39.098 
t5toa 15 556.00 1089.92 865.195 34.479 133.537 
t5trc 15 27.68 262.86 182.423 15.473 59.928 
t5trd 15 94.20 294.10 234.853 12.971 50.237 
t5tra 15 293.91 1009.76 753.525 43.906 170.048 
t15toc 15 169.11 254.62 221.823 6.700 25.949 
t15tod 15 446.40 675.30 551.953 16.954 65.662 
t15toa 15 354.72 469.28 403.285 9.096 35.227 
t15trc 15 17.37 49.04 31.942 2.955 11.444 
t15trd 15 89.10 212.00 138.187 9.267 35.891 
t15tra 15 166.08 282.56 227.307 9.636 37.319 
t15coc 15 127.50 217.09 179.007 6.530 25.291 
t15cod 15 1063.90 1199.60 1133.087 9.351 36.218 
t15coa 15 114.16 185.76 155.621 5.682 22.004 
t15cth 15 1.92 3.16 2.505 .099 .382 
t15peri 15 66.77 76.79 71.126 .800 3.099 
t15endo 15 48.00 61.40 55.384 1.187 4.598 
t25toc 15 200.96 290.92 256.064 7.281 28.198 
t25tod 15 672.00 984.40 786.700 20.479 79.316 
t25toa 15 288.32 375.68 326.347 7.914 30.653 
t25coc 15 183.10 276.23 237.463 7.294 28.248 
t25cod 15 1126.30 1244.60 1179.727 8.390 32.493 
t25coa 15 155.20 229.60 201.141 5.688 22.030 
t25cth 15 2.99 5.01 3.903 .127 .490 
t25peri 15 60.19 68.71 63.974 .772 2.991 
t25endo 15 29.03 47.20 39.247 1.130 4.375 
t35toc 15 231.37 346.44 292.517 9.055 35.070 
t35tod 15 806.10 986.50 896.253 14.213 55.046 
t35toa 15 284.16 393.12 333.653 9.329 36.130 
t35coc 15 225.16 326.83 283.627 7.971 30.871 
t35cod 15 1120.40 1243.10 1181.540 8.680 33.619 
t35coa 15 200.96 280.64 239.925 6.287 24.348 
t35cth 15 4.19 5.37 4.860 .104 .405 
t35peri 15 59.76 70.29 64.665 .899 3.483 
t35endo 15 28.32 43.13 34.131 .959 3.716 
Valid N (listwise) 15      
a. gender = women, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t45toc 15 263.72 382.71 336.045 8.584 33.245 
t45tod 15 795.80 992.30 901.767 16.571 64.179 
t45toa 15 317.12 444.00 373.835 10.573 40.950 
t45coc 15 246.93 371.55 319.019 8.671 33.584 
t45cod 15 1099.20 1228.90 1172.333 9.213 35.680 
t45coa 15 220.96 313.12 271.925 6.610 25.602 
t45cth 15 4.39 5.97 5.241 .115 .447 
t45peri 15 39.38 74.70 66.444 2.161 8.370 
t45endo 15 27.82 44.25 35.515 1.175 4.551 
t55toc 15 270.80 390.70 346.219 9.410 36.445 
t55tod 15 715.90 911.10 825.733 15.079 58.401 
t55toa 15 349.60 498.88 420.256 11.619 45.002 
t55coc 15 251.15 372.62 325.471 9.340 36.175 
t55cod 15 1093.10 1210.40 1158.993 9.173 35.528 
t55coa 15 229.76 318.24 280.512 7.001 27.113 
t55cth 15 4.12 5.69 4.914 .106 .409 
t55peri 15 66.28 79.18 72.574 1.007 3.899 
t55endo 15 36.15 50.47 41.701 1.106 4.282 
t65toc 15 275.69 427.35 354.943 10.625 41.150 
t65tod 15 608.60 816.30 720.393 13.985 54.164 
t65toa 15 401.28 574.72 493.589 13.718 53.130 
t65coc 15 243.43 397.65 323.332 10.156 39.335 
t65cod 15 1071.50 1197.30 1141.653 8.771 33.972 
t65coa 15 227.20 340.16 282.987 8.138 31.518 
t65cth 15 3.53 5.27 4.359 .110 .425 
t65peri 15 71.01 84.98 78.649 1.104 4.274 
t65endo 15 43.40 60.24 51.262 1.157 4.481 
t75toc 15 261.93 395.67 340.715 11.211 43.420 
t75tod 15 445.90 641.20 533.100 11.979 46.393 
t75toa 15 520.16 764.16 640.309 19.429 75.249 
t75coc 15 210.30 336.48 280.900 9.559 37.023 
t75cod 15 1042.30 1160.80 1108.413 8.609 33.342 
t75coa 15 194.08 293.76 253.163 7.807 30.236 
t75cth 15 2.58 3.93 3.184 .089 .343 
t75peri 15 80.85 97.99 89.558 1.355 5.249 
t75endo 15 62.73 77.54 69.757 1.327 5.138 
Valid N (listwise) 15      
a. gender = women, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t85toc 15 271.60 426.89 355.958 12.642 48.962 
t85tod 15 272.50 459.80 344.900 12.617 48.864 
t85toa 15 897.92 1201.76 1037.056 30.167 116.831 
t85trc 15 75.45 148.00 107.212 6.808 26.367 
t85trd 15 111.00 198.60 138.847 6.875 26.628 
t85tra 15 623.04 911.52 770.827 28.154 109.040 
t85coc 15 146.57 290.05 210.999 11.846 45.879 
t85cod 15 976.60 1082.90 1039.193 7.640 29.591 
t85coa 15 150.08 267.84 202.325 10.259 39.733 
t85cth 15 1.43 2.72 1.961 .095 .369 
t85peri 15 96.83 121.17 109.327 1.744 6.753 
t85endo 15 86.11 109.17 97.006 1.734 6.716 
t15imax 15 6400.69 11488.08 8979.191 360.446 1396.002 
t15imin 15 5577.83 10493.21 7989.473 320.387 1240.853 
t15irat 15 1.01 1.33 1.127 .023 .091 
t15ssi 15 954.17 1533.83 1289.679 41.872 162.168 
t15bsi 15 2.86E10 6.48E10 4.983E10 2.880E9 1.115E10 
t15bsitoatod2 15 76635206.35 1.68E8 1.236E8 6.658E6 2.5786E7 
t15ssitoc 15 5.13 6.48 5.817 .083 .321 
t25imax 15 6382.94 11681.99 8871.374 385.175 1491.777 
t25imin 15 4388.35 9217.47 6728.978 391.478 1516.187 
t25irat 15 1.00 1.85 1.354 .064 .246 
t25ssi 15 992.03 1544.09 1280.263 43.684 169.187 
t25ssitoc 15 4.13 5.50 5.002 .098 .378 
t35imax 15 7754.34 13912.47 10880.868 482.694 1869.466 
t35imin 15 4252.04 11315.12 7270.563 580.262 2247.345 
t35irat 15 1.03 2.19 1.596 .107 .414 
t35ssi 15 1061.07 1640.83 1354.413 50.708 196.390 
t35ssitoc 15 4.15 5.96 4.635 .117 .451 
t45imax 15 9065.61 18486.49 13984.372 715.842 2772.445 
t45imin 15 5393.02 13574.00 9296.122 605.399 2344.701 
t45irat 15 1.10 2.16 1.561 .093 .359 
t45ssi 15 1174.19 1797.79 1546.852 58.098 225.014 
t45ssitoc 15 4.05 5.14 4.589 .085 .330 
Valid N (listwise) 15      
a. gender = women, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
t55imax 15 10049.35 23850.48 16648.720 1014.971 3930.966 
t55imin 15 6537.24 16671.86 11793.023 712.918 2761.121 
t55irat 15 1.03 2.29 1.465 .109 .421 
t55ssi 15 1274.60 2084.40 1771.119 70.490 273.005 
t55ssitoc 15 4.32 5.75 5.097 .102 .392 
t65imax 15 13107.47 27718.32 21203.217 1169.928 4531.113 
t65imin 15 8306.73 21431.84 15243.628 1050.245 4067.599 
t65irat 15 1.07 2.42 1.459 .109 .422 
t65ssi 15 1581.27 2521.44 2105.020 84.672 327.934 
t65ssitoc 15 5.08 6.60 5.911 .103 .398 
t75imax 15 15578.51 35834.47 25923.957 1385.655 5366.620 
t75imin 15 11688.38 30237.95 20676.431 1442.642 5587.327 
t75irat 15 1.03 1.98 1.299 .076 .293 
t75ssi 15 1721.89 3054.51 2408.285 104.377 404.249 
t75ssitoc 15 6.41 7.77 7.042 .116 .448 
t85imax 15 24864.92 48157.96 39413.477 1612.822 6246.435 
t85imin 15 17557.96 46089.88 28456.121 1975.240 7650.071 
t85irat 15 1.04 2.05 1.440 .075 .292 
t85ssi 15 1991.57 3962.37 2857.820 140.563 544.396 
t85ssitoc 15 7.06 9.70 7.989 .176 .681 
toc515r 15 .95 1.33 1.183 .030 .116 
toc535r 15 .68 1.42 .906 .044 .172 
toc585r 15 .61 .87 .739 .020 .077 
toc565r 15 .61 .89 .740 .021 .081 
tcsa65 15 7737.76 14365.92 10628.725 548.903 2125.893 
fcsa65 15 1296.48 5571.68 3080.181 305.706 1183.992 
mcsa65 15 5201.44 9924.32 7011.157 341.366 1322.106 
Valid N (listwise) 15      
a. gender = women, decade = 50s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
total abmd g/cm2 30 1.030 1.511 1.253 .017 .095 
total bmc kg 30 2.03 4.34 3.080 .093 .509 
l1-l4 spine abmd 30 1.078 1.435 1.269 .017 .096 
l1-l4 spine bmc g 30 49.08 102.85 75.089 2.222 12.171 
left total hip abmd g/cm2 30 .825 1.623 1.165 .030 .165 
left total hip bmc g 30 22.90 56.72 38.131 1.401 7.673 
lnekabmd 30 .86 1.71 1.171 .031 .172 
lnekbmc 30 3.59 9.24 5.841 .209 1.142 
ltroabmd 30 .62 1.34 .942 .029 .156 
ltrobmc 30 6.01 18.55 12.133 .602 3.298 
Valid N (listwise) 30      
a. decade = 20s 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
total abmd g/cm2 29 1.084 1.474 1.239 .018 .097 
total bmc kg 29 1.91 4.35 3.075 .104 .558 
l1-l4 spine abmd 29 .997 1.528 1.254 .028 .151 
l1-l4 spine bmc g 29 53.99 99.97 70.850 2.020 10.875 
left total hip abmd g/cm2 29 .834 1.465 1.067 .02669 .1434 
left total hip bmc g 29 24.86 53.27 35.662 1.287 6.932 
lnekabmd 29 .80 1.43 1.056 .028 .151 
lnekbmc 29 3.69 7.93 5.357 .189 1.019 
ltroabmd 29 .64 1.26 .854 .024 .132 
ltrobmc 29 6.47 19.70 11.356 .604 3.252 
Valid N (listwise) 29      
a. decade = 30s 
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Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
total abmd g/cm2 25 1.096 1.510 1.245 .021 .106 
total bmc kg 25 2.14 4.59 3.025 .115 .575 
l1-l4 spine abmd 25 1.025 1.569 1.257 .029 .147 
l1-l4 spine bmc g 25 44.22 113.40 71.685 2.924 14.619 
left total hip abmd g/cm2 25 .890 1.301 1.070 .025 .127 
left total hip bmc g 25 25.02 54.46 36.196 1.459 7.294 
lnekabmd 25 .81 1.23 1.026 .023 .117 
lnekbmc 25 3.77 7.85 5.253 .196 .978 
ltroabmd 25 .65 1.18 .878 .028 .139 
ltrobmc 25 6.51 22.03 11.838 .739 3.695 
Valid N (listwise) 25      
a. decade = 40s 
 
Descriptive Statistics
a
 
 N Minimum Maximum Mean Std. Deviation 
 Statistic Statistic Statistic Statistic Std. Error Statistic 
total abmd g/cm2 30 1.004 1.363 1.1982 .0165 .091 
total bmc kg 30 1.82 4.14 2.932 .106 .579 
l1-l4 spine abmd 30 .917 1.504 1.200 .026 .142 
l1-l4 spine bmc g 30 48.44 103.26 71.220 2.497 13.674 
left total hip abmd g/cm2 30 .789 1.212 .998 .020 .111 
left total hip bmc g 30 23.16 46.52 33.622 1.101 6.031 
lnekabmd 30 .78 1.16 .957 .018 .097 
lnekbmc 30 3.78 6.23 4.869 .137 .748 
ltroabmd 30 .63 1.06 .818 .021 .112 
ltrobmc 30 6.80 19.06 10.969 .567 3.106 
Valid N (listwise) 30      
a. decade = 50s 
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Appendix E 
Raw Data Set 
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